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Abstract 
With the advent of DGHAL and PPH, treatments that purport to work by disrupting 
the arterial supply of haemorrhoids, there has been resurgence in interest in the 
vascular theory of pathogenesis of haemorrhoids. Despite uncertainty surrounding 
recurrence and complication rates there has been significant uptake of the new 
surgical approach due to decreased post-operative pain. However this has not 
been matched by discussion or evaluation of how haemorrhoidal disease and 
successful outcome should be evaluated. 
This thesis evaluates different approaches to the measurement of the burden of 
haemorrhoidal disease to the patient. A patient reported outcome measure was 
designed, administered and evaluated by the investigator. Reliability, 
reproducibility, validity, responsiveness and acceptability have been demonstrated. 
Three-dimensional ultrasound was used to acquire volumetric data and power 
Doppler angiography from the anal canal, which was shown to be reliable. 
Measures of power Doppler angiography were shown to be significantly lower in 
healthy volunteers than in patients. This technique represents promising value as 
an outcome measure of haemorrhoidal disease. 
A dual isotope-surgical nuclear probe technique attempted to measure change in 
volume of haemorrhoids following rubber band ligation, however consistent results 
were not obtained. Magnetic resonance imaging was able to demonstrate anal 
cushions and haemorrhoids, and the feasibility of this method has been 
demonstrated. 
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1 BACKGROUND & HYPOTHESES 
1.1 INTRODUCTION 
The word "haemorrhoid" is derived from the Greek: haima - blood and 
rhoos - flowing. The word "pile" is derived from the Latin pi/a, meaning a pill 
or ball. Humans have complained of haemorrhoids since at least biblical 
times [1], the anatomy of which has only recently been fully described [2]. 
The evidence for the aetiology and pathogenesis is surprisingly sparse, 
especially in light of increased interest in the surgical treatment of 
haemorrhoids. The basis for current treatments of haemorrhoids remains 
unclear. 
The anatomy and pathophysiology of both anal cushions and 
haemorrhoids will be discussed. Aetiological factors and postulated theories 
of pathogenesis are examined, with particular reference made to the newest 
form of treatment, stapled anopexy or procedure for prolapsing 
haemorrhoids (PPH) and Doppler guided haemorrhoidal artery ligation 
(DGHAL). 
1.2 ANATOMY OF THE ANAL CUSHIONS 
The anal canal has a triradiate lumen lined by an irregular layer of 
fibrovascular tissue. This layer is usually grouped into three anal cushions, 
which are normal structures, formed early on in embryonic life [3]. They 
usually occur in the left lateral, right anterior and right posterior positions, 
and are further subdivided by the columns of Morgagni. The cushions and 
the columns of Morgagni give the tissue above the dentate line a pleated 
appearance as the rectum narrows into the anal canal. The exact 
arrangement of anal cushions often does not follow the textbook 
~ r r a n g e m e n t t at 3,7 and 11 o'clock; Thomson reported 19 per cent of normal 
subjects with this configuration [2]. 
Anal cushions have three main components: mucosa; stroma 
containing blood vessels, smooth muscle and supporting connective tissue; 
and the anchoring smooth m ~ s c l e e fibre network. Beneath the mucosal layer 
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of the anal canal, there is a dense network of blood vessels. Miles' [4] 
description of a constant branching pattern of the superior rectal artery, two 
right and one left, which correspond to the spatial distribution of the anal 
cushions is discordant with many other descriptions [5, 6]. Following the 
publication of Thomson's seminal anatomical work, this description of anal 
arterial supply has been dismissed as erroneous [7]. 
The blood supply of the anal canal is derived from branches of the 
superior, middle and inferior rectal arteries. There is a significant variation 
between individuals in the contribution and branching pattern of each artery. 
In a study of fifty adult cadavers [2] Thomson demonstrated an average of 
five (0 - 8) branches of the superior rectal artery reaching the haemorrhoidal 
zone. There were substantial contributions from the middle rectal artery and 
inferior rectal artery in 76 and 42 per cent of cases respectively. It is 
interesting to note that branches of the middle rectal artery pierce the rectal 
wall anteriorly, whereas branches of the superior rectal artery do so 
posteriorly and laterally [8]. 
The anal submucosal venous plexus is characterised by discrete 
sacculations on the course of veins confined to the lower half of the anal 
canal, in greater quantity above than below the dentate line. Sections of vein 
of normal calibre interconnect these sacculations. They are normal 
structures, found in infants, adolescents and adults [2], although their 
presence was clearly felt to be the cause of haemorrhoids for nearly a 
century [8, 9]. 
Free communications both inferior and through the internal anal 
sphincter (lAS) have been demonstrated between the superior, middle and 
inferior rectal veins. Direct arteriovenous communications have been 
demonstrated histologically [10], radiologically [11] and with latex-injected 
preparations [2]. The anal canal venous system is more profuse than 
required for normal tissue nutrition and oxygenation [7], and the blood 
oxygen tension is arterial [12]. As suggested by several 19th century authors 
and Stelzner et al [10], anal submucosa may have an erectile property, akin 
to ~ a v e r n o u s s tissue, calling it corpus cavernosum recti. The arteriovenous 
communications may function to allow changes in the size of the cushions 
depending on whether the anal canal is closed or open. This stimulated the 
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theory that haemorrhoids may result from hyperplasia of the corpus 
cavernosum recti. 
A network of smooth muscle fibres arises partly from the internal anal 
sphincter and partly, by passing through the fasciculi of the lAS, from the 
conjoined longitudinal muscle. The whole component has been called 
Treitz's muscle, the muscularis submucosae ani, sustentator tunicae 
mucosae, corrugator cutis ani or the mucosal suspensory ligament. It is 
distributed around the haemorrhoidal venous plexus, into the perianal skin 
and back into the longitudinal muscle by passing around the lower border of 
the internal sphincter. Oblique bundles of lAS smooth muscle run alongside 
connective tissue and elastic fibres (fig 1-1). 
MusculariS 
mucosae - - - H ~ o I I ' J J
Treltz's ~ - . ~ ~
muscle 
Figure 1·1 Composite diagram of Treltz's muscle. 
The cushions drain via veins that pass through the circular muscle layer continuous 
witn the lAS and the conjoined longitudinal muscle. Reproduced from WHF 
Thoms<:>n's The Nature of Haemorrhoids [2], John Wiley and Sons. 
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Histological studies have shown that with increasing age, the 
supportive tissue contains an increased proportion of collagen fibres that are 
fragmented and disorganised. These changes are seen from the third 
decade of life, and seem to be a part of normal ageing [13]. One of 
Thomson's most important conclusions was that anal cushions are normal 
structures, and that haemorrhoids are symptomatic anal cushions that have 
undergone the degenerative process of ageing. 
1.3 FUNCTION OF ANAL CUSHIONS 
It has been demonstrated that the lAS cannot fully close the anal 
canal; the addition of both mucosal folds and venous filling is required. 
Calculation of tension within the lAS during distension confirms that 
complete closure of the anal canal is not possible by the lAS alone [14-16]. 
Based on pressure measurements in patients who underwent 
abdominoperineal resection, both pre-operatively and in the excised anal 
canal, vascular filling may contribute fifteen to twenty per cent of resting anal 
pressure [17]. Anal cushions are likely to act as a compliant plug to the anal 
canal; haemorrhoidectomy is known to reduce continence to infused saline 
[18]. 
The way in which the anal cushions empty prior to defaecation is not 
known. Active mechanisms include anal dilatation by formed stool, reducing 
the height of the cushions, and action of the muscularis submucosae 
displacing the anal c u s h i o n ~ . . Fibres of the proximal anal canal elevate the 
cushions, and the arching arrangement of the fibres is likely to cause venous 
compression [7]. Distally there may be eversion of the lAS causing 
compression of the vascular spaces. Thus there is an outward rotation of the 
vascular tissue, as the lAS relaxes during defaecation (see figs 1-2 and 1-3). 
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Figure 1-2 The effect of lAS relaxation. 
There is an outward rotation of the vascular tissue and the pecten band. 
Reproduced from Keighley, M.R.B., Surgery of the anus, rectum & colon. 3rd ed 
2008, Philadelphia: Saunders Elsevier. 
Rotet.oo 
01 a')al 
canal.baok to 
normal potUtion 
Figure 1-3 The effect of normal defaecation on the anal cushions. 
Reproduced from Keighley, M.R.B., Surgery of the anus, rectum & colon. 3rd ed 
2008, Philadelphia: Saunders Elsevier. 
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1.4 ANATOMY OF HAEMORRHOIDS 
Anatomical assessment of haemorrhoids compared with normal anal 
cushions is difficult as by definition they only differ in size and symptoms. 
Haemorrhoidectomy specimens will not represent the full spectrum of 
haemorrhoidal disease, as surgery is reserved for patients with persistent 
and marked symptoms associated with significant size and prolapse. 
Histological studies of haemorrhoidectomy specimens show squamous 
metaplasia of the mucosa, probably secondary to prolapse of the 
haemorrhoids. Chronic inflammatory changes of the stroma and blood 
vessels associated with mucosal ulceration, ischaemia and thrombosis may 
also be seen [12, 13]. Disordered, fragmented subepithelial smooth muscle 
has also been demonstrated in anal cushions during autopsy examination of 
older patients [13, 19]. 
Fibrosis of the lAS has been observed more frequently in patients with 
haemorrhoidal symptoms, than in autopsy specimens of patients without 
known haemorrhoidal disease. The amount of fibrosis was unrelated to 
manometry, haemorrhoid size or duration of symptoms [20]. The increased 
fibrosis in the lAS was felt to be unrelated to ageing because the mean age 
of the controls was greater than that of the haemorrhoid group. It was 
postulated that the fibrosis occurs as a result of longstanding venous 
congestion or repeated traction on the muscularis submucosae. 
1.5 PHYSIOLOGICAL STUDIES OF THE ANAL CANAL 
Despite differing methods, most studies comparing age and sex-
matched controls to patients with symptomatic haemorrhoids have shown a 
high maximum resting anal pressure in patients with haemorrhoids [21-27]. 
Prolapsing haemorrhoids are associated with lower resting pressures than 
non-prolapsing haemorrhoids [28-30]. 
Hancock [28] concluded that the abnormally high anal pressures are 
caused by increased tonic activity of both the internal and external 
sphincters. Such activity may impair venous drainage leading to vascular 
distension of the anal cushions. This increased tonic activity is abolished by 
J 
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anal dilatation with associated relief of symptoms, and therefore Hancock 
postulated that a sphincter abnormality is related to the development of 
symptoms in patients with haemorrhoids. 
Direct pressure measurements in anal cushions of patients with 
haemorrhoids were significantly higher than in age-matched controls [31, 
32]. Endoanal ultrasonographic imaging of the anal canal showed no 
significant difference in the thickness of the internal sphincter between 
patients with haemorrhoids and age-matched controls. Sun et aI., [31] 
therefore suggested that the high anal pressure in patients with 
haemorrhoids is due to hypertensive anal cushions rather than a hypertonic 
internal anal sphincter. 
However there is no test available to directly measure the pressure of 
the internal sphincter, and therefore it is possible that increased activity of 
the internal anal sphincter contributes to the pathogenesis of haemorrhoids. 
Arabi et aI., [22] proposed that there were two quite different groups of 
haemorrhoidal patients, based on anal pressure measurements. Only young 
male patients with non-prolapsing haemorrhoids had significantly higher anal 
pressures than age and sex-matched controls. The other group of patients 
were mostly multiparous females with prolapsing haemorrhoids and a lax 
anal canal. 
In the anal physiology chapter of the excellent book, The Haemorrhoid 
Syndrome [8], there is a tantalisingly brief mention of an unpublished study 
where local blood flow was assessed using 133Xenon. It was injected 
submucosally over the anal cushions and attempts were made to follow the 
clearance of the radionuclide. It was not clear where or how measurements 
were made, but Hancock states that no difference was found between a 
small group of controls and patients with haemorrhoids. Adrenaline was 
applied topically to the anal cushions, which reduced clearance time of the 
radionuclide, implying arteriolar vasoconstriction. Unfortunately 
reproducibility of the technique was poor and no further details of the study 
are available. 
, One other group examined the effect of vasoconstrictors on the local 
blood flow of the anal canal. Thulesius and Gjores [12] attempted to change 
the an'al flow by using topical ,and sUbcutaneous administration of adrenaline 
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and a vasoactive polypeptide, ornithine-vasopressin. Blood flow was 
examined using a thermal conductivity probe [33]. There was a drop (per 
cent of resting level) in the anal canal blood flow following administration of 
topical and submucosal adrenaline and topical ornithine-vasopressin, in 
comparison to a minor increase following submucosal sodium chloride, 
althou'gh there was no analysis of the statistical significance. 
1.6 PATHOGENESIS OF HAEMORRHOIDS 
1.6.1 Venous Obstruction 
Based on the available anatomical and physiological studies, it has 
been postulated that venous congestion of the anal cushions is the 
underlying pathological process for haemorrhoidal symptoms. The cushions 
congest due to failure of emptying during defaecation, the cushions are 
abnormally mobile, and the cushions may be trapped by a tight lAS. Free 
venous drainage has been demonstrated through and around the anorectal 
muscle layers [2]; it has been suggested that impacted faeces in the rectum 
will compress the veins and impede venous emptying. The act of straining 
increases intra-abdominal pressure, compressing the submucosal venous 
plexus, which in turn prevents rapid empting of the cushions. 
Other causes of raised intra-abdominal pressure including pregnancy, 
ascites, and pelvic tumour as well as raised portal venous pressure have 
been postulated as causative factors [34, 35]. 
Pregnancy seems to predispose to haemorrhoids [7] and may cause 
haemorrhoids in three ways. The increased levels of progesterone may relax 
the submucosal smooth muscle and soften the elastic fibres, which supports 
the anal cushions. The increased pelvic vascularity may affect the anal 
cushions, rendering them even more vascular. Women are more likely to 
s ~ f f e r r from constipation during pregnancy, possibly relating to recommended 
iron supplementation. 
In the past when haemorrhoids were considered to be varicosities of 
the' haemorrhoidal veins, one of the most quoted causes was increased 
venous pressure due to portal hypertension. There are no valves in the 
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portal venous system, which in conjunction with the erect position of the 
human adult should lead one to expect a higher frequency of enlarged, 
congested haemorrhoids in patients with portal hypertension. 
In 1958, Hunt [36] reported that all patients with portal hypertension 
underwent sigmoidoscopy without the discovery of any haemorrhoidal 
disease. Jacobs et al. studied the clinical records of 188 patients with portal 
hypertension at their institution. They found an incidence of 27.6% of 
symptomatic internal haemorrhoids, as documented by history and 
examination. The authors and their contemporaries [37] did not consider this 
to represent a significant difference from the normal population. 
A prospective study of 100 patients [38] with cirrhosis showed that the 
prevalence of anorectal varices increased with the presence of portal 
hypertension. Haemorrhoids occurred independently of anorectal varices 
and their presence was unrelated to the degree of portal hypertension. 
A prospective study [39] of 60 children with portal hypertension showed 
a significant incidence of haemorrhoids (33%), anorectal varices (35%) and 
external anal varices (15%). Children with extrahepatic disease had a higher 
incidence of both haemorrhoids and anorectal varices. Interestingly only four 
children (7%) complained of anorectal symptoms, and all were easily 
managed with conservative therapies. 
1.6.2 Prolapse of Anal Cushions 
Based on the observation of fragmentation of connective tissue from 
200 haemorrhoidectomy specimens, Gass and Adams [40] proposed that 
haemorrhoids were associated with a lax anus. Thomson [2] suggested that 
the degeneration of the anchoring smooth muscle leads to distal 
displacement of the anal cushions, making them more vulnerable to the 
shearing forces of the passage of hard stools. Straining causes an increase 
in venous pressure, leading to impaired venous return and stasis of blood 
within the haemorrhoidal zone. It has been demonstrated that stasis 
activates white cells to release inflammatory mediators. Inflammation leads 
to ircreased permeability, fragility and necrosis of the vessel wall and 
consequent bleeding. Further impediment of externally prolapsed 
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haemorrhoids by the anal sphincter leads to thrombosis. This theory 
proposed in 1975 is now widely accepted. 
1.6.3 Alternative Theories of Pathogenesis 
1.6.3.1 The Varicose Vein Theory 
This theory was based on the observation of the discrete sacculations 
of the anal submucosal plexus, which was thought to be pathological prior to 
anatomical studies of infants [41]. The development of these sacculations 
was explained by increased local venous pressure or by a localised 
weakness in the vein wall [42]. It appeared to explain the increased 
frequency of symptoms during pregnancy, as well as constipation and 
straining as aetiological factors. The absence of valves in the portosystemic 
anastomoses of the anal canal also seemed to give validity to the venous 
pressure theory. 
1.6.3.2 The Vascular Hyperplasia Theory 
The anal submucosal tissue is likened to cavernous tissue and called 
corpus cavernosum recti, indicating that the tissue might have erectile 
properties. It has been suggested that haemorrhoids occurred as a result of 
hyperplasia of the corpus cavernosum recti [43]. This appeared to explain its 
function as part of the anal continence mechanism. 
1.7 AETIOLOGY OF HAEMORRHOIDS 
The true prevalence of haemorrhoids is not known; hospital-based 
studies are not representative, community-based studies rely on self-
reporting and inaccuracies arise because patients and some doctors 
attribute any anorectal symptom to haemorrhoids. This has led to reported 
prevalence rates of 4.4% amongst adults in the United States [44], 36.4% of 
patients based at a London general practice [45], and 86% of new patients 
attending a colorectal surgical clinic [46]. These estimates mayor may not 
be accurate; factors such as self-reporting, and any anorectal symptom 
being attributed to haemorrhoids by patients or medical practitioners [47] will 
lead to" inaccuracy. 
There is a general increase in prevalence with age until the seventh 
decade, which is equal between the sexes. Men account for approximately 
60 % of hospitalised patients with haemorrhoids [22, 48, 49]. In many cases, 
women present during pregnancy and after childbirth [7]. In the general 
population the prevalence of haemorrhoids is equal between the genders 
[44,45,48], but women have been found to be more symptomatic on 
proctoscopic examination [46], and are more likely to have been 
symptomatic of longer duration [45]. High oestrogen receptor levels have 
been identified in haemorrhoids [50], which may explain haemorrhoidal 
symptoms during pregnancy. 
It has been stated that haemorrhoids are uncommon in rural Africa in 
contrast to urban Africa and developed countries. The low prevalence was 
accounted for by a higher fibre intake; however it could also be related to 
poor availability and acceptance of medical care. There is an increased 
prevalence amongst higher socioeconomic groups, but this may reflect 
health-seeking behaviour [34]. 
Despite the widely-held beliefs that inadequate fibre intake, prolonged 
sitting on the toilet and straining lead to the development of symptomatic 
haemorrhoids, there is little evidence to support this. Fibre -intake and the 
prevalence of haemorrhoids are not associated. There has not been an 
overall increase in fibre intake amongst Western populations [51] despite a 
fall in the prevalence of haemorrhoids [48]. If there is an association 
between lower incidence of haemorrhoids and rural society, other factors 
such as squatting position for defaecation, and lack of social restraint with 
regards to timing and location of defaecation may be just as important as 
dietary factors [52]. 
Positive family history is often recorded and treatment for 
haemorrhoids is more common in the medical history of parents of 
haemorrhoid patients, however this is just as likely to be related to dietary, 
cultural or behavioural factors as genetic factors [7]. 
Unfortunately there is little in the way of evidence with regard to 
defaecation habits. Anecdotally, the haemorrhoid patient will be one that sits 
for a longer duration on the lavatory, and may be obsessed by the necessity 
to open their bowels on a daily basis. Despite the lack of evidence, this 
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theory forms the basis for conservative management of haemorrhoidal 
disease [52]. 
Haemorrhoid sufferers report more constipation [35], lower stool 
frequency [35] and more straining [27, 28], however researchers have 
demonstrated normal bowel frequency in their study populations [45]. Indeed 
haemorrhoids may be the cause of a sense of constipation as a result of 
pain or mechanical impedance. The concept of constipation requires 
qualification as the patient's interpretation may relate to infrequent bowel 
movement, hard stools, which require straining to evacuate or a sensation of 
incomplete emptying. A history of constipation has been found to follow 
rather than precede that of haemorrhoids, with resolution of constipation with 
the onset of prolapse of haemorrhoids, suggesting that haemorrhoids are a 
cause of constipation. 
Further doubt on the causal relationship between constipation and 
haemorrhoids occurs following review of epidemiological data [44]. 
Population-based surveys demonstrated an increasing prevalence of 
constipation from the age of 65 years, and constipation was more common 
in blacks and families of lower socioeconomic status. This is a significantly 
different pattern to the haemorrhoid population, where there is peak 
prevalence in the age range 45 - 65 years, with a subsequent decline after 
the age of 65 years. Haemorrhoidal disease was a more common complaint 
in whites of higher socioeconomic status. 
1.8 NEW METHODS OF TREATING HAEMORRHOIDS 
1.8.1 Doppler-guided haemorrhoidal artery ligation 
First described in 1995 [53], DGHAL uses a specially adapted 
proctoscope with an incorporated Doppler probe. The branches of the 
superior rectal artery that feed the haemorrhoidal zone are located by the 
change in the Doppler signal. A "figure of eight" suture is placed in the 
submucosa to ligate each branch. DGHAL interrupts arterial inflow and 
tethers the mucosa, causing the haemorrhoids to shrink and retract. 
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The only randomised controlled trial comparing closed 
haemorrhoidectomy to DGHAL [S4] assessed analgesic requirement, length 
of post-operative stay, and time taken to return to normal activity all of which 
were lower in the DGHAL group (p < O. 01). Recurrence of symptoms was 
similar in both groups at 11.7±4.6 months follow-up. 
1.8.2 Procedure for Prolapsing Haemorrhoids 
Longo first described this alternative approach in 1998 [SS]. It is also 
known as circular stapled anopexy, and stapled haemorrhoidopexy. It has 
become increasingly popular for the treatment of third and fourth-degree 
haemorrhoids. A modified circular stapling device, similar to those used for 
low rectal anastomosis, is used to excise a ring of redundant rectal mucosa 
3 - 4 cm above the dentate line and proximal to the haemorrhoids 
themselves. The aim is to re-suspend the haemorrhoidal cushions back 
within the anal canal and interrupt the arterial inflow traversing the excised 
segment. 
Complications of PPH include rare cases of severe retroperitoneal and 
pelvic sepsis, rectal perforation and rectovaginal fistula [S6-S8]. Following 
these reports it has been emphasised that care must be taken with the depth 
of the purse-string suture, to avoid injury to the muscle of the rectal wall and 
the introduction of bacteria into the perirectal tissues. 
In a meta-analysis of fifteen trials including 1077 patients, qualitative 
analysis showed that PPH is less painful compared with standard 
haemorrhoidectomy [S9]. It also showed a shorter inpatient stay, operative 
time, and return to normal activity. The same meta-analysis demonstrated 
significantly worse recurrence rates after PPH. In one of the included trials 
[60], at a mean of 1S.9 months follow-up, recurrence rates were 11.8% after 
PPH compared to 0% after haemorrhoidectomy for third-degree 
haemorrhoids, and SO% compared to 0% for fourth-degree haemorrhoids. 
Further randomised controlled trials with longer follow-up are awaited before 
a consensus is agreed upon. 
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1.9 PHARMACOLOGICAL THERAPIES 
Micronised purified flavonoid fraction (MPFF) (Daflon®) is a 
phlebotropic drug, consists of 90% diosmin and 10% f1avonoids expressed 
as hesperidin. It is believed to improve venous tone and lymphatic drainage. 
It reduqes the expression of some endothelial adhesion molecules, thus 
inhibiting the activation, migration and adhesion of leukocytes. This leads to 
a reduction in the release of inflammatory mediators and consequent 
reduction in capillary hyperpermeability [61]. 
Three randomised double-blinded placebo-controlled trials have 
investigated the efficacy of flavonoid drugs during an acute episode of 
haemorrhoids, each of which have demonstrated statistically significant 
reduction in duration and severity of symptoms [62] , and apparently 
appeared to prevent relapse of bleeding [63]. 
1.10 EXPERIMENTAL ANIMAL MODELS 
Three different research groups have reported their experience with 
animal models of haemorrhoidal disease. Myers and Donovan [64] 
examined porcine rectums, following the induction of cryolesions with a 
liquid nitrogen probe. Post-mortem angiograms were performed between 
one hour and fourteen days following induction of the cryolesions. 
Submucosal vessels at one hour demonstrated marked distortion and hardly 
any contrast opacification. Submucosal vessels regained patency in lesions 
of less than 24 hours duration, but after 24 hours there was complete 
necrosis of the mucosa without any affect on the underlying muscle fibres. 
Zmora et al. [65] used a porcine model to examine the possibility of 
performing PPH on two occasions safely. Concern about potentially reduced 
blood perfusion to the ring of mucosa and submucosa between the two 
staple lines was the main reason for performing the study. Interestingly 
mucosal blood perfusion was assessed using a Laser Doppler Blood 
Perfusion Monitor, prior to, immediately after the second PPH procedure and 
one'month after the two PPH procedures. 
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At one month after application, the mean mucosal blood perfusion 
between the staple lines did not differ significantly from the mean perfusion 
outside that area. 
Mucosal blood perfusion of the distal anorectum was decreased in 
comparison to higher rectal segments. This phenomenon was found both in 
baseline measurements before the application of the first PPH suture line 
and after application of the second. 
There was a statistically significant decrease in blood perfusion in the 
ring between the staple lines compared to the proximal rectum when 
measured immediately after the procedure (p = 0.012, unpaired t-test). This 
trend was identified in baseline measurements before the application of any 
sutures, and the authors attributed these findings to the effect of the 
anoscope in the anal canal rather than the stapler. 
All flow measurements taken at one month after PPH were higher than 
those measured immediately after PPH. The authors cited calibration of the 
monitor and application of a different pressure on the tissue as possible 
causes for the differences found. 
Plapler [66] examined the effect of ligating the inferior haemorrhoidal 
vein in a group of Cebus apella monkeys. Histological study by the 
investigator had previously demonstrated similarity of the anal venous 
drainage in the monkey to that in humans, although this work was not 
published. The intention was to create hemorrhoids by reducing venous 
return from the perineal region. The induced haemorrhoids were noted to 
appear in 50% of the monkeys around the ninth post-operative day, and 
disappeared within two to three weeks. 
It is difficult to assess the value of this study, as no description of the 
morphological appearance of the pre-procedural anorectum is made. The 
apparent haemorrhoid was not examined histologically to assess the 
vasculature of the anorectum. No reference is made to Thomson's work, and 
the underlying principle that haemorrhoids are essentially enlarged, 
symptomatic anal cushions. The investigator acknowledged that the cause 
of haemorrhoids must be multi-factorial and ligation of the inferior 
haemorrhoidal vein (a term no longer used and presumably the inferior 
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rectal vein was ligated) is not a full explanation for the appearance of 
haemorrhoids. 
1.11 DISCUSSION AND HYPOTHESES 
In-summary, although there is a vast amount of literature published on 
haemorrhoidal disease particularly in the last decade, since the advent of 
PPH, recent experimental work on the underlying aetiology and 
pathogenesis is surprisingly sparse. Thomson's anatomical work 
represented a great advance at the time of publication, and is likely to be 
partly responsible for the advent of PPH some twenty years later. 
Anal cushions are normal structures, found in infants and adults. There 
is a complex pattern of arterial supply to the anorectum with a varying 
involvement of the superior, middle and inferior rectal arteries depending on 
the individual. Direct arteriovenous communications in the anal submucosa 
have been confirmed by a variety of methods; it has been postulated that 
these serve an erectile purpose to enable the anal cushions to form a 
compliant plug to the anal canal. The submucosal venous plexus, 
characterised by discrete sacculations, is sited within the cushions, and are 
part of the normal anatomy. 
Thomson's work confirmed that the varicose vein theory for the 
formation of haemorrhoids is invalid. The vascular hyperplasia theory made 
a resurgence in 1963 [10], albeit acknowledging that the vascular spaces 
represented a normal part of the anatomy, the corpus cavernosum recti. 
Thomson rejects this theory fc.;>r several reasons. First histological 
examination of haemorrhoidectomy specimens showed no evidence of 
hyperplasia. Second the haemorrhoids were noted to have a red granular 
mucosa due to a rich network of dilated capillaries in the lamina propria; 
bleeding from these vessels was clearly identified on some of the sections. 
Therefore the classical bleeding of haemorrhoids was deemed to originate 
from these superficial capillaries rather than the larger vascular spaces 
separated from the mucosa by connective tissue and the muscularis 
, 
mucosae. 
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Finally the results from a verbal survey on the order of occurrence of 
haemorrhoidal symptoms gave rise to the notion that bleeding was probably 
a secondary symptom to prolapse. This conclusion was based on the results 
from 80 consecutive patients admitted to hospital for surgical treatment, who 
were asked which of their symptoms started first. Thomson reports the 
results of 66 of these patients, of whom 60% reported prolapse, and 12% 
bleeding as their first symptom. Unfortunately it is unclear how the other 
patients are unaccounted for. The study suffers from recall bias, as well as 
the fact that only patients attending for surgery were included in this survey. 
These patients were likely to suffer from more advanced prolapsing disease, 
and therefore recall of other earlier symptoms could have been reduced. 
Having rejected the varicose vein and vascular hyperplasia theories, 
Thomson elaborates on the sliding anal lining theory. His findings confirm 
that anal cushions are normal structures, specialized highly vascular 
structures that contribute to the anal continence mechanism. The normal 
ageing process leading to degeneration of the supporting muscularis 
submucosae in conjunction with hard, bulky stools and an irregular bowel 
habit will cause prolapse of the cushions. Straining will lead to engorgement 
of the cushions making prolapse more likely. Prolapse will further impede 
venous drainage. 
The anatomy of the cushions has been thoroughly studied, however 
the physiological processes underlying the size and change of size of 
cushions or haemorrhoids has not been fully examined. Although Thomson 
states that prolapse is usually the first symptom of haemorrhoids, bleeding 
without prolapse from first-degree haemorrhoids is an accepted 
phenomenon [52], and it is possible that venous obstruction may playa 
greater role in the early stages of haemorrhoid development and symptoms. 
There is clinical evidence from newly developed techniques [53, 55] 
that by disrupting the blood flow in the haemorrhoidal arteries using circular 
stapling devices or suture ligation a reduction in haemorrhoidal volume and 
an improvement in symptoms occurs. However, these techniques are 
invasive, often require general anaesthesia and there is concern regarding 
the long":'term recurrence rate and the risk of incontinence associated with 
the use of circular stapling devices. It is possible that topical 
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pharmacological agents may have a less invasive role in the treatment of 
haemorrhoids by causing vasoconstriction of these arteries and symptomatic 
improvement. Before pharmacological therapies can even be considered, 
investigation of the possible vascular aetiology is required. Furthermore 
objective assessment methods are required if true efficacy of treatment is to 
be proven. A detailed review of current methods of assessment is presented 
in chapter 2. 
The overall aim of the work described in this thesis is to develop 
objective measures of the severity of haemorrhoidal disease and their 
response to treatment, with a view to future evaluation of pharmacological 
therapies for early stage haemorrhoidal disease. 
A secondary aim is to examine the hypothesis that there is a role for 
abnormal vascularity in the development of haemorrhoids. The following 
specific objectives will be addressed: 
• Develop and validate an index, which measures the symptoms of 
haemorrhoidal disease, thereby quantifying the effect of treatment on 
the symptoms of haemorrhoidal disease. (Chapter 2) 
• Investigate imaging-techniques that will allow semi-quantification of 
haemorrhoidal vascularity. 
• The techniques to be investigated are: 
o Three-dimensional ultrasound and Doppler imaging (Chapter 3) 
o Nuclear medicine investigations (Chapter 4) 
o Magnetic resonance imaging (Chapter 5) 
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2 HAEMORRHOID PATIENT REPORTED OUTCOME 
MEASURE 
2.1 INTRODUCTION 
The aim of this thesis is to enable the colorectal surgeon and 
researcher to assess haemorrhoidal disease objectively - investigating the 
measurement of new parameters that may change after treatment of 
haemorrhoids. A significant part of this work focuses on various radiological 
techniques, and their potential use in quantifying the burden of 
haemorrhoidal disease and the effect of treatment, however this thesis 
would be incomplete without a more conventional approach to assessment 
of haemorrhoidal disease using symptoms. 
Disease is defined as a specific illness or disorder characterized by a 
recognizable set of signs and symptoms attributable to heredity, infection, 
diet, or environment [67]. The World Health Organization defines health as a 
state of complete physical, mental and social well-being, and not merely the 
absence of disease or infirmity [68]. Measuring physiological parameters 
alone gives an incomplete picture of health when we are attempting to 
measure the effectiveness of an intervention. 
A literature search undertaken in January 2005 showed that although 
there is considerable interest in and debate on the merits of new surgical 
i n t e r v e n t i o n ~ . . for haemorrhoids, very little has been published on how 
haemorrhoidal disease is assessed or what denotes successful outcome. 
There are two areas of the literature review that are pertinent to how 
surgeons currently gauge successful treatment of haemorrhoids. First the 
literature published on the stapled haemorrhoidopexy operation, and 
second, a review of available classification systems for haemorrhoids. The 
latter should enable the surgeon to assess the severity of haemorrhoids, 
naturally leading to the appropriate choice of management. 
19 
2.1.1 Procedure for Prolapsing Haemorrhoids 
As this is one of the newer treatment options available with wide 
uptake across Europe and America, it was important to review the literature; 
new methods of assessing outcome may have been introduced. 
The literature review of the stapled haemorrhoidopexy studies show 
that although there is great enthusiasm for this operation, there is an 
absence of standardized outcome measures. There is extensive variation in 
the choice of outcome measures, and the timing of assessment (see tables 
2-1 and 2-2). There is still considerable debate about the long-term 
recurrence rates, as well as its suitability to fourth-degree haemorrhoids. 
This situation could be resolved by the use of an instrument using patient 
reported outcome measures. 
2.1.2 Classification Systems 
Classification of haemorrhoids should allow the surgeon to assess the 
severity and the potential impact on the patient. It should also direct the 
surgeon to the most appropriate treatment for the patient. It is also a tool to 
aid objective assessment of new treatments. 
The most commonly used classification, described by Goligher [69], 
divides haemorrhoids into four grades. First-degree haemorrhoids project 
slightly into the lumen of the anal canal when the veins are congested during 
defaecation. Second-degree haemorrhoids form larger swellings that 
protrude int'? the anal canal and descend towards the anal orifice, and may 
appear externally during straining but will return spontaneously after 
defaecation. Third-degree haemorrhoids-protrude during defaecation and 
require digital replacement. Fourth-degree haemorrhoids. are irreducible. 
This classification is purely anatomical and does not take into account the 
symptoms that are associated with haemorrhoids such as bleeding, pruritus, 
soiling and pain. 
Examination of the anal canal shows the mucosa and submucosa 
above the dentate line to be uneven and arranged into folds, the so-called 
anal cushions. Sensation of pain in the anal canal can only be attributable to 
pathologies residing below the dentate line, and therefore pain in most 
instances should not be attributable to internal haemorrhoids. The 
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discomfort associated with grade I haemorrhoids is usually associated with 
anal hypertonicity [70]. The discomfort associated with grade III 
haemorrhoids is variable, ranging from a dragging sensation to severe 
proctalgia, and probably arises from sources in the wall of the anal canal 
and pelvic floor. Pain suffered by patients with grade IV haemorrhoids 
usually relates to secondary complications such as thrombosis or ulceration. 
Thomson et al. [71] proposed a modification of Goligher's 
classification, linking symptoms to the increasing stages of severity. Stage 1 
is the same as Goligher's grade I, the symptoms of which are bleeding. 
Stage 2 haemorrhoids prolapse with bowel movements and reduce 
spontaneously. Symptoms include bleeding and prolapse. Stage 3 
haemorrhoids are divided into minor and major categories. Minor stage 3 
haemorrhoids prolapse with bowel movements and require manual 
reduction, and symptoms include bleeding, prolapse, discharge, discomfort 
and pruritus. Major stage 3 haemorrhoids prolapse at times other then bowel 
movements, necessitating frequent attempts to replace the haemorrhoids. 
Minor stage 4 haemorrhoids are prolapsed and cannot be replaced, and 
symptoms include pain as well as the others previously mentioned. Major 
stage 4 haemorrhoids are thrombosed internal and external haemorrhoids, 
leading to severe pain and sometimes necrosis and ulceration. 
Following the introduction of the stapled anopexy technique by Longo 
[72] in 1998, there has been a deluge of publications surrounding this 
technique. U.nfortunately this has not been mirrored by consistent 
stratification of results by classification of haemorrhoids (see table 2-1 and 
2-2). 
In a discussion paper Lunniss and Mann [70] proposed a modification 
of previously published classifications, based on morphology, that is to say 
the size and degree of prolapse. Stage 0 refers to anal cushions that may 
bleed rarely and do not prolapse. Stage 1 refers to small haemorrhoids that 
bleed intermittently. A minor definite increase in size is visualized during 
proctoscopy. Stage 2 refers to intermediate haemorrhoids that bleed 
frequently, sometimes profusely, and also prolapse on defaecation but 
return to their original position spontaneously. The individual haemorrhoids 
are described as being moderately increased in size. Stage 3 refers to large 
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haemorrhoids that bleed frequently and often profusely. They prolapse and 
require aid to reduce them. Proctoscopy confirms a major increase in size, 
sometimes circumferential. Stage 4 haemorrhoids are permanently 
prolapsed and irreducible. They are described as bleeding profusely, with an 
extreme increase in size, also associated with haemorrhoids in secondary 
positions. 
By linking the degree of bleeding and prolapse, size and possible 
additional features to haemorrhoidal development, the authors proposed that 
all haemorrhoids could be placed in one of the stages, therefore allowing 
accurate comparison of treatments. Additional features mentioned are 
pruritus, discomfort, skin tags, pain as a result of thrombosis or other 
complications, and soiling. 
Although the authors state that an increase in size cannot be 
accurately measured, they state that recognizable affects i.e. degree of 
prolapse are sufficiently associated with size to classify haemorrhoids into 
separate groups. However it is well known that size may also be affected by 
day-to-day variation, including pre- and post-defaecation. Manipulation with 
a proctoscope can cause the haemorrhoids to engorge significantly [52]. 
The authors aim to have the classification based on the natural history 
of haemorrhoidal disease, as far as it is known. Normally on defaecation, the 
anal cushions are flattened and held against the internal anal sphincter by 
the submucosal smooth muscle fibres. Bright red bleeding arises from 
damaged capillaries in the lamina propria indicating displacement of the 
more lax and friable mucosa, such that it becomes pinched between the 
passing stool and the dentate line. This constitutes first-degree or stage I 
haemorrhoids. 
Prolapse occurs as a result of further and prolonged stresses at 
defaecation and sitting with an unsupported perineum. Excessive straining 
causes engorgement of the cushions so that they swell into the lumen of the 
relaxed anal canal, where they are then subject to the shearing effect of 
passing stool. Depending on the extent of tissue stretching and 
fragmentation, the cushions will demonstrate a varying degree of prolapse. 
Nevertheless this classification system suffers the same inherent 
issues that Goligher's does. It does not take into account the burden of other 
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symptoms; such as discomfort, pruritus and soiling; which anecdotally at 
least patients find as troublesome as bleeding and prolapse. The Lunniss 
classification also dictates that bleeding becomes more profuse with 
increasing severity of prolapse, although it is pointed out that stage 4 
haemorrhoids may occasionally cease to bleed if mucosal thickening and 
squamous metaplasia has occurred. However patients do present with 
symptoms of intermittent prolapse and no bleeding. Gaj and Trecca [73] 
have discussed this issue: the difference between haemorrhoids and a 
possible separate clinical entity of mucosal prolapse. 
The other main issue with any classification system for haemorrhoids is 
that grading is based on the patient's condition at the time of clinical 
assessment. Very little is known about the natural history of haemorrhoidal 
disease. It is well k n o w ~ ~ that a significant proportion of patients do not have 
symptoms on a regular basis. Keighley and Williams state that different 
degrees of prolapse can occur at different times of the menstrual cycle in 
women, or even at different times of the day [52]. 
In 2000 Gaj et al., [74] proposed an alternative classification system for 
haemorrhoids called PATE 2000. P denotes internal haemorrhoids and for 
each position the haemorrhoid must be classified as first, second, third or 
fourth degree. There is also an option for circumferential haemorrhoids, 
again classified by degree. A refers to the absence or presence of an acute 
event, either oedema or thrombosis. T refers to anal canal tone and can be 
hypotonic, normotonic or hypertonic. E refers to the presence of external 
haemorrhoids and the options for position are left lateral, anterior and right 
posterior. PATE 2000 was evaluated in 204 consecutive patients from 
eleven coloproctological centres [75]. Patients with other proctological 
disease or who had undergone previous proctological surgery were 
excluded. The examining specialist completed an assessment form on each 
patient detailing the old and new classification systems. Unfortunately very 
little information was available on the study population, methodology or 
results. The authors stated that PATE 2000 was three times superior to the 
old one, and that a McNemar test was statistically significant. 
The only other available classification system is one using endoscopic 
methods [76]. Haemorrhoids were assessed on tne basis of circumferential 
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distribution of internal haemorrhoids (range), diameter of largest 
haemorrhoids (form) and the presence of red colour signs in accordance 
with the general rules for endoscopic findings of oesophagogastric varices. 
The authors compared endoscopic findings with a simple evaluation of 
prolapse and bleeding prior to endoscopy and rubber band ligation. They 
found a significant correlation between bleeding score and range, form and 
red colour signs. There was also a significant correlation between prolapse 
score and form. However this study would not be particularly practical for 
evaluation of patients, with respect to exposure or time required to carry out 
treatment. 
There have been very few recent anatomical studies of haemorrhoidal 
disease; Thomson's [2] seminal work being the most extensively referenced. 
Morgado et al. [77] exa.mined anal canal sections in 32 foetuses, 20 healthy 
adult males and 100 haemorrhoidectomy specimens. The anal canal 
specimens from adult males without anorectal pathology were similar to 
those of foetuses, but differed in that the submucosal vessels contained a 
higher ratio of collagen to muscle fibres. The collagen fibres within the 
submucosa; interdigitating the internal anal sphincter; had a heterogeneous 
fragmented appearance and again there was a higher ratio of collagen to 
muscle fibres in the sphincteric muscle mass. 
The sphincteric muscle exhibited a greater number of blood vessels 
with irregular walls and the muscle bundles were less uniform than in the 
foetal specimens. The intersphincteric groove contained blood vessels with 
sclerotic walls, some showing signs of long-standing thrombosis. The 
collagen fibres at this level were particularly fragmented. 
Histological study of the haemorrhoidectomy specimens revealed 
severe inflammation affecting the connective tissue and walls of the arterial 
and venous blood vessels. Fragmented collagen fibres had replaced muscle 
tissue. Some cases had ischaemic changes in the mucosa, as a result of 
local haematoma, leading to ulceration. 
The same authors also assessed 816 medical records of patients with 
haemorrhoidal disease. Standard classification, bowel symptoms and 
surgical procedures were evaluated. 29.3% of the under 40 years group 
were operated on for massive thrombosis, in comparison to 5.7% of the over 
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40 years group. Unfortunately there was no other information available on 
this large group of patients. On the basis of their review of literature at the 
time, the authors proposed that a different classification could be used: 
bleeding haemorrhoidal disease; prolapsing haemorrhoidal disease; 
thrombotic haemorrhoidal disease; and mixed haemorrhoidal disease. 
Essentially the authors argued that classification should be based on 
symptoms, as a way of choosing the most appropriate treatment. A 
symptom-based classification should be sufficiently comprehensive to 
incorporate most, if not all, the principal symptoms that may be attributable 
to haemorrhoids. It was also unclear from the methodology as to the 
inclusion and exclusion criteria for the 816 medical records assessed. It 
appears possible that cases of haemorrhoidal disease occurring as a result 
of fistulae, fissures, ne,?plasms or any local pathology that represented part 
of a systemic disease were included in the cohort studied. 
Overall most of the classification systems available are all anatomically 
based. Correct grading of haemorrhoids is dependent on several factors, all 
of which are liable to observer error, and possible variation in the natural 
history of haemorrhoid symptoms. 
Differentiating between grade I and II haemorrhoids could be 
dependent on the assessor's history taking and examination skills. It is not 
uncommon for a patient to be referred to a surgical clinic, but be 
asymptomatic at the time of assessment. However based on the history 
taken the patient may well have had recent episodes of prolapse. In these 
circumstances patients are often keen to undergo treatment, in an attempt to 
prevent further symptomatic episodes. 
Differentiating between grades II and III haemorrhoids can also be 
liable to circumstances. The patient may be unwilling to digitally replace 
haemorrhoids, or they may return to the normal position if given more time. 
Large haemorrhoids are perhaps more likely to be classified as grade III 
because of the surgeon's assessment of size. Grade III haemorrhoids may 
also be incorrectly classified as grade IV if associated with a large external 
component. Clinical examination can be difficult and the patient themselves 
may be attempting to replace an external skin tag rather than a prolapsing 
haemorrhoid. 
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2.1.3 Patient Reported Outcomes 
Prior to considering the design of such an instrument, justification for 
its design and use is required. More and more medical publications include 
the keywords quality of life (QoL); a search of the National Library of 
Medicine's Pub Med database reveals three times as many publications in 
2005 as in 1995. QoL is recognized as a major endpoint for phase III 
randomized clinical trials. A recent systematic review identified 1,275 
different instruments measuring health-related quality of life (HRQL) and 
other related outcomes by the year 2000 [78]. 
Several clinical trials organizations have introduced the notion of QoL 
as a standard part of new trials. The European Organization for Research 
and Treatment of Cancer (EORTC) states that its mission is to "to develop, 
conduct, coordinate and stimulate translational and clinical research to 
improve the standards of care by increasing survival and patient quality of 
life [79]." As far back as 1985 the US Food and Drug Administration (FDA) 
recognized the benefit of QoL as well as increased survival, as a justification 
for approval of new anti-cancer drugs [80]. 
The definition of HRQL and QoL and related concepts such as health 
status and perceived health has been disputed and elusive, resulting in no 
single concept being universally adopted [81,82]. In a recent review of 68 
different HRQL models, Taillefer et al. [83] observed that about 25 % of 
authors did not provide a definition of the concept. When definitions were 
provided, they differed significantly in their content. 
Therefore the FDA has proposed the umbrella term patient reported 
outcomes (PRO): "a measurement of any aspect of a patient's health status 
that comes directly from the patient (Le., without the interpretation of the 
patient's responses by a physician or anyone else)" [84]. 
The importance of assessing health outcomes has become 
increasingly evident in the practice of medicine. This has been driven both 
by patients, who are becoming more involved in the decisions affecting their 
health, and the increased interest in health economics particularly in light of 
a larger and older population. A better understanding of patient perception of 
haemorrhoidal disease should optimize clinical decision-making in terms of 
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achieving outcomes that matter most to patients. Surgeons are well aware 
that patients' reporting of symptoms, and the degree to which they are 
affected by the symptoms, vary greatly with similar levels of appearance on 
examination. 
Therefore it is highly desirable for clinicians to have a uniform and 
reproducible method to assess symptoms. It would enable the clinician to 
monitor progression of disease for individual patients by providing an 
objective symptom score to follow. It also facilitates the comparison of 
results in clinical studies of the outcomes of different treatment modalities 
conducted at different sites and at different times. This type of clinical 
information, when combined with physiological measures and other test 
results, should give a far more detailed picture of disease status in patients 
with haemorrhoids. 
Patient reported outcomes (PRO) are abundant in clinical medicine, 
and can be used for three purposes: discriminating between subjects, 
predicting prognosis or the results of a test, and evaluating change over 
time. 
A discriminative measure is used to distinguish between individuals or 
groups based on an underlying dimension, where there is no external 
criterion or gold standard available for validating these measures. One of the 
most useful aspects of discriminative functional status measures is in 
surveys, which attempt to quantify the burden of illness across different 
communities [85]. 
A predictive measure is used to classify individuals into a set of 
predefined measurement categories when a gold standard is available, 
either concurrently or prospectively, to determine whether individuals have 
been classified correctly. This type of index is generally used as a screening 
or diagnostic instrument to identify which specific individuals have or will 
develop a target condition or outcome. 
An evaluative measure is used to assess the magnitude of longitudinal 
change in an individual or group on the dimension of interest. The 
development of evaluative instruments has provided the main focus for 
those interested in measurement of quality of life. Such instruments are 
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needed for quantifying the treatment benefit in clinical trials, and for 
measuring quality adjusted life years in cost-utility analyses. 
A number of research groups have developed generic measures, 
designed for different patient populations. Health profiles such as the SF-36 
[86], the Nottingham health profile [87] and the sickness impact profile [88] 
measure several health domains. More recently the need for disease-
specific questionnaires for use in clinical trials has been recognized, leading 
to the design and validation of instruments for studies in cancer and 
rheumatology [89]. 
2.1.4 Gastrointestinal PROMs 
Before considering the design and evaluation of a haemorrhoid PROM, 
it was essential to ensure that other similar measures had not been 
designed by other researchers. A literature review was undertaken using the 
National Library of Medicine, Web of Science (lSI) and PubMed Entrez 
databases, as well as a variety of on-line sources [90-93]. In particular the 
Patient-Reported Outcome and Quality of Life Instrument Database was 
carefully perused as its' aims are to identify and describe PRO and QoL 
instruments to help researchers choose appropriate instruments and 
facilitate access to them. 
The Gastrointestinal Quality of Life Index [94] (GIQU) was designed to 
measure quality of life in any patient with gastrointestinal disease. The 
original intention was also to design several small organ-specific modules, 
which could be selected for use, dependent upon the site of impairment. The 
authors were only able to identify a few organ-specific items by their higher 
prevalence in their item-testing phase. There was no evidence of a 
haemorrhoid-specific patient reported outcome measure in published 
literature. 
2.2 AIM 
The aim of this study is to develop and validate an evaluative PROM to 
measure the symptoms of patients with haemorrhoids and to evaluate the 
effect of treatment, with a view to using it as an outcome measure in future 
clinical trials. 
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, Author Outcome Measures 
Pain Sx Analg Ret Satisfn Comp Rec RetN QoL Man Op Hosp 
Work Activ Durn Durn 
Boccasanta[95] ~ ~ ~ ~ ~ ~
Brown [96] ~ ~ ~ ~ ~ ~
Cheetham[97] ~ ~ ~ ~ ~ ~ ~ ~
CorreaRovelo[98] ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
Ganio[99] ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
Hetzer[100] ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
Ho[101] ~ ~ ~ ~ ~ ~
Kairaluoma[102] ~ ~ ~ ~ ~ ~
Krska[103] ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
L ~ u [ 1 0 4 ] ] ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
Mehigan[105] ~ ~ ~ ~ ~ ~ ~ ~
-_.-
-
- - . - - . ~ ~ _._. --
--
Table 2·1 Assessment of the outcome measures examined in studies comparing PPH to conventional surgery. 
Abbreviations are listed below table 2-2. 
I\.) 
co 
Sec Proct 
Intervn 
~ ~
~ ~
Author Outcome Measures 
Pain Sx Analg 
Ortiz[60] 
" " " 
Palimento[106] 
" 
Pavlidis[107] 
" " 
Racalbuto[108] 
" 
Rowsell[109] 
" " 
Senagore[110] 
" " 
Shalaby[111 ] 
" " 
Wilson[112] 
" 
Table 2-2 Continuation of table 2-1. 
Sx - Symptoms 
Satisfn - Satisfaction 
Ret N Activ - Return to Normal Activity 
Op Durn - Operative Duration 
Proct - Proctoscopic Appearance 
w 
o 
Ret 
Work 
Satisfn Compns Rec 
" " 
" " 
" " 
" 
" 
" " 
" 
Analg - Analgesic Use 
Compns - Complications 
QoL - Quality of Life 
RetN 
Activ 
" 
" 
" 
Hosp Durn - Hospital Stay Duration 
QoL Man Op Hosp Sec Proct 
Durn Durn Intervn 
" 
" " " 
" " " 
" " 
Ret Work - Time to Return to Work 
Rec - Recurrence 
Man - Anorectal Manometry 
Sec Intervn - Secondary Intervention 
Potential Items To Be Evaluated 
Pain or discomfort on defaecation 
Pain or discomfort at times other than defaecation 
Bleeding on defaecation 
Bleeding at times other than defaecation 
Prolapse on straining 
Prolapse that needs to be manually reduced 
Prolapse that cannot be manually reduced 
Itch or irritation 
Mucus or slime discharge 
Soiling of underwear 
Feeling of incomplete emptying of the bowel 
Table 2-3 Potential items to be evaluated during phase I. 
Selection followed literature review and discussion with colleagues. 
--------------------------------
1 A) How often do you get pain or discomfort on opening your bowels'? 
Never 
_ Lea thaD once a mODth 
At least once a mODth, but less thaD once a week 
At least once a week, but less thaD once a day 
_ With each motioD 
1 B) If y ~ u u do get pain or discomfort on opening your bowels. how much does 
this affect your life'? 
_ NotataU 
Slllhdy 
Moderately 
Quite a bit 
Alreatdeal 
---------------------------
Figure 2-1 An example of an item from the HSI-1. 
It demonstrates the choices available to the patient when asked to evaluate the 
frequency of symptoms and the affect on quality of life. 
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2.3 METHOD 
2.3.1 Phase I - Item Selection, Testing & Reduction 
The initial item pool was selected after a literature review [7, 13, 
34, 41, 113-119], thorough evaluation of established colorectal surgical 
textbooks [8, 120-123], and discussion with colorectal consultants at 
Queen's Medical Centre. The final list of items is listed in table 2-3. 
Phase I was based on work carried out by another clinical research 
fellow, who had completed his research time at Queen's Medical 
Centre. The initial haemorrhoid symptom index (HSI-1, figs 8-1 and 8-2 
in appendix 8-1) was tested on 60 patients recruited in a general 
surgical outpatients clinic between March and October 2004. Patients 
were asked to complete the questionnaire in clinic prior to undergoing 
treatment if it were deemed appropriate. Informed consent was 
obtained prior to the patient completing the questionnaire. 
The HSI-1 was divided into a section covering patient demographics, 
and a section covering the patient's symptoms. The patient was 
questioned on the frequency of each symptom and how much that 
particular item affected their quality of life. The exact wording for a 
given item is depicted in figure 2-1. 
Each symptom was scored from 0 (never) to 4 (with each 
moti<?,n). The affect of the symptom on the patient's life was also scored 
from 0 (not at all) to 4 (a great deal). Patient characteristics are shown 
in table 2-4. The results from the 60 completed questionnaires were 
assessed, and the current haemorrhoid PROM was based on the 
selected items. Items were selected if 50% of the patients had 
experienced the symptom in question. Results of the HSI-1 are 
summarized in table 2-5. 
Each item has been ranked according to how many patients 
experienced that particular symptom. Bleeding at times other than 
defaecation, prolapse that requires manual reduction and prolapse that 
cannot be reduced were all items experienced by less than 50 % of 
patients, and therefore were not included in the haemorrhoid PROM. 
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2.3.2 Phase II - Design of a Haemorrhoid PROM 
The planned level of observation was the individual patient, in 
particular the measurement of an individual's change due to treatment 
by rubber band ligation. This treatment was chosen as the study's 
setting was in a general surgical clinic. The most frequent treatment for 
a newly referred patient, diagnosed with grades I to III haemorrhoids is 
rubber band ligation [124]. This would allow for the greatest number of 
potential recruits to the study in this setting. 
Thus far, the purpose of the study was to use an evaluative 
instrument to measure the effect of rubber band ligation on symptoms 
experienced by patients with haemorrhoids. Therefore a high level of 
responsiveness, as well as validity and reliability, is required for this 
instrument. 
The next point to consider is whether to use a generic or a 
disease specific instrument. Generic instruments cover a broad range 
of quality of life dimensions in a single instrument. Including many 
health related dimensions removes the need to select dimensions for a 
particular study and allows for the detection of unexpected effects. 
However a broad approach may reduce responsiveness to the effect of 
treatment. 
Disease specific instruments reduce patient burden and increase 
acceptability by including only relevant dimensions, which may 
increase responsiveness. Disadvantages are the lack of comparability 
of results with those from other disease groups and the possibility of 
missing effects in dimensions that are not included. One approach, 
representing a compromise, is to include both disease specific and 
generic measures in a study. 
2.3.2.1 Examining Criterion & Construct Validity 
As there is no gold standard criterion for the assessment of 
treatment for haemorrhoids, a different solution was required for 
evaluating validity of the proposed haemorrhoid PROM. One option 
available is to use health-related quality of life measures and examine 
their relationship to the scores generated by each item in the PROM. 
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The other option was to use an established measure of health 
related quality of life such as the SF-36 index [86] or a gastrointestinal 
quality of life index [94] (GIQLI). The issue here is increased burden for 
the participant, as well as completing an index that doesn't appear to 
have any direct relevance to the participant's haemorrhoid symptoms. 
This could affect the face validity of the haemorrhoid PROM. As neither 
of these measures has been validated in a haemorrhoid patient 
population, there is little advantage to using them in this study. Instead 
the patient was asked about the effect of a particular symptom on 
HRQL. Symptoms that are scored highly should also have high scores 
for the HRQL if the PROM has good construct validity. 
2.3.2.2 Item Scaling 
Given that the symptoms may vary in frequency, the patient was 
asked to reflect on their symptoms over the previous month, and then 
quantify the number of days in an average week that they had a 
particular symptom. The choice ranged from 0 to 7 days per week. The 
o day option was given as the patient may have had symptoms, but 
less frequently than one day per week. Clearly the patient may not 
have had the symptom at all, and an option is given to tick a box for 
"no". 
2.3.2.3 Haemorrhoid PROM Construction & Layout 
The PROM (figs 8-3 to 8-8 in appendix 8-1) was divided into three 
sections; the first of which gathered information about the patient 
including age, gender, occupation, and duration of time that the patient 
had been aware of having haemorrhoids. Section 2 asked for details of 
medical history, prescribed medication, and details of previous 
treatment for haemorrhoids. Patients were also asked about analgesia 
use and topical treatment for haemorrhoid symptoms, and were asked 
to quantify how often these therapies had been used over the previous 
month. Patients were also asked whether any family members also had 
haemorrhoids, and how badly they were affected. Clearly an adjectival 
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scale is more appropriate here, and five categories are available to 
choose from. 
Section 3 entitled "Your symptoms now" is divided into ten 
questions, eight of which ask the same question about each of the final 
items chosen after evaluation of the results of HSI-1 (table 2-5). The 
final two questions ask the patient to quantify the effect of pain or 
discomfort and the other symptoms grouped together on their quality of 
life. They are asked to make a mark on a VAS. Anchors are placed at 
each end of the line designating 0 and 10; with an explanation that 0 
means no effect whatsoever, and 10 means that their symptoms 
completely dominate their life. 
The patients were given contact details of the researcher on the 
front cover of the questionnaire, and they were reminded to check that 
all questions were completed. 
2.3.2.4 Administration of Haemorrhoid PROM 
Options for administration of the PROM include face-to-face 
interviews, telephone interviews and mailed questionnaires. The 
advantages of face-to-face interviewing include absolute certainty that 
the respondent alone provides the information, and reduction of the 
number of items omitted by the respondent; it is more difficult to refuse 
to answer than to simply omit a response to an item on the form. The 
interviewer can determine if the participant is having any difficulty 
understanding the items, whether it is the grasp of language, the 
presence of a learning difficulty, or simply boredom. The interviewer 
would be able to rephrase the question if necessary. The converse of 
this is that the interviewer may alter the meaning of the question. 
The disadvantages include increased cost and time required to 
carry out the interview, as well as the effect of the interviewer 
themselves; biases of the interviewer, and his or her social and ethnic 
characteristics. It is well known that interviewers can subtly 
communicate what answers they wish to hear, even if they are not 
aware of doing so. This can be overcome by training, and regular 
review by a supervisor, however this entails further expense and time 
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required. It has been shown that race can have an effect on the 
responses of the interviewee, and the reasons given include social 
desirability, interpersonal deference, or courtesy to a polite stranger. 
Female interviewers normally have fewer refusers and higher 
completion rates than males. Responses may be different to female 
interviewers; Pollner [125] found that both men and women reported 
more symptoms of depression and substance abuse to female 
interviewers, and furthermore the difference in response rates are more 
likely to occur with male interviewees. 
It was decided that the PROM should be self-administered. This 
method was employed for cost effectiveness, ease, efficiency, and 
privacy and to eliminate interviewer bias. 
2.3.3 Ethics 
Ethical approval was gained from the North Nottinghamshire 
Research Ethics Committee (part of the Central Office for Research 
ethics Committees), and concurrent approval was also given by the 
Research & Development Department at Nottingham University 
Hospital NHS Trust. The University of Nottingham Medical School 
Ethics Committee approved the administration of the questionnaire to 
healthy volunteers. 
2.3.4 Inc.lusion Criteria 
Patients were considered for recruitment to the study if they had 
haemorrhoidal disease that required rubber-band ligation treatment. 
Either gender was considered. Healthy volunteers were considered for 
recruitment to the study provided that there was no history of 
gastrointestinal disease. 
2.3.5 Exclusion Criteria 
Patients were excluded from the study based on the following 
criteria: rectal bleeding that had not been investigated or any other 
colorectal pathology. 
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2.3.6 Recruitment 
Patients were recruited from a general surgical clinic and had 
undergone clinical assessment and investigations as appropriate, to 
exclude other colorectal pathology, before being asked to participate in 
the study. Patients underwent digital rectal examination, proctoscopy 
and rigid sigmoidoscopy to allow confirmation of haemorrhoids, and 
exclude any anal or rectal pathology. 
The study was explained to each potential recruit in detail, which 
was reinforced by an information sheet that was read at the time of 
assessment. An explanation of the rubber band ligation process was 
given. If the patient was happy to consent immediately to the study and 
the treatment, the questionnaire was completed before undergoing 
rubber band ligation. The patient was left alone in a clinic room to 
complete the questionnaire. 
Some patients preferred to have more time to consider either 
taking part in the study or having rubber band ligation performed. 
Patients gave permission to be contacted by telephone, and were 
contacted 2 to 3 days later. They were given the opportunity to ask 
further questions. If the patient wished to proceed with rubber band 
ligation, they were offered an appointment to return to the department 
of surgery. A letter confirmed this appointment. If the patient had 
c o n s e n t e ~ , , to taking part in the study, they were asked to complete the 
consent form and questionnaire at home and bring the paperwork to 
the appointment. 
All patients gave informed consent. A copy was given to the 
patient, another copy filed in the hospital medical record and another 
kept for research documentation. 
The first twenty-two patients were asked to complete an extra 
questionnaire 24 hours after the first pre-treatment questionnaire. Each 
of these patients had already completed and returned the first 
questionnaire prior to starting the second pre-treatment questionnaire. 
Healthy volunteers were recruited via poster advertisements that 
were placed around the University of Nottingham medical school. All 
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volunteers gave informed consent and completed the questionnaire in 
the absence of the investigator. 
2.3.7 Statistical analysis 
Distribution of the data, factoring on the basis of degree of 
haemorrhoids, was examined with the Kolmogorov-Smirnov test. 
Homogeneity of variance, factoring on the basis of degree of 
haemorrhoids, of the untransformed data was examined with Levene's 
test. Differences between the healthy volunteer group and the patient 
groups were assessed by the Wilcoxon rank-sum test. Validity was 
assessed by performing the Spearman's correlation coefficient (r) 
between symptom items and quality of life scores. Reproducibility of 
the haemorrhoid PROM was assessed by performing intra-class 
correlations. Internal consistency was assessed with Cronbach's o. 
As the data for each variable was not normally distributed and 
lacked homogeneity of variance, Friedman's ANOVA was used to 
assess each variable. Wilcoxon signed-rank tests, correcting for the 
number of tests, was performed to assess the size of effect. A 
Bonferroni correction was applied and so all effects are reported at a 
0.0167 level of significance. The effect size r = Z /..[N. 
2.4 RESUL TS - PHASE II 
2.4.1 Recruitment & Retention 
One hundred and forty four consecutive patients were asked to 
participate in this study over a 24-month period. Of these 116 
consented to participate in this study. One patient was excluded, after 
initially being diagnosed with second-degree haemorrhoids, as she 
developed a posterior anal fissure in between being assessed and 
returning for the rubber band 
Of the' remaining 115 patients (see fig 2-2), 72 completed all three 
questionnaires, 22 completed two questionnaires and 21 completed the 
.first questionnaire only. Of the 22 who completed two questionnaires, 
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11 completed the first and second, and the other 11 the first and third 
questionnaires. 
2.4.2 Study Group Characteristics: sections 1 and 2. 
Overall 55.7 % of the participants were male. There was no 
significant difference in gender-split based on the degree of 
haemorrhoids, as shown in table 2-6. The average age of the 
participant was 51.1 ± 14.4 years (range 20 - 80 years). The 
participant reported duration of haemorrhoid symptoms for an average 
of 11.1 ± 1.1 years (range 0 - 50 years). Occupation demographics are 
set out in table 8-1 of appendix 8-1. 
Previous medical history responses were categorized into one of 
fourteen groups based on the first fourteen categories of the 
International Classification of Diseases version 10. The majority of 
conditions declared involved the circulatory or digestive systems (see 
table 8-2 in appendix 8-1), which did not include colo recta I pathology. 
Current medication use was categorized in a similar manner to 
that of medical conditions but also included a further category covering 
anaesthetic agents. Fifty-two per cent of the participants were not on 
any regular medication (fig 8-9 in appendix 8-1 ). 
There was no significant difference in use of topical treatment 
between males and females or between first, second or third degree 
groups. There was no significant difference in analgesic use between 
the degree of haemorrhoids or between males and females. Figure 2-3 
summarises the participants' previous treatments. Sixty-six per cent of 
patients had not received treatment of their haemorrhoids prior to entry 
into the study and the proposed rubber band ligation. 
2.4.3 Internal Consistency 
Internal consistency of the questionnaire was assessed with 
Cronbach's a at each time-point in relation to RBL. Results are 
displayed in table 2-7. The value of Cronbach's a for the total score 
was calculated at 0.832 prior to rubber band ligation, 0.861 four weeks 
after RBL and 0.885 eight weeks after rubber band ligation. 
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Encouragingly it is noted that the values of the item-total correlations 
are all above 0.3 [126], apart from bleeding at 4 weeks post rubber 
band ligation, but removal of bleeding as an item does not increase 
Cronbach's ()( by a large amount. 
2.4.4 Test-Retest Reliability 
Test-retest reliability was examined by means of intra-class 
correlations and is summarised in table 2-8. The average total score of 
the first test was 22.4 ± 3.1, and the retest score was 22.9± 3.1.The 
intraclass correlation coefficient for the total score was 0.987 (0.970-
0.995), and denotes a high level of reliability. The Bland-Altman plot is 
displayed in fig 2-4. 
2.4.5 Validity 
2.4.5.1 Healthy volunteers 
Twelve healthy volunteers completed the haemorrhoid PROM to 
allow further assessment of validity. Females accounted for 75% of the 
group. The mean age was 27.8 (18 - 57) years. The mean total score 
was 1.58 (0 - 7); the mean quality of life score affected by pain 0.03 
(0.0 - 0.4) and the mean quality of life score affected by other 
symptoms 0.01 (0.0 - 0.1). Four volunteers scored three individual 
items aboye zero: one scored 6 days per week for pain when opening 
bowels, two scored 2 days per week for itch/ irritation, two scored 2 
days per week and one scored 1 day per week for the sensation of 
incomplete emptying. 
The healthy volunteer group (Mdn = 0.00) had a significantly 
lower total symptom score than the pre-RBL patient group (Mdn = 
19.00), Ws = 112.0, P < 0.001, r = -0.48; than the 4-week post-RBL 
patient group (Mdn = 15.00), Ws =150.5, P < 0.001, r = -0.49, and the 
8-week post-RBL patient group (Mdn = 7.50), Ws = 231.5, P < 0.001, r 
= -0.40. 
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2.4.5.2 Internal validation 
Validity was assessed by correlating the individual scores for 
each variable against the quality of life scores at each time-point in 
relation to RBL. Pain when opening bowels and pain when not opening 
bowels was correlated against quality of life affected by pain. Results 
are summarised in table 2-9. Based on Cohen's criteria, both variables 
show a significant correlation at the 0.01 level with a medium to large 
effect suggesting that the measures have a common underlying 
dimension. 
The other variables were correlated against quality of life affected by 
other symptoms. Results are summarised in table 2-10. All variables 
showed a significant correlation with a moderate to large effect size at 
all time-points in relation to RBL, apart from bleeding and itch/ irritation. 
The Spearman correlation of the total score to the quality of life 
affected by pain score was 0.629 prior to RBL, 0.720 at four weeks 
post RBL and 0.664 at eight weeks post RBL all with a significance 
value of < 0.001. 
2.4.5.3 Item analysis and effect on validity of total symptom 
score. 
The results reported in the previous section show that the 
symptom and the total scores correlate significantly with the quality of 
life s c o r e s ~ ~ however the magnitude of correlations between bleeding, 
itch/ irritation and quality of life score was lower than in other items. 
Scores from these items were deleted from the total score to further 
explore internal validity of the haemorrhoid PROM and are summarised 
in table 2-11. There was not a significant increase in the correlations at 
any time-point, when the score for bleeding or itch/ irritation was 
removed. 
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Item Frequency 
Mean age (years range) 53 (24 - 88) 
Mean duration (years range) 9.7 (0.5 - 42) 
Female (%) 27 (45.0) 
Analgesic use (%) 6 (10.0) 
Ointment use (%) 16 (26.7) 
Previous rubber band ligation (%) 14 (23.3) 
Previous injection sclerotherapy (%) 9 (15.0) 
Previous haemorrhoidectomy (%) 2 (3.33) 
Other colorectal conditions (%) 21 (35.0) 
. Table 2-4 Demographics of patients who completed HSI-1 . 
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Mean Pt Mean 
Item Score Score Score 
(Sx) Of 0 (%) (Life) 
Bleeding on defaecation 2.23 10.00 1.72 
Feeling of incomplete 
1.97 18.33 1.35 
emptying 
Pain or discomfort on 
1.92 23.33 1.17 
defaecation 
Prolapse on straining 1.95 28.33 1.13 
Itch or irritation 1.70 28.33 1.12 
Pain or discomfort at 
times other 1.48 35.00 1.03 
than defaecation 
Soiling of underclothes 1.62 35.00 1.35 
Mucus or slime discharge 1.25 41.67 1.00 
Prolapse that needs to be 
0.90 63.33 0.58 
reduced 
Bleeding at times other 
0.60 66.67 0.65 
than defaecation 
Prolapse that cannot be 
0.73 76.67 0.38 
reduced 
Table 2·5 Results of phase I. 
The mean score for each item, the mean effect on quality of life and 
proportion of patients scoring zero are presented. 
Pt 
Score 
Of 0 (%) 
20.00 
30.00 
35.00 
40.00 
40.00 
41.67 
36.67 
50.00 
70.00 
68.33 
80.00 
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Figure 2-2 Flow-chart demonstrating patient completion of the HS1-2. 
Degree I Male (%) I Female (%) 
First 52.4 47.6 
Second 57.5 42.5 
Third 57.6 42.4 
Table 2-6 Demographics of participants of HSI-2. 
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60% - 66% 
40% -
- . 20% 
16% 
3% 
1% 
7% I I 8% 
I I I I I I 0% 
NONE INJECTION SCLEROTHERAPY OTHER 
RUBBER BAND LIGATION SURGERY MULTIPLE 
Figure 2-3 Participant's' previous experience of treatment. 
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Item Corrected Item-Total Cronbach's a If Item 
Correlation Deleted 
0/52 4/52 8/52 0/52 4/52 8/52 
Pain when opening 
.560 .573 .584 .812 .847 .877 
bowels 
Pain when not 
.618 .706 .720 .807 .836 .867 
opening bowels 
Bleeding 
.370 .246 .564 .830 .872 .877 
Lumps on straining 
.411 .404 .653 .828 .864 .872 
Itch/ irritation 
.447 .768 .720 .824 .829 .865 
Mucus/ slime 
.549 .427 .583 .814 .858 .876 
Soiling 
.503 .574 .440 .818 .847 .885 
Incomplete emptying 
.534 .561 .503 .815 .849 .881 
Pain affecting QoL 
.648 .732 .733 .803 .834 .866 
.. 
Other symptoms 
.572 .750 .693 .811 .832 .868 
affecting QoL 
Table 2-7 Internal consistency pre-RBL, four and eight weeks after RBL. 
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Item Intra-class Range 
Correlation 
Pain when opening bowels .992 (0.980 - 0.997) 
Pain when not opening .855 (0.652 - 0.940) 
bowels 
Bleeding .852 (0.644 - 0.939) 
Lumps on straining .987 (0.969 - 0.995) 
Itch/ irritation .993 (0.983 - 0.997) 
Mucus/ slime .996 (0.991 - 0.998) 
Soiling .841 (0.616 - 0.934) 
Incomplete emptying .963 (0.910 - 0.984) 
Pain affecting QoL .976 (0.827 - 0.971) 
Other symptoms affecting QoL .987 (0.970 - 0.995) 
Table 2·8 Intraclass correlation coefficients for repeatability of individual 
items. 
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Figure 2·4 Bland·Altman plot of the repeated measurement to test reliability of the 
haemorrhoid PROM. 
Correlation of pain Pre - RBL 4/52 post- 8/52 post-
variables to quality of life RBL RBL 
affected by pain. rs p rs p rs p 
Pain when opening bowels .429 <0.01 .599 <0.01 .559 <0.01 
., 
Pain when not opening .406 <0.01 .677 <0.01 .572 <0.01 
bowels 
. 
Table 2·9 Correlation of pain scores against quality of life affected by pam 
scores. 
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Correlation of other Pre - RBL 4/52 post- S/52 post-
variables to quality of life RBL RBL 
affected by other rs p rs p rs p 
symptoms. 
Bleeding 0.198 0.017 0.171 0.061 0.464 <0.01 
Lumps on straining 0.351 <0.01 0.327 0.001 0.423 <0.01 
Itch/ Irritation 0.269 0.002 0.716 <0.01 0.532 <0.01 
Mucus/ Slime 0.392 <0.01 0.351 0.001 0.451 <0.01 
Soiling 0.442 <0.01 0.464 <0.01 0.434 <0.01 
Incomplete emptying 0.335 <0.01 0.580 <0.01 0.339 0.001 
Total score 0.569 <0.01 0.744 <0.01 0.670 <0.01 
.. 
Table 2-10 Correlation of variables with QOL affected by other symptoms 
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- - - - - - - - - - - - - - - ~ - - - - - - - ~ - - -
Time-point Item removed QoL affected QoL affected 
by pain by other 
symptoms 
Pre RBL None 0.629 0.569 
Bleeding 0.632 0.564 
Itch! irritation 0.603 0.572 
4 weeks post None 0.720 0.740 
RBL Bleeding 0.759 0.763 
Itch! irritation 0.678 0.700 
8 weeks post None 0.664 0.670 
RBL B I ~ e d i n g g 0.675 0.656 
Itch! irritation 0.664 0.650 
. Table 2-11 Effect of Item removal on total score correlation with quality 
of life score. 
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2.4.6 Responsiveness 
Each item changed significantly over the eight-week period and the 
results are summarised in figs 2-5 to 2-14. Items that changed with a 
medium size effect (-0.3 S r S -0.5) included bleeding, lumps on straining, 
itch or irritation and the quality of life scores. 
The total score changed significantly over the eight weeks of the 
questionnaire assessment (X2(2) = 59.98, P < 0.05). The scores changed 
significantly from entry into the study to eight weeks post rubber band 
ligation, T = 286, r = -0.50, and from four to eight weeks post rubber band 
ligation, T = 342, r = -0.42 (see fig 2-15). 
Although all individual items changed significantly with a graded 
decrease in score from pre"rubber band ligation to eight weeks, none of the 
items changed with a large size effect. Significant changes were also 
identified between pre-rubber band ligation and four week scores, as well as 
between four and eight week scores, however the majority of these changes 
were only with a small size effect and are therefore not reported in detail. 
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Figure 2-5 Mean score for pain when bowels open. 
The score changed significantly over the 8-week period: 
X2(2) = 12.07, p < 0.05 , T = 296, r = -0.25. 
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Figure 2-6 Mean score for pain when bowels not open 
The score changed significantly over the 8-week period: 
X2(2) = 20. 19, p < 0.05), T = 305.5, r = -0 .24. 
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Figure 2-7 Mean score for bleeding. 
The bleeding score changed significantly over the 8-week period: 
X2(2) = 45.72, P < 0.05, T = 173, r = -0.45. 
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Figure 2-8 Mean score for lumps on straining. 
The score for lumps on straining changed significantly over the 8-week 
period: X2(2) = 32. 56,p < 0.05: T = 125, r = -0.40. 
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Figure 2-9 Mean score for itch or irritation. 
The scores changed significantly over the 8-week period: X2(2) = 
31.30, p < 0.0) , T = 254 , r = -0.40 . 
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Figure 2-10 Mean score for mucus or slime. 
The scores changed significantly over the 8-week period: X2(2) = 
28.25, p < 0.0) , T = 115, r = -0.31 . 
3.00 Error bars: 95% CI 
2.50 
= c: 
~ ~ 2.00 
.... 
~ ~
• l:; 1 .50 
~ ~
VI 
c:: 
.. 
• 1 .00 
:!E 
0.50 
0.00 
PRE-RBL 4152 POST-RBL 8152 POST-RBL 
TIME 
Figure 2-11 Mean score for soiling. 
The scores changed significantly over the 8-week period: X2(2) = 
10.56, P < 0.05, T = 228.5, r = -0.21. . 
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Figure 2-12 Mean score for incomplete emptying. 
The scores changed significantly over the 8-week period: X2(2) = 
23.71,p < 0.05, T = 189, r = -0 .32. 
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Figure 2-13 Mean score for QOL affected by pain, 
The scores changed significantly over the 8-week period: X2 (2) = 
34.10, P < 0.05, T = 391.5, r = -0.39. 
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Figure 2-14 Mean score for QOL affected by other symptoms. 
The scores changed significantly over the 8-week period: X2(2) = 
39.79,p < 0.05, T = 877.5, r = -0.41 . 
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Figure 2-15 Mean total score. 
The total score changed significantly over the 8-week period: X2(2) = 
59.98, p < 0.05 , T = 286, r = -0.50. 
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2.4.6.1 Analysis of responsiveness by gender. 
The data was analysed for differences in responses between males 
and females. Females showed a significant decrease for several items 
where males did not, including the two pain scores (figs 2-16 and 2-17) and 
soiling (fig 2-18). Females had higher quality of life scores affected by both 
pain and other symptoms, although males still showed a significant 
decrease in the effect of pain and other symptoms on their quality of life 
scores. 
The score for other symptoms affecting quality of life significantly 
changed from entry into the study to eight weeks post rubber band ligation: 
for males X2(2) = 9.97, P < 0.05, T = 183.5, r = -0.32; and for females, 
X2(2) = 36.79, P < 0.05), T = 75, r = -0.49 (fig 2-19). 
The score for pain affecting quality of life significantly changed from 
entry into the study to eight weeks post rubber band ligation: for males 
x2(2) = 16.06, P < 0.05, T = 128.5, r = -0.37; and for females, X2(2) = 
20.24, P < 0.05), T = 71.5, r = -0.41 (fig 2-20). 
2.4.6.2 Analysis of responsiveness by age. 
The data was analysed for differences in responses between different 
age groups. The patient group was divided into two, as smaller groups did 
not provide any meaningful changes between the groups. 
In the 0 - 45 years group, the score for pain when opening bowels changed 
significantly from entry into the study to eight weeks post rubber band 
ligation, (x2 (2) = 9.28, P < 0.05), T = 16, r = -0.40. No significant change 
was seen in the 46 - 90 years group (fig 2-21). 
In both groups, the score for pain when not opening bowels changed 
significantly from entry into the study to eight weeks post rubber band 
ligation: (x2 (2) = 8.33, P < 0.05), T = 10, r = -0.36 for the 0 - 45 years 
group; and (x2 (2) = 15.44, P < 0.05), T = 64.5, r = -0.33 for the 46 - 90 
years group (fig 2-22). 
In the 0 ..;,. 45 years group, the score for pain affecting quality of life did 
not change significantly over the eight weeks of the questionnaire 
a s s ~ s s m e n t t (x2 (2) = 5.71, P = 0.06), however in the 46 - 90 years group, 
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the score for pain affecting quality of life changed significantly from entry into 
the study to eight weeks post rubber band ligation, (x2 (2) = 32.48, P < 
0.05), T = 129, r = -0.43 (fig 2-23). 
In the 0 - 45 years group, the score for other symptoms affecting 
quality of life did not change significantly over the eight weeks of the 
questionnaire assessment (x2 (2) = 5.45, p = 0.067), however in the 46 -
90 years group, the score for pain affecting quality of life changed 
significantly from entry into the study to eight weeks post rubber band 
ligation, (x2 (2) = 36.97,p < 0.05), T = 132.5, r = -0.48 (fig 2-24). 
2.4.6.3 Analysis of responsiveness by degree of haemorrhoids 
The data was analysed for differences in responses between different 
degrees of haemorrhoids. "In all participants irrespective of degree, the score 
for bleeding significantly changed over the eight weeks of the questionnaire 
assessment: for first-degree X2(2) = 20.86, P < 0.05, T = 24, r = -0.49; for 
second-degree X2(2) = 16.21, p < 0.05, T = 23.5, r = -0.43; and for third-
degree haemorrhoids, X2(2) = 14.00,p < 0.05, T = 14.5, r = -0.43 (fig 2-25). 
With respect to the items: pain when not opening bowels; lumps on 
straining; mucus or slime; and sensation of incomplete emptying, there was 
a difference between the differing degrees. There were no significant 
changes for participants with first-degree haemorrhoids, whereas 
participants with second and third-degree haemorrhoids showed significant 
changes with a medium size effect (figs 2-26 to 2-29). 
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Figure 2-16 Gender differences in pain when opening bowels. 
The scores only changed significantly for females: X2 (2) = 6.97, P < 0.05 , 
T = 60, r = -0.32. 
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Figure 2-17 Difference in pain when not opening bowels 
between the genders. 
The scores only changed significantly for females: X2 (2) = 15.9 1, P < 
0.05 , T = 62.5, r = -0.33. 
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Figure 2-18 Differences in scores for soiling between the 
genders. 
The scores only changed significantly for females: X2 (2) = 7.32, P < 0.05 , 
T = 44.5, r = -0.28 
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Figure 2-19 Gender differences in scores for quality of life 
affected by other symptoms. 
There was a smaller size effect for males (r = -0 .32) than for females (r = -
0.49). 
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Figure 2-20 Differences between the genders in quality of life 
scores affected by pain. 
Although the scores decreased Significantly for both genders, the scores 
were higher in females at all time-points. 
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Figure 2-21 Scores for pain when opening bowels by age 
group. 
No significant change for pain when opening bowels is identified for the 46 
- 90 years age group compared to the 0 - 45 years group. 
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Figure 2-22 Scores for pain when not opening bowels by age 
group. 
Significant changes are identified for both age groups for pain when not 
opening bowels. 
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Figure 2-23 Scores for pain affecting QoL by age group. 
Significant changes are identified for the 46 - 90 years group for pain 
affecting quality of life. 
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Figure 2-24 Scores for other symptoms affecting QoL by age 
group. 
Significant changes are identified for the 46 - 90 years group for other 
symptoms affecting quality of life. 
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Figure 2-25 Scores for bleeding analysed by degree. 
Significant changes for bleeding are identified in all categories of 
haemorrhoid degree. 
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Figure 2-26 Scores for pain when bowels not opening by 
degree. 
Significant changes for 2nd degree from entry to 8-weeks post RBL and 
3rd degree from 4 to 8 weeks post RBL. 
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Figure 2-27 Scores for lumps on straining by degree of 
haemorrhoids. 
Significant changes for 2nd and 3rd degree from entry to 8-weeks post 
RBL. 
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Figure 2-28 Scores for mucus! slime by degree of 
haemorrhoids. 
Significant changes for 2nd and 3rd degree from entry to 8-weeks post 
RBL. 
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Figure 2-29 Score for sensation of incomplete emptying by 
degree of haemorrhoids. 
Significant changes for 2nd and 3rd degree from entry to 8-weeks post 
RBL. 
2.4.6.4 Analysis by previous treatment 
The dataset was analysed by whether the participants had had 
previous treatment for haemorrhoids. In both groups, there was no 
significant change in score over the eight weeks of the questionnaire 
assessment for pain for soiling. 
For the following variables: pain when not opening bowels, bleeding, 
lumps on straining and incomplete emptying (table 2-11), only the group who 
had had no previous treatment showed a significant change in scores over 
the eight weeks. 
For the remaining variables, both groups showed significant changes 
between entry to the study and eight weeks post rubber band ligation (table 
2-12). 
2.4.6.5 Analysis by requirement for further treatment 
The dataset was analysed by whether the participants required 
further treatment of their haemorrhoids. In the group requiring further 
treatment (n=30) there was no significant change in score for any of the 
symptom variables. 
For the group that did not require further treatment (n =52), all 
measured symptom variables, except soiling, showed a significant change in 
score over the eight weeks of the questionnaire assessment. The test 
statistic and size of effect are summarized in table 2-13. 
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o v 8 weeks No previous treatment Previous treatment 
N =76 N =39 
Degree (%) 38.2 1 32.9 1 28.9 33.3 1 38.5 1 28.2 
Age ± SE (yrs) 49.6 ± 1.7 54.0 ±2.2 
Male (%) 55.3 56.4 
Pain when not X2 (2) = 16.91, P < 0.05 NS 
opening bowels T=152r=-0.39 
Bleeding X2 (2) = 46.12,p < 0.05 NS 
T = 40 r = -0.51 
Lumps on straining X2 (2) = 26.95, P < 0.05 NS 
T = 56 r = -0.44 
Incomplete emptying X2· (2) = 26.26, P < 0.05 NS 
T = 56 r = -0.39 
Table 2-11 Comparison of participants by previous treatment 
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o v 8 weeks No previous treatment Previous treatment 
N =76 N = 39 
Pain on opening X2 (2) = 19.20, P < 0.05 X2 (2) =£ 6.54, P < 0.05 
bowels T = 76 r = -0.33 r < -0.3 
Mucus! slime X2 (2) = 22.11,p < 0.05 X2 (2) = 9.41, P < 0.05 
T = 66.5 r = -0.33 r < -0.3 
Itch! irritation X2 (2) = 21.16, p < 0.05 X2 (2) = 11.65, P < 0.05 
T = 147.5 r = -0.35 T = 17.5 r = -0.50 
Pain affecting X2 (2) = 19.92, P < 0.05 X2 (2) = 16.64, P < 0.05 
QoL T = 176.5 r = -0.42 r < -0.3 
Other Sx X2 (2) ;::: 23.23, p < 0.05 X2 (2) = 18.90, P < 0.05 
affecting QoL T = 235 r = -0.42 T = 54 r = -0.36 
Total Score X2 (2) = 51.52, P < 0.05 X2 (2) = 9.49, P < 0.05 
T=103r=-0.54 T = 43 r = -0.38 
. Table 2-12 Effect of prevIous treatment on change in symptom scores 
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o v 8 Weeks X2(2) Size of effect 
n = 52 
Pain when opening bowels 18.72 T = 68, r = -0.36 
Pain when not opening bowels 22.56 T = 48, r = -0.36 
Bleeding 46.22 T = 27, r = -0.51 
Lumps on straining 33.10 T=18,r=-0.48 
Itch/ irritation 29.57 T = 81, r = -0.42 
Mucus/ slime 36.43 T = 14.5, r = -0.40 
Incomplete emptying 20.84 T = 39.5, r = -0.35 
Total score 65.20 T = 39, r = -0.58 
Pain affecting QoL 35.20 T = 41.5, r = -0.51 
Other symptoms affecting QoL 39.08 T = 51.5, r = -0.55 
Table 2-13 AnalysIs of group not requiring further treatment. 
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2.5 Summary of Results 
The haemorrhoid PROM demonstrated high values of Cronbach's 
alpha before rubber band ligation (0.832), four (0.862) and eight (0.885) 
weeks after rubber band ligation; and therefore internal consistency is high. 
This suggests that the covariation in the items reflects an underlying 
dimension that may be more important than any single item. 
Data from 22 consecutive patients with haemorrhoids, assessed and 
re-assessed after 24 hours, were used to estimate the test-retest reliability of 
the haemorrhoid PROM. The intraclass correlation coefficient for the total 
score was 0.987 (0.970 - 0.995) and denotes a high level of reliability. 
Results from the validation studies during phase II, are based on 115 
patients completing the 8 symptom items and the 2 quality of life visual 
analogue scores. The Spearman correlation coefficient of the total score to 
the quality of life affected by pain score was 0.629 prior to RBL, 0.720 at four 
weeks post RBL and 0.664 at eight weeks post RBL all with a significance 
value of < 0.001. The Spearman correlation of the total score to the quality 
of life affected by other symptoms score was 0.569 prior to RBL, 0.744 at 
four weeks post RBL and 0.670 at eight weeks post RBL all with a 
significance value of < 0.001. The moderate to strong correlations suggests 
that the items have a common underlying dimension. 
Validity was further verified by comparing healthy volunteers to the 
haemorrhoid patient group. The healthy volunteer group (Mdn = 0.00) had a 
significantly lower total symptom score than the pre-RBL patient group (Mdn 
= 19.00), Ws = 112.0, P < 0.001, r = -0.48; than the 4-week post-RBL patient 
group (Mdn = 15.00), Ws =150.5, P < 0.001, r = -0.49, and the 8-week post-
RBL patient group (Mdn = 7.50), Ws = 231.5, P < 0.001, r = -0.40. 
All items within the haemorrhoid PROM demonstrated significant 
changes eight weeks after rubber band ligation, particularly bleeding, lumps 
on straining, itch or irritation, the quality of life scores and the total score. 
Analysis by gender demonstrated that the changes in pain scores were 
more likely to be due to female participants, although males still 
demonstrated significant changes in the quality of life score affected by pain. 
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Analysis by degree demonstrated that the changes in bleeding score 
were significant amongst first, second and third degree haemorrhoid 
participants. Significant changes were demonstrated for second and third 
degree haemorrhoids with the lumps on straining, pain when not opening 
bowels, mucus or slime, or sensation of incomplete emptying items. 
In the group of patients that required further treatment after the eight-
week period, no significant decrease in any of the item scores was 
demonstrated. 
2.6 DISCUSSION 
The aim of this part of the thesis was to develop and validate an 
evaluative PROM, specifically for haemorrhoidal disease. Phase I of this 
study was comprised of item selection, item reduction and testing leading to 
modification of the initial HSI-1. The decision to remove items from HSI-1 if 
50% or more of the patients had not experienced the item at all (a score of 
zero) is an inherently subjective judgement, and was made following 
discussion with a public health expert. Similar judgements have been made 
in the development of an irritable bowel syndrome QoL measure [127]. 
Other investigators [128] have chosen 30% as a cut-off level, in the 
assessment of patients with oesophageal cancer. Eypasch et aI., used 25% 
in the development of the Gastrointestinal Quality of Life Index [94]. 
Phase II involved construction, administration and analysis of the 
haemorrhoid PROM. One of the changes in the content was the approach to 
scaling of the items; this was extremely important to ensure that the PROM 
would be able to detect change in the outcome measures following rubber 
band ligation. 
Scaling of the items needed to be decided on the basis of the proposed 
use of the PROM as well as the natural history of haemorrhoids. Very little is 
known about the day-to-day changes of symptoms in individuals with 
haemorrhoids, and therefore the scaling of items was modified, increasing 
the response options on the scale to increase item responsiveness [85], on 
the basis that the intended use is evaluative. 
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Using an adjectival scale is not as reliable as a more objective 
numerical measure, particularly if the intention is to measure outcomes 
following an intervention. Interpretation of phrases such as "sometimes" and 
"frequently" are likely to differ even within the same individual at different 
times, particularly as symptoms change [129, 130]. 
To encourage accurate assessment of symptom burden, the items 
were scaled on the basis of time. The choice to use frequency of symptoms 
rather than a descriptive response scale has also been made in the 
investigation of outcomes following haemorrhoidal surgery [131]. This study 
reported a reduction in symptoms following PPH and diathermy 
haemorrhoidectomy, however although the investigators stated that the 
bowel function questionnaire completed by participants was validated [132, 
133], no publication was identified in which validation studies were 
presented. 
Internal consistency for the haemorrhoid PROM is high with values of 
Cronbach's a above 0.8 at all time-points in the study. A more sophisticated 
method of measuring scale reliability is to use Cronbach's a. According to 
DeVellis [134], the range of possible values may be interpreted as follows: 
less than 0.6 is unacceptable; between 0.6 and 0.65 is undesirable; between 
0.65 and 0.7 is minimally acceptable; between 0.7 and 0.8 is respectable; 
and above 0.8 is very good. 
Golden. et a/., [135] advise that a should be calculated on a sample at 
least twice as large as the number of scale items, however this may not be 
sufficient if there are only a few scale items. Streiner and Norman [136] 
suggest that if a is greater than 0.9, there is likely to be items that are 
duplicating each other. It is argued that in these circumstances the scale can 
be reduced to improve ease of use by the participant. 
However Cortina [137] notes that such general guidelines need to be 
used with caution because the value of a depends on the number of items in 
the scale. It is possible to get a large value of a because there are a lot of 
items in the scale, rather than the scale being reliable in itself. 
Kirshner and Guyatt [85] discuss the rationale for performing internal 
consistency measures in evaluative indexes. Cronbach's a is based on the 
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assumption that the accuracy of the index will increase with the covariance 
of the items and the number of items. This is true of a discriminative index 
but not of an evaluative one. Items in an evaluative index do not need to 
correlate with each other at a single point in time, but must be consistent in 
the way they measure change in health status between two points in time. 
Increasing the number of items in an index, whether they correlate well with 
each other, can increase the chance of including items that are not sensitive 
to efficacious treatment. Random error will be introduced, obscuring 
treatment effect, and increasing participant burden. 
All instruments purporting to be measuring aspects of health or 
disease must produce the same results under the same conditions. 
Reproducibility assessed by intraclass correlations was high as should be 
expected, particularly as the PROM was re-administered after one day. The 
short time period between completion of the PROM is a possible source of 
bias, as the patient is more likely to recollect their response, but as little is 
known of the natural history of haemorrhoidal disease, it was deemed to be 
appropriate to exclude variability due to genuine change in haemorrhoidal 
disease status. 
There is still considerable debate [138] about the choice of method for 
measuring agreement of continuous data, and therefore both intraclass 
correlation coefficient and limits of agreement were used to assess 
reproducibility. The advantage of the ICC is that it measures both the 
variation between subjects in the study and variation between the observers 
[139] i.e. the results from the two PROMs. 
Validity of a patient based outcome measure is complex because 
instruments are measuring an inherently subjective phenomenon [140]. 
Face validity examines whether an instrument appears to be measuring 
what it is intended to measure [141]. There is no formal method for 
evaluating face validity [142]. Guyatt and Cook stated that evaluation of the 
level of relevant expertise involved in generating the content of an 
instrument is important in the evaluation of face validity [143]. This part of 
the thesis involved input by a public health physician who has extensive 
experience of developing and validating outcome measures [144-147] as 
well as an academic colorectal surgeon with similar experience [148,149]. 
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The other criterion is the involvement of patients in the generation and 
confirmation of the instrument's content [150], which was not evaluated in 
this study. This may represent an area of future development if the 
haemorrhoid PROM were to be used as a predictive index of measurement, 
i.e. as a tool in the choice of management modality. 
By definition, criterion validity cannot be truly examined because a 
gold standard is not available for comparison, however it is generally 
acknowledged that in these circumstances a reference test is one that is 
generally acknowledged to be the best test available. 
Therefore the next step is to examine construct validity, which refers 
to the extent to which a measuring instrument correlates with measures of 
other variables that are predicted by, or make sense according to a theory of 
how the variables are related [142]. This requires examination of the extent 
of agreement of patient-reported scores with laboratory or clinical measures 
of disease severity [151], or of the ability of the instrument to distinguish 
between patient groups [152]. 
In this study validity was examined in several ways. First, although 
the haemorrhoid PROM is intended to be an evaluative measure, it is 
important to verify that healthy volunteers did not score high values in the 
haemorrhoid PROM. This was confirmed at all time-points of completion of 
the PROM by the patients, thus confirming that the PROM can also 
discriminate Qetween patients and healthy volunteers. 
The second form of validation was to assess correlation of the 
individual items with quality of life scores. There are no agreed standards for 
how high correlations should be between an instrument and other variables 
in order to establish construct validity [142]. McDowell and Newell have 
stated that correlation coefficients of 0.60 may be strong enough evidence to 
support construct validity [153], however validated studies have used a 
value of 0.40 [127]. 
Although higher values of correlation coefficient were identified for the 
pain scores and total scores, the bleeding and itchl irritation items did not 
correlate well with the QOL score affected by other symptoms. It appears 
that although bleeding and itchl irritation are common symptoms described 
by flaemorrhoid patients, its impact on quality of life is not as significant as 
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the other symptoms within the haemorrhoid PROM. One can postulate that 
by placing all symptoms other than pain into one group, the patient is more 
likely to rank other symptoms such as prolapse as more important to the 
overall effect on quality of life. 
Further validation of the PROM was evaluated by comparing patients 
who clinically required further treatment with those did not. It is encouraging 
to note that there was a significant decrease in all items except itch! irritation 
with moderate sized effect. Higher sizes of effect (r > 0.5) were 
demonstrated with bleeding, the total score and quality of life scores. 
Comparing the item and total scores between varying degrees of 
haemorrhoids produced some interesting and encouraging trends. As would 
be expected patients with first-degree haemorrhoids demonstrated both 
lower scores and low responsiveness to intervention for the items lumps on 
straining. Similar results for pain when not opening bowels, sensation of 
incomplete emptying and mucus or slime are all more likely to be related to 
larger haemorrhoids i.e. ones that prolapse. 
Of interest significant decreases in the bleeding scores were identified 
in all degrees of haemorrhoids, which does not correspond with the majority 
of previous discussions of classification [69, 74, 77], apart from that reported 
by Lunniss and Mann [70, 71]. 
Responsiveness of the entire patient group was also demonstrated for 
all of the i t e m ~ ~ and the total score with a moderate size effect. This satisfies 
an important aspect of developing and validating an evaluative measure, 
which must demonstrate within subject longitudinal change [85]. There are a 
variety of methods for assessing responsiveness which include, examination 
of improvement in scores following application of a treatment of known 
efficacy [85] as used in this study, correlation with change in other scores 
[89], modified standardized response mean [154], sensitivity and specificity 
of change scores [155]. The alternative methods require a physiological or 
other clinical measure to compare to, independent evidence that the patient 
is clinically stable, or an independent standard to determine true change in a 
patient [142]. All of these methods require some form of independent 
measure, which has a similar role to that of a gold standard for evaluating 
criterion validity. 
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In conclusion this study represents encouraging findings and the 
statistical analyses supports preliminary validity of the haemorrhoid PROM, 
however it is acknowledged that there were weaknesses in the study. The 
study population was relatively small, and indeed development and 
validation of a QOL-related PROM can take several years [156] and involve 
extensive numbers of patients. 
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3 THREE-DIMENSIONAL ULTRASOUND AND 
POWER DOPPLER IMAGING 
3.1 INTRODUCTION 
Before discussing the possible methods of assessing volume and 
vascularity of haemorrhoids by using three-dimensional ( 3 ~ ) ) ultrasound 
(US) and Power Doppler (PO) imaging, it is important to discuss the use of 
two-dimensional (20) ultrasound in anal canal imaging, and how it has 
progressed over the last thirty years. 
3.1.1 Two-Dimensional Anal Endosonography 
Anal endosonography (AES) was derived from the development of 
transrectal ultrasound of the prostate [157] and consequent US-guided 
prostatic biopsy [158]. Over the past thirty years AES has been used with 
increasing and more widespread skill to evaluate a spectrum of anorectal 
disorders. 
US waves (2.5 - 15 MHz) are emitted from a piezoelectric crystal and 
depending on tissue characteristics the wave is absorbed, reflected or 
scattered. The reflected waves are transformed into an image. Transrectal 
probes designed for the prostate were found to be unsuitable for AES as 
they caused ,anatomical distortion and discomfort. Therefore high-frequency 
rotating probes protected by a sonolucent hard plastic cone with a maximum 
diameter of 2 cm were designed [159]. This technique gives a series of axial 
images as the probe is slowly withdrawn from the anal canal. 
AES has been thoroughly investigated in healthy volunteers [160-
162]. Several studies have established basic anatomy by making 
comparisons with cadavers [163,164]. The puborectalis muscle, the medial 
part of the levator ani muscle, is easily visualized and serves as a point of 
orientation. It appears as a V-shaped echogenic (white) band, which slings 
posteriorly around the rectum. 
As the probe is withdrawn this band closes anteriorly, thus forming 
the external anal sphincter (EAS). It takes on a different acoustic pattern, 
showing mixed echogenicity with a linear pattern, giving it a "streaky" 
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appearance. The thickness of the EAS is approximately 5-10 mm. In 
females, the anterior portion of the EAS is shorter and thinner, explaining its 
vulnerability to damage during childbirth. A negative correlation between age 
and EAS thickness has been demonstrated in a study of 150 nulliparous 
women aged between 19 and 80 years [161]. Other studies have failed to 
show the same results but suffered from significantly smaller numbers of 
participants [160, 162]. 
The internal anal sphincter (lAS) lies within the EAS and is seen as a 
thin homogenous hypoechoic (black) band, of approximately 1-3 mm in 
width. The lAS increases in thickness with age in both patients and healthy 
volunteers. 
The submucosal layer is of mixed echogenic appearance and is 
collapsed as a result of the pressure of the endoanal probe. There is some 
evidence that the submucosal layer is thicker in patients with haemorrhoids 
[165]. It has also been reported that small hypoechoic areas are seen 
predominantly at the 3, 7 and 11 o'clock positions, which in the authors' 
opinion represented venous channels [161]. The mucosa cannot be 
consistently identified as a separate layer, due to the compression of the 
probe and the frequencies used. 
The longitudinal muscle when seen appears as a mixed echogenic 
layer. One group were able to distinguish this layer from the EAS in 40 % of 
women [1661:. Frudinger et al did so in 67% of the normal female volunteers 
studied. There is no correlation between thickness of the longitudinal muscle 
and age. 
3.1.2 Three-Dimensional Ultrasound 
Conventional US provides 2D views of 3D structures that an 
experienced ultrasonographer has to dynamically examine in order to create 
their own 3D impression of the object of interest [167]. In contrast, 3DUS 
allows the simultaneous assessment of individual sectional planes, which 
dependent upon the particular field of interest may be examined in one of 
several different viewing modalities to maximise the information available 
and improve spatial awareness [168, 169]. Uniquely, 3D US allows 
demonstration of the coronal plane perpendicular to the transducer face 
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facilitating the identification of surface irregularities, which can then be 
accounted for during volume measurement [170]. 
3.1.2.1 Data Acquisition 
All 3D US techniques rely upon production of a composite of multiple 
20 scan images. Computing software is then used to fill in the gaps or 
'interpolate' between these images to produce a solid volume. There are 
several methods available for the acquisition and subsequent display and 
assessment of 3D US data. 
Many commercially available systems (e.g. Siemens SieScape™) 
and fully freehand image acquisition and offline computer processing 
techniques are available. These assume that the acquired images are 
equidistant and parallel, which is rarely true. Alternatively, electromagnetic 
position sensing devices precisely locate the ultrasound transducer while 
scanning freehand. This is described as a 'six-degrees-of-freedom' method 
as it provides three-dimensional co-ordinates in addition to angulation in 
three dimensions. 
Whilst relatively complex, largely due to the need to calibrate the position-
sensing device, this method is highly accurate [171, 172]. Mechanical 
transducer arms (e.g. TomTec™) ensure the acquisition of perfectly parallel 
images at predefined linear intervals but are less well suited to non-linear 
objects [173]. 
.. 
Probably the most commonly used and reported technique involves 
the use of purpose built phased array ultrasound transducers. These 
transducers fan or rotate the ultrasound beam and acquire two-dimensional 
images at predefined intervals, described as the 'swept-volume' technique. 
Abdominal transducers produce a pyramid-shaped volume and vaginal 
transducers a cone-shaped volume (fig 3-1). This allows the exact spatial 
co-ordinates of 20 images to be incorporated and an accurate volume to be 
created. They are easy to use and produce standardised volumes of densely 
sampled data without irregular gaps. They have been measured to have a 
mean absolute error of around 1 % for distance and 6.4% for volume under 
experimental conditions using tissue-mimicking ultr.asound phantoms in a 
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water bath [174]. Their main limitation is the maximum volume that can be 
measured due to the position and size of the transducer. 
3.1.2.2 Data Analysis 
When one thinks of 3D imaging in terms of its measurement 
capability the most obvious parameter considered is that of volume. Whilst 
volume may be estimated from measurements made with conventional 20 
US, such measurements use various formulae based upon certain 
geometric assumptions [175]. Volume estimation based on 3D US still 
involves a degree of geometric assumption, as data are reconstructed based 
upon their most probable position within a Cartesian grid system, but utilises 
much more information. There are two basic methods employed to calculate 
volume from a 3D dataset: the conventional 'full planar' or 'contour' method 
and the more recently introduced 'rotational' method possible through Virtual 
Organ Computer-aided Analysis (VOCAL TM) which also generates a 3D 
model of the object of interest [176]. Both techniques involve manual 
delineation of the object of interest in the multiplanar display that shows the 
three perpendicular planes characteristic of 3D US. 
3D US can also be used to acquire vascular information through the 
simultaneous application of Doppler US. Conventional colour Doppler is not 
suited to 3D imaging due to the continual changes in colour induced by 
variations in blood flow velocity and direction [177]. PO produces a more 
stable image that facilitates data acquisition and assessment particularly of 
longer vascular segments, which are displayed continuously on screen 
[178]. This information is acquired as the US beam is swept through an 
angle determined by the observer dependent upon the size and position of 
the object of interest. The Power Doppler signal may then be quantified by 
one of several currently available software programmes. 
The vast majority of the medical literature reports the use of the 
'histogram' facility within 3D View and more recently 40 View (GE Kretz, 
Zipf, Austria) [179] (fig 3-2). This calculates three indices of vascularity 
based upon the signal intensity within, and distribution of, colour voxels 
within the defined volume, where a voxel refers to c;I volume element or 
three-dimensional pixel. The Vascularisation Index (VI) reflects the ratio of 
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Power Doppler information within the total dataset relative to both colour and 
grey information. The Flow Index (FI) represents the mean Power Doppler 
signal intensity, and the Vascularisation Flow Index represents a 
combination of the two [180]. The VI is presented as a percentage figure, 
and although the FI and VFI may range between 0 and 100 they are 
generally quoted without units. 
3.1.3 Transperineal Ultrasonography 
First described in 1974 [181] transperineal ultrasonography (TPUS) 
has been used in a wide variety of clinical settings. These are listed in table 
3.1. Several investigators have presented evaluation of anal sphincter 
anatomy, defects, and perianal pathology through a transperineal approach 
[182-193]. A selection oftransducers have been used including transvaginal, 
linear and curved linear with varying frequencies, between 3 and 12 MHz. 
The transperineal approach has several potential advantages over 
AES, including absence of distortion of the anal canal by the transducer 
during examination, visualization of perirectal processes several centimetres 
from the rectal lumen, multiplanar view if using 3D US or sagittal views by 
turning the transducer through 90 degrees, and greater acceptability to the 
patient, especially when pain or diminished size of the anorectal lumen is an 
issue. 
Disadvantages include limited penetration above the caudal 5cm of 
the rectum and potential contact problems with air, depending on the shape 
of the transducer. AES may also provide more detailed information because 
of higher resolution and closer contact to the examined tissue. 
The EAS appears as a hyperechoic ring and the proximal part is 
adjacent to the sling of the puborectalis, which is hyperechoic as well. The 
mucosa and submucosa are clearly evident as the hyperechoic central 
portion surrounded by the hypoechoic lAS. 
Only one published study has documented the thickness of the lAS 
and EAS on both TPUS and AES. Females (n = 64) who had been referred 
for urinary incontinence, with no previous history of anorectal surgery, were 
scanned by both methods. The mean thickness of the lAS was 2.1 ± 0.8 mm 
and 2.8 ± 0.7 mm on AES and TPUS respectively. The mean thickness of 
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the EAS was 6.2 ± 1.5 mm and 5.6 ± 1.8 mm respectively. Statistical 
analysis by t-test showed a significant difference between EAS and TPUS 
for both the lAS (p < 0.0001) and EAS (p < 0.039). TPUS identified two more 
defects within the sphincters than EAS, but this was not statistically different. 
These defects were not confirmed surgically and the authors did not 
question their patients about symptoms of faecal incontinence [194]. 
Speciality 
Obstetrics [191] 
Paediatrics [183, 186, 190] 
Clinical Presentation 
Placenta praevia 
Incompetent cervix 
Preterm labour 
Presenting part of foetus 
Urethral obstruction 
Anorectal anomaly 
Ambiguous genitalia 
Vaginal anomaly 
Presacral mass 
Traumatic priapism 
Gynaecology [182,185,188,192, Pelvic floor (static! dynamic) 
193, 195] Stress incontinence 
Neoplasia 
Surgery [187,189,194] 
Infertility 
Sphincter evaluation 
Perianal fistula disease 
Sphincter evaluation 
Distal ureteric calculi 
Table 3·1 Indications for transperineal ultrasonography. 
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3.1.4 The Use of Doppler Ultrasonography 
The Doppler effect produced with ultrasonic frequencies has been 
used in medicine for almost fifty years. In that time, advances in technology 
have made it possible to use Doppler effect not only to determine whether 
flow is present but also to visualize flow in two and even three dimensions 
as well as providing semi-quantitative information. 
The shift in frequency is related to the contraction or expansion of 
wavelengths ahead of or behind the sound-emitting object. Because US is 
used in a transmit-echo approach, there is a Doppler effect with the sound 
arriving at the scattering object and a Doppler effect as the sound is 
reflected from that object back toward the US transducer. In US the round 
trip for sound is related to the depth and speed of sound in tissue. The 
Doppler equation is denoted by 
fD = 4f = 2·fo· vrbc' cos 9 
c 
Equation 3-1 The Doppler equation. 
fD is the Doppler shift frequency, fo is the transmitted frequency, Vrbc is velocity of 
the red blood cell, e is the angle between the direction of sound propagation and 
the motion of the particle and c is the speed of sound in tissue (assumed to be 
1540 msec-1). Hence the velocity of red blood cells can be derived. 
The application of this equation in basic US equipment will produce 
estimates of the blood flow velocity from the frequency shifts within the 
lumen and the variation of blood flow velocity within the cardiac cycle [196]. 
3.1.4.1 Continuous Wave Doppler 
In this form of Doppler, sound is emitted from a transmitting 
transducer continuously. A second receiving transducer must detect sound 
that echoes back. The two transducers are arranged to overlap their beams, 
resulting in a region of interest (ROI) where the Doppler shifted signals may 
be detected. 
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3.1.4.2 Pulsed Wave Doppler 
Pulsed sound is used instead of continuous sound. Pulsed wave 
Doppler US is also referred to as duplex Doppler US. This refers to the fact 
that the instrument shares time and interrogation of acoustic pulses with a 8-
mode operation, thereby providing both a 8-mode image (2D) and pulsed-
wave Doppler information. 
A pulsed wave instrument uses a single transducer in pulse echo 
mode, and this is typically the same transducer used for 8-mode imaging. 
The transducer is used to transmit a pulse down an axis defined by the 
operator. A train of pulses (8 to 20 pulses sent sequentially) is transmitted 
down the axis to sample a volume at a depth defined by the transducer 
beam width and the ranQe gate. 
The range gate, which can be adjusted by the operator, is the means 
by which returning echoes from a particular range in time are separated out 
for analysis by the Doppler instrumentation. The operator is also able to 
adjust the angle between the ultrasound beam axis and the primary direction 
of blood flow in the vessel. There are higher errors in velocity estimation as 
the angle approaches 90°. This adjustment of the Doppler angle by the 
operator corrects the calculated velocity. Doppler angles between 30° and 
60° are easiest to image while providing velocity estimation with a minimal 
error. 
The returning Doppler frequency shifts are electronically converted by 
a mathematical technique, fast Fourier transformation, and displayed against 
time as a waveform. This waveform, which represents changes in blood flow 
velocity throughout the cardiac cycle, can be analysed to generate indices of 
blood flow in terms of the absolute flow velocities during peak systole and 
diastole as well as providing an indication of the resistance to flow over the 
whole cardiac cycle. Two formulae are used to calculate the degree of 
resistance to flow: the Resistance Index (RI) and the Pulsatility Index (PI). 
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RI = 
PSV -EDV 
PSV 
Equation 3-2 The RI or Pourcelot's ratio. 
PSV is peak systolic velocity, EDV is end diastolic velocity. The index ranges from 
o to 1.00 with the latter occurring in the absence of end diastolic flow [197]. 
The RI is easily measured by defining the maximal systolic flow 
velocity and the end-diastolic flow velocity as two separate points. The PI is 
calculated by the on-board computer following manual delineation of the 
complete waveform over three to four consecutive and comparable cardiac 
cycles. 
PSV -EDV 
PI = 
Equation 3-3 Calculation of the PI. 
PSV is peak systolic velocity, EDV is end diastolic velocity. Vm is the mean velocity 
[198]. 
The PI has the advantage therefore of taking into consideration more 
of the frequencies within any given waveform. 
3.1.4.3 Colour Doppler 
Colour flow imaging takes the pulsed-wave Doppler concept a step 
further by using Doppler frequency shift detection over a set of range gates 
along a number of acoustic lines. The result is a 2D image depicting flow 
that is superimposed on the 2D grey-scale image generated from 
backscattered echoes. 
It is important to provide real-time colour flow imaging. Shorter 
interrogation pulses are used to achieve this. Pulsed-wave Doppler uses 8 -
20 pulses, whilst colour Doppler uses 2 - 4 pulses for each line in the colour 
flow image. This means that colour Doppler is less sensitive to flow, at lower 
flow rates and in smaller vessels compared to pulsed-wave Doppler 
ultrasound. 
Colour Doppler is a measure of the directional component of the 
velocity of blood moving through a sample volume: It suffers from inherent 
limitations including a tendency for noise to overwhelm the flow signal if the 
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gain is too high or the Doppler display threshold too low, Doppler angle 
dependence and aliasing. 
Aliasing occurs as a result of sampling of data at discrete points in 
time, in particular when the rate at which interrogating pulses are sent to 
obtain the phase shift information is less than twice the value of the Doppler 
shift frequency. The data points in the sample and hold circuit are obtained 
at specific intervals in time (d T). Two samples or less per period of the 
maximum frequency will result in an erroneous lower frequency being 
reconstructed from the sample and hold data. 
The sampling rate also known as the pulse repetition frequency 
(PRF) and is dictated by the depth of the range gate in the body, and 
therefore by the round trip time (RTT) between the transducer and the range 
gate depth. This is expressed as 
1 C 
PRF = -= -------
RTT 2. range gate dept" 
Equation 3·4 Calculation of pulse repetition frequency. 
Where PRF is samples per second, RTT is the round trip time in seconds, c is the 
speed of sound propagation in tissue (1540 msec-1), and range gate depth is in 
metres. 
3.1.4.4 Power Doppler 
This is a variation of colour flow imaging, where instead of depicting 
the mean Doppler frequency shift, the Doppler shift frequencies are summed 
up. The hue and brightness of the colour signal represents the power in the 
Doppler signal, which is related to the number of red blood cells producing 
the Doppler shift. Colour flow imaging depicts both the velocity and direction 
of flow, but the power mode imaging depicts only the intensity of the Doppler 
shift. The advantage of power Doppler (PD) is that slow flow rates and small 
vessels are more easily depicted in comparison to colour flow imaging [199]. 
Power Doppler displays several advantages over colour Doppler. The 
main advantage is the increased gain that can be employed. In power 
Doppler, noise is assigned to a homogeneous background, even when gain 
is increased greatly over the level at which noise begins to obscure a colour 
Doppler image. In colour Doppler noise appears as a random colour totally 
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obscuring any information-containing signal. This is a result of inherent 
differences in the information being displayed when colour and power 
Doppler images are produced. 
Noise is extraneous, unwanted signal that invade the electrical or 
optical system in use. Doppler noise is a random process and therefore has 
a random phase angle. The frequency shift in colour Doppler is dependent 
on the rate of change of the phase angle, and therefore noise can appear as 
flow from any direction and of any velocity. 
Noise has a very different appearance in power mode. Noise has a 
very low power when compared to information-containing signal and 
assumes a uniform appearance, whereas information-containing signal 
appears as a different colour. Power Doppler uses more of the available 
dynamic range when producing flow images, thus increasing a machine's 
flow sensitivity [200]. 
Another advantage of Power Doppler over colour Doppler is that it is 
essentially angle independent. Initially this is difficult to understand when 
studying the Doppler frequency equation (equation 3-1). The number of 
cells, which cause scatter, at any given location is angle independent. Once 
the number of cells has been dictated by physiological circumstances, the 
power Doppler signal appears the same from any direction as long as a 
Doppler shift is detectable. 
Another advantage of power Doppler is that it may also be used to 
objectively assess vascularity through the quantification of the signal 
amplitudes following the development of various image analysis computer 
software programmes [201]. Therefore the main role of power Doppler 
imaging is to define the position and distribution of vessels within any given 
field and to demonstrate the presence of flow within them [202]. By 
displaying background noise as a uniformly colour readily distinguished from 
true flow the usable dynamic range is extended and the sensitivity enhanced 
[203] 
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3.2 AIMS 
The aim of this study was three-fold. Primarily it was to establish a 
reliable method of imaging the anal canal including haemorrhoids in patients 
and anal cushions in healthy volunteers using three-dimensional Doppler 
US. The second aim was to assess methods for semi-quantification of 
vascularity of haemorrhoids and anal cushions. The final aim was to assess 
the effect of rubber band ligation treatment on the vascularity of the 
haemorrhoidal zone. 
3.3 METHOD 
The methods sectiqn is divided into three parts. The first phase 
focuses on early work, which determined the optimum equipment and 
technique for obtaining US images and Doppler studies of the anal canal, 
anal cushions and haemorrhoids. The second phase examines the choices 
available for measurement of volume and vascularity from 3D US datasets. 
The third phase focuses on analysis of 3D Doppler US studies, including 
accuracy of software measurement techniques, potential changes in Doppler 
measures over time, following treatment, and possible correlation with 
symptom scoring in healthy volunteers and patients. 
3.3.1 Ethics 
Ethical approval to image thirty patients was gained from the 
Nottingham Research Ethics Committee 2 (part of the Central Office for 
Research Ethics Committees). Concurrent approval was also given by the 
Research & Development Department at Nottingham University Hospital 
NHS Trust. Approval was given by the University of Nottingham Medical 
School Ethics Committee to scan healthy volunteers. 
3.3.2 Equipment 
The choice of Doppler modality was limited to the availability at NUH 
NHS Trust and the University of Nottingham. Nurture is the infertility 
treatment centre based in NUH NHS Trust and owns a Voluson 730 
Expert® machine capable of 3D US, duplex Doppler and Power Doppler 
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imaging. I have been very fortunate in having access both to the machine 
and the time of the staff within Nurture. 
At the beginning of the study, there were several questions to be 
answered. Which of the available modalities are the most appropriate for 
measuring blood flow in the anal canal: pulsed wave Doppler or power 
Doppler? Secondly would it be possible to carry out endoanal scanning 
without compressing the haemorrhoids and therefore altering blood flow in 
the region? Finally the only probe initially available for use was a 
transvaginal probe, and the question here was how suitable this would be for 
endoanal scanning. 
All scans have been carried out on the same Voluson® 730 Expert 
machine and with the help of the senior untrasonographer from Nurture, 
Jeanette Clewes, and consultant gynaecologist Nicholas Raine-Fenning. 
3.4 METHOD PHASE I: Determination Of Approach and 
Ultrasound Technique 
3.4.1 Experimental Design 1 
A 47 year-old patient with second-degree haemorrhoids was 
positioned in the left lateral position, with the hips and knees flexed. An 
attempt was made to pass an Eisenhammer retractor to allow placement of 
the endovaginal probe adjacent to each haemorrhoid. Unfortunately the 
patient could not tolerate this part of the procedure, and therefore the 
7.5MHz endovaginal transducer (RIC 5-9) of 2.5cm diameter was inserted 
into the anal canal without being able to verify it's exact depth. 
Angling the thumb depression of the transducer towards the 12, 3, 6 
and 9 o'clock lithotomy positions, pulsed wave Doppler was used to assess 
blood flow in the region. 
3.4.2 Experimental Design 2 
Three male patients were examined in this experimental design. The 
first two patients, aged 42 years and 55 years, were undergoing PPH, and 
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therefore were scanned under a general anaesthetic. The third patient aged 
77 years attended prior to undergoing a haemorrhoidectomy. 
Prior to scanning the patient a disposable proctoscope had been 
marked with 1 cm graduations. The distance from the distal level of the 
haemorrhoids to the anal verge was measured. The sheath covering the 
endovaginal transducer had also been marked with 1 cm graduations, and 
therefore the transducer was placed into the anal canal just below the 
haemorrhoids. The transducer's thumb depression was orientated to the 12 
0' clock position. Every effort was made by the researcher to limit movement 
of the transducer. The third patient was asked to remain as still as possible. 
3.4.3 Experimental Design 3 
An endoanal probe (RRE 6-10), lent by GE, was trialled in this 
experimental design. A 48 year-old female with second-degree 
haemorrhoids was positioned in the left lateral position. The endoanal probe 
was placed 3cm into the anal canal, at the level of the haemorrhoids at the 3 
o'clock lithotomy position. A 3D power Doppler dataset was acquired on the 
slow speed sweep mode with a pre-determined angle of 120 degrees, with a 
set depth of O.Scm. This was repeated at the 7 and 11 o'clock positions. This 
process was repeated with the endovaginal probe. 
3.4.4 Experimental Design 4 
A 48 year-old female with second-degree haemorrhoids was scanned 
in the supine position with the hips flexed and abducted. The endovaginal 
probe was placed on the perineum of the patient, with the thumb depression 
in the 6 o'clock position, and the probe angled at approximately seventy 
degrees to the horizontal. 
3D grey-scale datasets were acquired on the medium speed sweep 
mode, and 3D power Doppler datasets were acquired on the slow speed 
sweep mode. The probe was removed from the perineum and then 
replaced, and further acquisitions of grey scale and power Doppler datasets 
were made. 
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3.4.5 Determination of power Doppler settings 
A further part of the initial study was designed to establish the best 
power Doppler settings for examination of the anal canal. This was 
performed by adjusting a single parameter, and maintaining the others at a 
constant level. The baselines used were the standard abdominal and 
penetration protocols saved on the Voluson® 730 Expert machine. 3D 
power Doppler datasets were acquired at each setting and then examined 
subjectively to determine the settings, which provided the clearest vascular 
information without creating artefact or exaggerating attenuation. 
3.5 RESULTS PHASE I: Determination of approach and 
ultrasound technique 
3.5.1 Experimental design 1 
Figures 3-3 and 3-4 are examples of the images acquired using 
pulsed wave Doppler. A scale with 1 cm markings is present on the left hand 
side of the screen. The most obvious feature of both images is the presence 
of gas-filled loops of bowel surrounded by multiple blood vessels, 
approximately 1 cm from the tip of the transducer. 
Another feature is the presence of multiple large vessels that were 
both arteria.! and venous in nature (venous trace not shown). Most 
importantly it was not possible to see any anatomical landmarks such as the 
pubis and bladder. 
In figure 3-4 a range gate had been positioned over one of the larger 
vessels, and an arterial waveform was clearly evident. To calculate indices 
of blood flow, the cursor is used to trace the waveform of at least three 
cycles. Indices of blood flow from pulsed wave Doppler include PSV, EDV, 
Vm, PI and Rio The values are shown in the bottom right-hand corner. 
The process of tracing the waveform must be carried out during the 
scan. The resulting image and vascular indices must then be stored in 
Sonoview, the hard-drive of the 730 Expert. It is not possible to calculate the 
vascular indices once the image has been stored. 
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3.5.2 Experimental design 2 
The aim of this experiment was to position the transducer in the anal 
canal, without compressing the haemorrhoids, thereby imaging them in a 
more physiological state. Figures 3-S and 3-6 show images acquired from 
pre-operative patients. 
On assessing the images acquired from each of the three patients, it 
became clear that the quality of imaging was poor. It had been difficult to 
reproduce the same image in each patient. Maintaining the transducer in the 
anal canal at the required depth (2 - 4 cm) was awkward as the tone of the 
anal canal naturally ejects the transducer. 
Although the transducer may not have been compressing the haemorrhoids, 
it is logical to assume that its presence will affect blood flow in the region. 
3.5.3 Experimental design 3 
The endoanal transducer (RRE 6-10) is normally used for imaging the 
prostate, and hence has a head angled at approximately 30 degrees to the 
handle. Unfortunately the quality of imagin'g was very poor, most likely due 
to malfunction rather than being inappropriate for the desired purpose. 
Therefore data was acquired using the endovaginal probe (RIC S-9) (figs 3-7 
to 3-9). The aim of this experimental design was to acquire power Doppler 
information from a ring of submucosa at the level of the haemorrhoids; 
hence the depth was set to O.Scm. 
Overall, the same problems were encountered as in experimental 
design 2. Maintaining the transducer within the anal canal at the desired 
depth was difficult. Angling the transducer, by orientating the thumb 
depression, to the 3,7 and 11 o'clock positions was awkward and slightly 
uncomfortable for the patient. It was likely that there was an overlap of 
acquisition of data between the three 120-degree sectors. 
3.5.4 Experimental design 4 
At this point in the study, a literature search using the terms "three-
dimensional", "3D", "ultrasonography" and "anal sphincter" produced several 
papers where the authors[184, 18S, 192] had used the transperineal route to 
e)(amine the pelvic floor and anal sphincters. 
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This particular technique appeared very attractive with respect to imaging 
haemorrhoids, as there would be no compression of the haemorrhoids or 
stretching of the anal canal. The approach was more likely to be acceptable 
to the patient or volunteer. These images were immediately convincing, 
particularly when viewing the transverse images (figs 3-10 and 3-11). 
3.5.5 Choice of approach and ultrasound technique 
On reviewing the experimental designs and the acquired images, the 
transperineal approach was judged to be the most successful. The axial 
transperineal images were the most similar to endoanal images, with respect 
to the surrounding sphincters. The mucosa and submucosa are seen as 
separate structures, and visual correlation to the proctoscopic appearances 
of anal cushions or haemorrhoids is apparent. Doppler signal was visualised 
in the submucosa (fig 3-11) of all the imaged patients. The technique was 
less invasive and did not involve compression of the haemorrhoids or 
dilatation of the anal canal. 
3.5.6 Final power Doppler settings 
When determining the most appropriate settings the three key factors 
considered were the total amount of power Doppler information within the 
final 3D dataset, the degree of attenuation, small vessel information at the 
level of the submucosa and the vessel clarity overall. 
.. 
A fast acquisition speed was regularly associated with a subjective 
loss of power Doppler information relative to the medium and slow 
acquisition speeds. Little difference was seen between the medium and 
slower acquisition speeds although the latter was associated with a higher 
incidence of movement artefact. 
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Factor 
Pulse Repetition Frequency 
Power 
Gain 
Wall Motion Filter 
Acquisition Speed 
Setting 
0.6 
100 
-5.6 
Low 1 
Medium 
Table 3·2 Final settings used for all subsequent patient and volunteer studies. 
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Figure 3-1 Automated method of 3D US data acquisition. 
The US beam is directed to a starting point and then swept through 
an angle defined by the user, who's mid-point is the initial image on 
the screen. During this 'sweep' a series of 20 planes are acquired 
each with reference to the adjacent planes and equidistant between 
them. Image courtesy of Kretztechnik H' , Zipf, Austria / Medison H ' , 
Seoul, Korea. 
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Figure 3-2 Transperineal ultrasound. 
Perineal position of the probe to obtain different cross-sections of 
the anal canal. Reproduced from Kleinubing, H., Jr., et aI., 
Transperineal ultrasonography: new method to image the anorectal 
region. Dis Colon Rectum, 2000. 43(11): p. 1572-4. Image courtesy 
of Wolters Kluwer Health. 
Figure 3-3 Experimental Design 1 
Pulsed wave Doppler assessment of anal canal. 
(0 
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Figure 3-4 Experimental Design 1 
Range gate applied to vessel. The waveform represents changes in 
blood flow velocity through eight cardiac cycles . 
Figure 3-5 Experimental Design 2. 3D image acquired using 
power Doppler from a pre-operative patient. 
The multiplanar display of the 3D ultrasound datasets demonstrates 
three mutually related orthogonal planes at gO-degrees to one 
another. The upper left image represents the longitudinal plane, the 
upper right image the coronal plane and the lower left image the 
transverse plane. The lower right image represents the 
amalgamation of all three planes. 
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Figure 3-6 Experimental Design 2. Transverse image of third-
degree haemorrhoids, acquired using 3D power Doppler. 
The mixed echogenic central portion where there is evident blood 
flow could be interpreted as the mucosa and submucosa (yellow 
arrow). Therefore the surrounding hypoechoic area could represent 
the internal anal sphincter (blue arrow). It then follows that the 
surrounding hyperechoic area could represent the external anal 
sphincter (red arrow). Significant artefact is also noted. 
Figure 3-7 Experimental Design 3. 
Power Doppler data acquired using a sweep angle of 120-degrees 
with a set depth of penetration of O.Scm. 
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Figure 3-8 Experimental Design 3. 
The rotation angle is selected (in the example above, 30 degrees) 
and the manual mode of measurement entered. The entire sector 
was then traced using a Graphire4TM pen and tablet until completion 
of 180 degrees of rotation and the generation of a calculated 
volume. 
Figure 3-9 Experimental Design 3. The rotational technique of 
volume calculation. 
The dataset has already been rotated through 180 degrees about 
the central axis. VOCAL gives the user the opportunity to adjust the 
manually delineated border. The resultant 3D model is shown in the 
lower right of the image, along with the calculated volume. 
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Figure 3-10 Experimental Design 4. Multiplanar view of anal 
canal using TPUS. 
As the thumb depression had been orientated to the 6 o'clock 
position, the sagittal image is in the top left (A-plane), the 
transverse image in the top right (B-plane) and the coronal image in 
the bottom left (C-plane) . 
Figure '3-11 Transverse image of the anal canal. 
The yellow arrow shows the mixed echogenic central mucosa and 
submucosa , within which the folds of mucosa can be seen. The 
blue arrow points to the hypoechoic internal sphincter, and the red 
arrow to the hyperechoic external sphincter, which is visibly 
deficient anteriorly. 
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Figure 3-12 Transverse EAS obtained at the level of the middle 
anal canal. 
The external sphincter ring (between blue arrows) is fully formed 
anteriorly, and the internal sphincter (between red arrows) is intact. 
The submucosa is the hyperechoic ring internal to the hypoechoic 
lAS. Image courtesy of Debbie Bush, Department of Surgery, UHN 
NHS Trust. 
3.6 METHOD PHASE II: Data Analysis 
Analysis of the US data was conducted using 4D View on a MacBook 
Pro, running Parallels version 3.0. Volume measurements were largely 
undertaken using Virtual Organ Computer-aided Analysis II (VOCAL 'I'M II) 
software within 4D View, as this was used to quantify the power Doppler 
signal within a pre-defined shape. Quantification of power Doppler signal is 
not possible with conventional volume measurement as this technique does 
not define a model, and whilst 4D View can be used to examine the power 
Doppler signal it can only do so through the application of a pre-set or user-
defined shape. 
Shell imaging facilitates the generation of a parallel contour outside, 
inside or symmetrically across the originally defined surface contour. For the 
purposes of examining the surrounding sphincters an 'outside' shell was 
used so that vascular information from the surrounding smooth muscle could 
be obtained. 
With VOCALTM II, all of the individual sectional planes within any given 
volume can be retrieved and displayed as conventional2D images or as a 
3D image. For measurement purposes the multiplanar display was used 
throughout (fig 3-10). This display allows the three mutually related 
perpendicular sectional planes to be visualised simultaneously. Because the 
planes are at 90 degrees to each other, this display is often referred to as 
the orthogonal image display. The images can be rotated in any direction 
and if one plane is moved the corresponding planes move in a reciprocal 
manner. This allows a specific region to be viewed in each of the three 
planes. Prior to any measurement the multi planar display was orientated to 
provide consistent reference to the data acquired. This involved ensuring the 
sagittal image was shown in the upper left image (the A plane), the 
transverse image in the upper right image (the B plane) and the coronal view 
in the lower left image (the C plane). The transducer was always orientated 
such that the sagittal view of the anorectal angle was on screen at the start 
of the data acquisition and was thus seen in the A plane following data 
acquisition with the remaining planes shown as outlined above. 
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3.6.1 Rotational Volume Measurement 
Rotational measurements of regions of interest from the anal canal 
were undertaken with VOCAL 1M II, an extension of 40 View. The basic 
principle of VOCAL II is the combination of 3D ultrasound tissue presented 
as voxels and the geometric information of surfaces in a 3D dataset. 
Calculation of the surface geometry is the first step of VOCAL II. The surface 
geometry is defined by rotating an image plane around a fixed axis, and 
defining 20 contours on each plane. 
There are four rotation angles to choose from: 30, 15, 9 or 6 degrees. 
The entire dataset is rotated about 180 degrees and therefore this results in 
6, 12, 20 or 30 planes respectively being available for measurement. 
The intention of this 'part of the study was to define a reproducible 
region of interest (ROI) of the anorectum, which included the haemorrhoids 
or anal cushions. The power Doppler signal could then be quantified within 
the ROI, using the 'histogram' facility (fig 3-18), which generates the three 
indices of vascularity, previously described in section 3.1.2.2. (See appendix 
8.2 for a more detailed explanation). 
For these rotational measurements two callipers were placed at the 
superior and inferior aspects of the submucosa on the axial view (fig 3-13). 
The junction between the submucosa and internal anal sphincter is then 
traced in a clockwise fashion using a Graphire4TMpen and tablet (fig 3-14) . 
.. 
The volume is rotated through 9 degrees about the resultant axis; the 
submucosa-internal anal sphincter interface is again traced to ensure all of 
the submucosa had been included (figs 3-15 & 3-16). The final volume of 
interest is accepted (fig 3-17) and the vascular induces are calculated via 
the histogram facility (fig 3-18). 
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3.6.2 Sphere as Volume of Interest 
For the purposes of this part of the study, the initial multiplanar image 
(fig 3-19) is magnified by a factor of 1.5. Static volume contrast imaging 
(VCI) is used to increase the differentiation between the tissue layers (figs 3-
20 and 3-21). The cursor is then centred on both the axial and coronal 
images (fig 3-21). The coronal image is then rotated until the axis runs on a 
true vertical. The cursor is then moved along the vertical axis of the coronal 
image until puborectalis is just visualised on the axial image (fig 3-22). 
VOCAL II was then selected, following which a sphere as the region of 
interest is selected. Two c ~ l I i p e r s s are placed at the anterior and posterior 
aspects of the submucosa - internal anal sphincter interface (fig 3-23). The 
volume is rotated about the resultant axis to ensure they were appropriately 
sited and that all of the submucosa has been included. The anal canal 
sphere is defined as the volume defined by the diameter set by the callipers 
(fig 3-24). The region of interest is accepted and the histogram is then 
displayed. 
3.7 RESUL TS PHASE II: Data Analysis 
3.7.1 Rotatio"nal Volume Measurement 
Although this method was initially thought to be promising, difficulties 
with delineating the ROI soon became apparent. The coronal and sagittal 
views cannot be defined at the submucosa -lAS interface (see figs 3-16 
and 3-17), because the anorectum is a tubular structure with no cranial or 
caudal limits. The only cranial and caudal limits are those set by the 
limitations of the volume acquisition of the transperineal transducer. 
As seen in figure 3-17 the final ROI is essentially tubular, centred on 
the anorectal angle. Within VOCAL II whilst manually defining the ROI, there 
was no available option to measure a set distance from the anorectal angle 
to produce a three-dimensional tube of set length cen.tred on the anorectal 
a n g l ~ ~ Therefore this method of defining a ROI was rejected. 
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3.7.2 Sphere as Region of Interest 
Alternative methods of analysis of the anal canal were assessed, as 
the cranial and caudal aspects of an essentially tubular structure were 
impossible to delineate accurately or with high reproducibility with the 
rotational method. 
VOCAL II also allows the user to use a sphere as a ROI rather than 
defining the ROI manually on each 2D plane. The diameter of the sphere is 
set by the callipers, and the position set by the cursor visualised on each of 
the three orthogonal planes. By positioning the sphere at the anorectal 
angle, confirmed by visualization of the puborectalis muscle, and by setting 
the diameter of the sphere by the submucosal axial diameter, a reproducible 
ROI could be assessed. 
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Figure 3-13 Rotational Volume Measurement 
Two callipers are placed at the superior and inferior aspects of the 
submucosa on the transverse view. 
Figure 3-14 Rotational Volume Measurement 
This volume has been rotated around the set axis, and then the 
junction between the submucosa and the internal anal sphincter is 
traced. 
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Figure 3-15 Rotational Volume Measurement 1 
The volume has been rotated again around the axis. Note the 
change .in orientation of the orthogonal planes. 
Figure 3-16 Rotational Volume Measurement 2 
As the volume is rotated, it becomes more difficult to delineate the 
interface between the submucosa and the internal anal sphincter, 
which is unsurprising as there is no anatomical superior limit to the 
submucosa; it is continuous with that of the rectum. 
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Figure 3-17 Rotational Volume Measurement 3 
The volume of interest has been rotated through 180 degrees, and 
a volum.e has been generated. 
Figure 3-18 Rotational Volume Measurement 4 
The histogram facility has been generated , and the results show the 
three vascular indices. 
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Figure 3-19 Sphere as Region of Interest 1. 
Initial volume before adjustments are made for sphere volume 
analysis. 
Figure 3-20 Sphere as Region of Interest 2. 
Using static vel to increase differentiation between submucosa and 
the internal anal sphincter. 
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Figure 3·21 Sphere as Region of Interest 3. 
Magnification by a factor of 1.5, and centring of cursor on axial and 
coronal planes . Note the coronal plane is now vertical. 
Figure 3·22 Sphere as Region of Interest 4. 
The puborectalis sling is identified in the axial image. 
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Figure 3-23 Sphere as Region of Interest 5. 
Callipers are placed at the submucosa-internal anal sphincter 
interface. 
Figure 3-24 Sphere as Region of Interest 6. 
VOCAL generates a sphere who's diameter is based on the 
distance between the calipers . In this example VOCAL has also 
been used to generate a 2mm shell external to the sphere. A 
histogram is then applied to generate the vascular indices (not 
shown). 
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3.8 METHOD PHASE III: Patient and Healthy Volunteer 
Studies 
3.8.1 Protocol for imaging patients and volunteers. 
Following the first and second parts of the study to establish best 
technique and software analysis, fifteen patients and eleven healthy 
volunteers were recruited between December 2005 and June 2007. All 
patients were recruited from a general surgical clinic, following a standard 
history and examination including proctoscopy and rigid sigmoidoscopy to 
exclude other colorectal pathology. All patients were diagnosed with 
haemorrhoids; treatment ,?ptions were discussed and consent to rubber 
band ligation was obtained prior to the study being mentioned. Patients were 
offered time to consider joining the study, and were contacted by telephone 
to arrange either the first scan or a return to clinic for rubber band ligation if 
they did not wish to participate in the study. 
The same Voluson 7300 ™ machine (Kretztechnik ™ , Zipf, Austria / 
MedisonTM, Seoul, Korea) and 7.5 MHz transvaginal probe were used 
throughout. All 3D data was acquired in an identical fashion with the 20 
plane being swept through a specific fan plane by automatic rotation of the 
mechanical transducer (fig 3-2). Ultrasound data analysis was conducted 
using 40 View (Kretztechnik / Medison) and was performed with Virtual 
Organ Computer-aided Analysis (VOCAlTMII) using the anorectal angle 
sphere method. Each patient was scanned via the transperineal approach 
immediately before rubber band ligation, two, six and eight weeks after 
rubber band ligation. 
The probe was positioned on the perineum (see fig 3-2) and at least 
three sets of 3D power Doppler data acquisitions were performed. The 
probe was removed between each dataset acquisition and the process was 
repeated at least twice. Immediately after the first scan, rubber band ligation 
of haemorrhoids·was performed. 
Eleven healthy volunteers were recruited via posters placed around the 
University of Nottingham medical school and University Hospital 
. 
Nottif)gham. A general history was taken from each volunteer prior to 
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recruitment and scanning, to exclude any colorectal history. Each volunteer 
was scanned on days one, three and thirty-five from the start of the study. 
As for each patient, at least three datasets were acquired during each scan. 
Each patient and volunteer was scanned in a supine position with 
knees flexed and hips abducted. For 3D data acquisition, a sagittal view of 
the anal canal was obtained and the volume mode entered. The resultant 
truncated sector defining the area of interest was then centred over the 
anorectal angle, adjusted accordingly and the sweep angle set to 85° to 
ensure that the greatest volume was obtained. The patient was asked to 
remain as still as possible and every effort was made by the 
ultrasonographer to limit inappropriate movements of the transducer. The 3D 
dataset was then acquired using the slow sweep mode. The signals are 
processed and converted into digital information for storage in the 
computer's random access memory. 
The spatial peak temporal average intensity of ultrasound for B-mode 
and Doppler examinations was maintained at <80Wcm-2, which is well within 
the safety limits recommended by the Bioeffects Committee of the American 
Institute of Ultrasound in Medicine [204, 205]. The Thermal Index (TI) and 
Mechanical Index (MI) were maintained below 0.5 and 0.3 respectively 
throughout the thesis in keeping with the Guidelines of the British Medical 
Ultrasound Society [206]. 
Standardisation of the US settings was ensured by using the same 
predefined probe programme without adjustment once the programme had 
been loaded. Prior to each acquisition the power Doppler settings were 
checked to ensure they had not changed during manipulation of the volume 
sector, which can lead to an automatic increase or decrease in the settings 
with larger and smaller volumes respectively. 
For both volume and power Doppler acquisitions the resultant 
multi planar display was immediately examined to ensure that the complete 
area had been captured with particular attention being given to the sagittal 
image in the A plane. If the volume was complete and considered of 
sufficient quality, with no power Doppler artefact, s u c ~ ~ as typical 'flash' 
artefC!,cts seen with bowel movements or patient coughing, the dataset was 
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then stored to a magnetic optical disk. If there was apparent artefact, the 
dataset was reacquired until a satisfactory image was obtained. This was 
readily evident and easily distinguishable from true power Doppler 
information, as it appeared suddenly and occupied large areas of the 
screen. In contrast, true information from the anal submucosa was seen as 
relatively small areas of signal, which remained relatively constant. 
40 View was used on a MacBook Pro to receive and store the 3D 
datasets and for subsequent analysis of vascularity. The volume datasets 
were first loaded from the magnetic optical disk and, following Cartesian 
conversion, saved onto a DVD. Cartesian conversion is essential prior to the 
digital transfer of 3D data to ensure the three coordinates of each pixel are 
recorded and correctly spatially orientated. The manufacturer recommends 
that 3D information is stored in this orthogonal grid co-ordinate system as it 
simplifies the algorithms for visualisation and also reduces image-computing 
time. The individual units of volume in this Cartesian storage are referred to 
as voxels (volume elements). 
3.8.2 Comparison of Scanning Female and Male Patients and 
Volunteers. 
The entire study group were female; this was related partly to the 
quality of imaging obtained with the endovaginal probe in males. Maintaining 
the endovaginal probe in a stable position on the perineal surface of males 
proved to be more difficult than in females. The average acquisition time for 
the 3D power Doppler dataset was 42 seconds, during which the transducer 
must be maintained in a completely stable position. 
As the primary aim of the study was to establish a reliable method of 
imaging haemorrhoids and anal cushions, a decision was made to 
ultrasound females only for the remainder of this study, and to recruit 
possible male patient and healthy volunteers to other studies within the 
thesis. Subjectively it became apparent to the investigator that there was 
more reluctance from male patients and volunteers to consider taking part in 
this study, which was more intrusive than the MRI study. 
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3.8.3 Patient and Volunteer Characteristics 
The average age of the patient participant was 46.4 ± 2.1 years 
(range 35 - 62 years). The participant reported duration of haemorrhoid 
symptoms for an average of 9.6 ± 2.5years (range 1 - 33years). 42.9% of 
the patients had 1st degree, 42.9% had 2nd degree and 14.2% had 3rd 
degree haemorrhoids. The average age of the volunteers was 38.7 ± 3.6 
years (21 - 57 years). No significant difference was identified between the 
age profiles of the patients and healthy volunteers (Independent t-test: t (23) 
= -1.99 P >.05). 
3.8.4 Patient and Volunteer Studies 
Prior to making any comparisons between pre and post-treatment 
datasets, or between patients and healthy volunteers, it was essential to 
analyse the reproducibility of producing and analysing the anorectal angle 
sphere. The following separate studies were performed: 
1) Study 1: The reliability of VOCAL /I for semi-quantification of anal canal 
vascularity - serial measurements of the same dataset. 
Repeated measures were made of the same single dataset acquired 
from both patients and healthy volunteers at the various time-points in the 
study. Sixty-three individual datasets were assessed by randomising the 
order of analysis and anonym ising the patient or volunteer identification 
number both on the VOCAL software screen and on the spreadsheet used 
for data entry. Each dataset was assessed five times. 
2) Study 2: The reliability of VOCAL /I for semi-quantification of anal canal 
vascularity - comparison of serial datasets from the same occasion. 
Three datasets acquired after removing and replacing the transducer from 
the perineum between each acquisition, from each of eighty-seven scans of 
patients and healthy volunteers at the various time-points in the study were 
assessed for agreement. The order of analysis was randomised and the 
patient or volunteer identification number was anonymised on the VOCAL II 
software screen and on the spreadsheet used for data entry. 
3) Study 3: Comparison of Volume and Vascularity Measures from Healthy 
Volunteers Over Time 
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Datasets from each time-point (days 1,3 and 35) were compared for eleven 
healthy volunteers. An average of three measurements was taken for each 
time point. The order of analysis was randomised and the volunteer 
identification number was anonymised on the VOCAL II software screen and 
on the spreadsheet used for data entry. 
4) Study 4: Comparison of Vascularity Measures from Pre-Rubber Band 
Ligation Patients with Healthy Volunteers 
Day 1 datasets of fifteen patients were compared to day 1 datasets of 
eleven healthy volunteers. The order of analysis was randomised and the 
patient or volunteer identification number was anonymised on the VOCAL 
software screen and on the spreadsheet used for data entry. 
5) Study 5: Comparison of Vascularity Measures from Pre and Post-Rubber 
Band Ligation Patients' 
Volume and vascular indices from patients were measured and 
compared over four time-points (days 1, 14,42 and 56) within an eight-week 
period, with day 1 representing the pre-rubber band ligation time-point. An 
average of three measurements was taken for each time point. The order of 
analysis was randomised and the patient identification number was 
anonymised on the VOCAL software screen and on the spreadsheet used 
for data entry. 
3.8.5 Statistical Analysis 
Distribution of the data was examined with the Kolmogorov-Smirnov 
test. Homogeneity of variance was examined with Levene's test. Data was 
not normally distributed and lacked homogeneity of variance and therefore 
all statistical test were non-parametric. Reproducibility of the vascular 
indices was assessed by performing intra-class correlations. 
Differences between the healthy volunteer's data for day 1, day 3 and day 
35 was assessed by the Friedman ANOVA test. 
Differences between the healthy volunteer group and the patient group 
was assessed by the Mann-Whitney test. Wilcoxon signed-rank tests, 
correcting for the number of tests, was performed to assess the size of 
effect. A Bonferroni correction was applied and so all effects are reported at 
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a 0.0167 level of significance. The effect size r = z/.JN. A one-tailed 
assessment was performed as the null hypothesis states that there is no 
difference between the vascularity indices of pre-treatment patients and 
healthy volunteers. 
Differences between the pre-treatment and post-treatment groups were 
assessed by the Wilcoxon's signed rank test. The effect size r = Z /.IN. A 
one-tailed assessment was performed as the null hypothesis states that 
there is no difference between the vascularity indices of pre-treatment 
patients and post-treatment patients. 
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3.9 RESUL TS PHASE III: Patient and Healthy Volunteer 
Studies. 
3.9.1 Study 1: Serial Measurements of the Same Dataset. 
The intraobserver ICCs were very high for measurements of both 
volume and vascularity within the anal canal sphere and the outer 2mm 
shell, apart from the Flow Index measurement in the 2mm outer shell (table 
3-3). 
Measurement Mean ICC ± 95% CI 
Sphere Volume 0.968 (0.951 - 0.979) 
Sphere VI 0.968 (0.952 - 0.980) 
Sphere FI 0.944 (0.914 - 0.964) 
Sphere VFI 0.966 (0.948 - 0.978) 
Shell Volume 0.978 (0.966 - 0.986) 
Shell VI 0.982 (0.973 - 0.989) 
Shell .. FI 0.866 (0.797 - 0.915) 
Shell VFI 0.966 (0.948 - 0.978) 
Table 3-3 Results of study 1. 
The mean intraobserver ICCs ± 95% CI for repeated measures of volume and 
vascularity of the anal canal sphere and its 2mm outer shell from a single dataset. 
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3.9.2 Study 2: Serial Measurements of Three Datasets from Same 
Patient on Same Occasion 
The intraobserver ICCs were very high for measurements of both 
volume and vascularity within the anal canal sphere and the outer 2mm 
shell, apart from the Flow Index measurement in the 2mm outer shell (table 
3-4). 
Measurement Mean ICC :t 95% CI 
Sphere Volume 0.963 (0.948 - 0.975) 
Sphere VI 0.948 (0.926 - 0.965) 
Sphere FI 0.860 (0.800 - 0.905) 
Sphere VFI 0.947 (0.924 - 0.964) 
Shell Volume 0.965 (0.949- 0.976) 
Shell VI 0.932 (0.903 - 0.954) 
Shell FI 0.862 (0.803 - 0.906) 
Shell VFI 0.928 (0.897 - 0.951) 
Table 3-4 Results of study 2. 
The mean intraobserver ICCs± 95% CI for repeated measures of volume and 
vascularity of the anal canal sphere and its 2mm outer shell from consecutive 
datasets on the same occasion. 
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3.9.3 Study 3: Comparison of Measurements from Healthy 
Volunteers Over Time 
Volume and vascular indices were compared from healthy volunteers 
over three time-points (days 1, 3 and 35) within a five-week period. None of 
the vascular indices changed significantly over the five weeks (table 3-5 and 
figs 3-25 to 3-32), and therefore further statistical tests were not performed 
to assess for size of effect. 
Measurement X2(2) P 
Sphere Volume 1.800 0.436 
Sphere VI 0.667 0.763 
Sphere FI 0.974 0.682 
Sphere VFI 0.154 0.947 
Shell Volume 1.800 0.436 
Shell VI 3.436 0.186 
Shell FI 1.897 0.437 
Shell VFI 2.263 0.345 
Table 3·5 Study 3. 
Friedman's ANOVA to assess for change in vascularity measures over a five week 
period. 
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Figure 3-25 Study 3: Mean volume of the anorectal sphere in 
healthy volunteers over a five-week period. 
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Figure 3-26 Study 3: Mean vascularization index of the 
anorectal sphere in healthy volunteers over a five-week period. 
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Figure 3-27 Study 3: Mean flow index of the anorectal sphere in 
healthy volunteers over a five-week period. 
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Figure 3-28 Study 3: Mean vascular flow index of the anorectal 
sphere in healthy volunteers over a five-week period. 
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Figure 3-29 Study 3: Mean volume of the anorectal shell in 
healthy volunteers over a five-week period. 
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Figure 3-30 Study 3: Mean vascularization index of the 
anorectal shell in healthy volunteers over a five-week period. 
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Figure 3-31 Study 3: Mean flow index of the anorectal shell in 
healthy volunteers over a five-week period. 
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Figure 3-32 Study 3: Mean vascular flow index of the anorectal 
shell in healthy volunteers over a five-week period. 
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3.9.4 Study 4: Comparison of Vascularity Measures from Pre-
Rubber Band Ligation Patients with Healthy Volunteers 
All sphere and 2mm external shell volumes and vascular index values 
were significantly higher (p < 0.05) in pre-RBL patients compared to the 
volunteers (day 1). The size of effect was large (r ~ ~ 0.5) for the volume and 
FI values for both the anorectal sphere and external 2mm shell. The size of 
effect was medium (r ~ ~ 0.3) for the VI and VFI values of both the anorectal 
sphere and external 2mm shell. The results are summarised in tables 3-6 to 
3-7 and figs 3-33 to 3-40. 
Mean Mean VI Mean FI Mean VFI Volume Sphere Sphere Sphere Sphere 
Mann-Whitney U 25.000 44.000 29.000 42.000 
Z -2.847 -1.807 -2.628 -1.916 
Exact Sig. (1-tailed) .002 .036 .004 .028 
Table 3-6 Comparing pre-RBL patients with volunteers: results for vascular 
indices within the anorectal sphere. 
Mean Vol Mean VI Mean FI Mean VFI 
.. Shell Shell Shell Shell 
Mann-Whitney U 25.000 45.000 31.000 
45.500 
Z -2.847 -1.752 
-2.518 -1.725 
Exact Sig. (1-tailed) .002 .042 .005 .043 
Table 3-7 Comparing pre-RBL patients with volunteers: results for vascular 
indices within the external 2mm shell. 
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Figure 3-33 Study 4: Sphere volume 
Pre-RBL patient sphere volume (Mdn = 1.16) differed significantly 
from that of volunteers (Mdn = 0.71). 
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Figure 3-34 Study 4: Sphere VI. 
Pre-RBL patient sphere VI (Mdn = 0.59 differed significantly from 
that of volunteers (Mdn = 0.17). 
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Figure 3-35 Study 4: Sphere FI. 
Pre-RBL patient sphere FI (Mdn = 24.51) differed significantly from 
that of volunteers (Mdn = 15.32). 
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Figure 3-36 Study 4: Sphere VFI. 
Pre-RBL patient sphere VFI (Mdn = 0.15) differed significantly from 
that of volunteers (Mdn = 0.04). 
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Figure 3-37 Study 4: Shell volume_ 
Pre-RBL patient external shell volume (Mdn = 1.43) differed 
significantly from that of volunteers (Mdn = 1.08). 
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Figure 3-38 Study 4: Shell VI. 
Pre-RBL patient external shell VI (Mdn = 0.44) differed significantly 
from that of volunteers (Mdn = 0.09). 
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Figure 3-39 Study 4: Shell FL 
Pre-RBL patient external shell FI (Mdn = 25.00) differed significantly 
from that of volunteers (Mdn = 17.82). 
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Figure 3-40 Study 4: Shell VFL 
Pre-RBL patient external shell VFI (Mdn = 0.11) differed 
significantly from that of volunteers (Mdn = 0.02). 
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3.9.5 Study 5: Comparison of Pre-Rubber Band Ligation and 
Post-Rubber Band Ligation Measurements 
Statistical analysis of sphere and external shell volume and vascular 
indices are summarised in tables 3-8 and 3-9. Significant changes with their 
size effect are highlighted in bold. 
Sphere volume was significantly lower on day 14 (Mdn = 1.11), on 
day 42 (Mdn = 0.99) and on day 56 (Mdn = 1.04) in comparison to that 
measured on day 1 (Mdn = 1.41), prior to RBL (see fig 3-41). Sphere VI was 
significantly lower on day 14 (Mdn = 0.17) compared to that measured on 
day 1 (Mdn = 1.16). Sphere VI values then increased over the remaining six 
weeks, with day 42 (Mdn = 0.70) and day 56 (Mdn = 0.45) values showing a 
significant difference to that measured on day 14 (see fig 3-42). 
Sphere VFI values (see fig 3-43) followed the same pattern to that of 
VI values; VFI was significantly lower on day 14 (Mdn = 0.04) compared to 
that measured on day 1 (Mdn = 0.30). VFI values increased over the 
remaining six weeks to 0.18 on day 42 and 0.11 on day 56. 
Sphere FI values (see fig 3-44) did not show any significant changes 
apart from those measured on day 14 (Mdn = 21.80) and day 42 (Mdn = 
25.09). 
Shell volume was significantly lower on day 14 (Mdn = 1.39), on day 
42 (Mdn = 1.29) and on day 56 (Mdn = 1.34) in comparison to that 
measured on day 1 (Mdn = 1.60), prior to RBL (see fig 3-45). Shell VI was 
significantly lower on day 14 (Mdn = 0.26) compared to that measured on 
day 1 (Mdn = 1.04). Shell VI values then increased over the remaining six 
weeks, with day 42 (Mdn = 0.69) and day 56 (Mdn = 0.44) values showing a 
significant difference to that measured on day 14 (see fig 3-46). 
Shell VFI values (see fig 3-47) followed the same pattern to that of VI 
values; VFI was significantly lower on day 14 (Mdn = 0.07) compared to that 
measured on day 1 (Mdn = 0.28). VFI values increased over the remaining 
six weeks to 0.18 on day 42 and 0.11 on day 56. 
Shell FI values (see fig 3-48) did not show any significant changes 
apart from those measured on day 14 (Mdn = 24.46) and day 42 (Mdn = 
26.06). 
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Day Sphere Sphere Sphere Sphere 
Volume VI FI VFI 
1 v 14 T= 10.00 T= 5.00 T = 19.00 T= 5.00 
P = 0.021 P = 0.005 P = 0.120 P = 0.005 
r= -0.44 r = -0.53 r = -0.53 
1 v 42 T= 8.00 T = 39.00 T = 44.00 T = 40.00 
P = 0.003 P = 0.342 P = 0.473 P = 0.368 
r= -0.51 
1 v 56 T= 16.00 T = 27.00 T = 38.00 T = 28.00 
p = 0.02 P = 0.108 P = 0.318 P = 0.122 
r = -0.44 
14 v 42 T = 32.00 T= 10.00 T= 12.00 T= 11.00 
P = 0.483 P = 0.021 P = 0.034 P = 0.027 
r= -0.44 r= -0.40 r= -0.42 
14 v 56 T = 29.00 T= 11.00 T = 16.00 T= 12.00 
P = 0.382 P = 0.027 P = 0.074 P = 0.034 
r = -0.42 r= -0.37 
42 v 56 T = 45.00 T= 8.00 T = 29.00 T= 16.00 
P = 0.500 P = 0.006 p=0.137 P = 0.020 
r = -0.48 r= -0.40 
. . Table 3·8 Wilcoxon signed rank test of sphere volume and vascular mdlces . 
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Day Shell Shell Shell Shell 
Volume VI FI VFI 
1 v 14 T= 10.00 T= 6.00 T= 5.00 T= 6.00 
P = 0.021 P = 0.007 P = 0.005 P = 0.007 
r = -0.44 r = -0.51 r = -0.51 
1 v 42 T= 8.00 T = 38.00 T = 42.00 T = 39.00 
P = 0.003 P = 0.318 P = 0.420 P = 0.342 
r = -0.51 
1 v 56 T= 16.00 T = 23.00 T = 30.00 T = 25.00 
P = 0.02 P = 0.064 P = 0.153 P = 0.084 
r = -0.51 
14 v 42 T = 32.00 T= 7.00 T= 13.00 T= 7.00 
P = 0.483 P = 0.009 P = 0.042 P = 0.009 
-
r= -0.49 r= -0.38 r= -0.49 
14 v 56 T = 29.00 T= 9.00 T = 20.00 T= 11.00 
P = 0.382 P = 0.016 p=0.139 P = 0.027 
r= -0.45 r = -0.42 
42 v 56 T = 29.00 T= 8.00 T = 32.00 T= 14.00 
P = 0.382 P = 0.003 p = 0.188 P = 0.013 
r = -0.51 r = -0.42 
. . . Table 3·9 Wilcoxon signed rank test of shell volume and vascular indices . 
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Figure 3-41 Study 5: Changes in sphere volume prior to and 
after rubber band ligation. 
Mean Sphere Vascularization Index Prior To and After Rubber Band Ligation 
:> 
w 
7.000 
6.000 
5.000 
ffi 4.000 
:I: Q. 
II) 
~ ~ 3.000 
~ ~
2.000 
1.000 
0 .000 
DAY 1 DAY 14 DAY 42 DAY 56 
TIME 
Figure 3-42 Study 5: Changes in sphere VI prior to and after 
rubber band ligation. 
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Figure 3-43 Study 5: Changes in sphere FI prior to and after 
rubber band ligation. 
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Figure 3-44 Study 5: Changes in sphere VFI prior to and after 
rubber band ligation. 
134 
2.200 
2.000 
1 .800 
-I g 
:::l 1.600 
W 
:I: 
(I) 
~ ~ 1.400 
:!: 
1.200 
1.000 
0.800 
Mean Shell Volume Prior To and After Rubber Band Ligation 
, 
- '--
r--'--
r--'--
-'-
r---
r---
..... -
r--- '--- ~ ~
'--
'--r-
DAY 1 DAY 14 DAY 42 DAY 56 
TIME 
Figure 3-45 Study 5: Changes in shell volume prior to and after 
rubber band ligation. 
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Figure 3-46 Study 5: Changes in shell VI prior to and after 
rubber band ligation. 
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Figure 3-47 Study 5: Changes in shell FI prior to and after 
rubber band ligation. 
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Figure 3-48 Study 5: Changes in shell VFI prior to and after 
rubber band ligation. 
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3. 10 SUMMARY OF RESULTS 
Phase I of the study involved evaluating the best technique for imaging 
the haemorrhoidal zone within the anal canal. Both endoanal and 
transperineal approaches were assessed. The transperineal approach was 
judged to be superior to the endoanal approach, because of lack of 
compression of the haemorrhoids or anal cushions in volunteers. Endoanal 
techniques did not produce interpretable or reproducible images. There was 
visualization of the submucosa as well as the mucosal folds with the 
transperineal approach. 
Phase II of the study compared the available options within VOCAL II 
for delineating a reproducible ROI within the acquired 3D volume dataset 
from the transperineal approach. Manual and sphere options are available 
for producing a ROI, without which vascular indices cannot be measured. 
The rotational method of delineating a ROI was found to be unreliable 
due to the way in which the cranial and caudal limits of the anorectum 
cannot be defined within VOCAL II. 
The only other available option within VOCAL II was to set a sphere as 
the ROL To allow a reproducible method of placing the sphere within the 
anal canal, an anatomical landmark needs to be used to allow the 
investigator to place the sphere in the same position in the anal canal. 
Phase III of the study comprised an assessment of patients and 
volunteers using the anorectal sphere method to evaluate the vascular 
indices, and their possible changes over time and with treatment. The initial 
step was to evaluate the reliability of the measuring technique. Multiple 
measurements of a single dataset demonstrated high intraclass correlations. 
Comparison of the anorectal sphere volume and vascular index 
measurements from three datasets, between which the transducer had been 
removed from the perineum and then replaced, demonstrated high intraclass 
correlations. The method of producing a sphere at the anorectal angle from 
VOCAL™ II is a reliable method. The method of acquiring the 3D volume by 
the transperineal route is also reliable, allowing consequent evaluation of the 
vascular indices and possible changes over time and with treatment. 
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Evaluation of the anorectal angle sphere volume and vascular indices 
from healthy volunteers over a five-week period showed no significant 
differences between any of the three time-points. 
Comparison between pre-treatment patients and healthy volunteers 
showed significant differences between the two groups for both sphere and 
shell volume and vascular indices, apart from the flow index measures. 
Comparison between pre and post treatment sphere and shell volume 
and vascular indices showed significant differences for both sphere and 
shell volume, VI and VFI measures. 
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3.11 DISCUSSION 
The first aim of the study was to establish a reliable method of 
acquiring an ultrasound based dataset including Doppler information, to 
enable assessment of vascularity of the anal cushions in subjects without 
haemorrhoidal symptoms, and in patients with haemorrhoidal symptoms. 
Early on in the thesis period it became clear that anal cushions or 
haemorrhoids could not be imaged with an endoanal approach, due to the 
compressive effect of the transducer. Attempts to insert the transducer just 
distal to the haemorrhoids did not produce images with identifiable anatomy, 
partly due to artefact secondary to movement of the transducer and anal 
tone, which naturally expelled the transducer. Other authors confirm that 
anal cushions or the submucosa cannot be visualised or measured [207, 
208] via the endoanal route. 
In this study the transperineal route produced images, in all scanned 
patients and volunteers, which identified anatomical landmarks such as the 
lAS, EAS and the puborectalis at the anorectal junction. These findings are 
supported by recent publications, which evaluated anal cushions in the 
context of faecal incontinence and haemorrhoids by the transvaginal and 
transperineal routes [207, 209, 210]. 
In each of these studies two-dimensional ultrasound was employed to 
measure the cross-sectional area enclosed by the lAS, and the area 
enclosed by the anal cushions at the level of the mid-anal canal. The 
cushion to canal (C:C) ratio was derived from these measurements. A 
greater value of C:C ratio indicated larger anal cushions. The level of the 
canal was confirmed by visualising the U-shaped EAS [207], which the 
authors stated was indistinguishable from the puborectalis. 
Rather than assessing 2-D ultrasound, this part of the thesis 
evaluated the acquisition of transperineal 3-D ultrasound datasets. This has 
been evaluated by other investigators in the dynamics of the pelvic floor 
[182], but not with respect to haemorrhoids. The phased array transducer 
employed in this study acquires 2-D images at pre-defined intervals, 
ensuring that the exact spatial co-ordinates of 2-D images are reconstructed 
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into a Cartesian based-grid system. 3-D US potentially allows for more 
accurate and reproducible volume measurements because the various 
display modalities allow the observer to correct for any surface irregularities 
[211]. Demonstration of the coronal image is specific to 3-D US and this 
plane provides more spatial information than either the transverse or 
longitudinal images, both of which are obtainable with conventional 2-D 
ultrasonography through a simple rotation of the transducer [169]. 
The second aim of the study was to assess methods for semi-
quantification of vascularity of haemorrhoids and anal cushions. Therefore 
the next logical step was to decide which Doppler method was most 
suitable. 
Due to the method in which pulsed Doppler information is obtained, it 
cannot be acquired from a 3D dataset. Although transperineal evaluation of 
pulsed Doppler information was not evaluated in this study, pulsed Doppler 
was rejected as a method of evaluating vascularity of the anal canal due to 
operator dependent error, experience of the operator and Doppler angle 
reliance [212, 213]. 
Generally if flow within individual vessels is to be examined, the 
combination of colour and duplex Doppler provides better information, 
however solid organs are often better assessed with power Doppler as it 
provides an overall view of the vascularity of the entire organ [214]. Given 
that the calibre of branches of the supplying rectal arteries (average 
diameter of 1.7mm [215]) and the haemorrhoidal venous plexus is small, 
and that flow is directly proportional to the fourth power of the radius 
according to Poiseuille's law [216], one can calculate that there is low 
velocity of flow within these vessels. Features of power Doppler include the 
ability to display the distribution of the strength of the returning Doppler 
signal, increased sensitivity to low flow, and reduction of noise in the image 
[199]. 
The most obvious advantage of the GE 730 Expert is the opportunity 
to evaluate the potential the combination of power Doppler angiography, 
VOCAL TMII and it's histogram facility. This software has been used in the 
evaluation of endometrial and subendometrial volume and blood flow of 
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apparently fertile and infertile females [217]; with some studies showing 
reduced VI, FI and VFI in women with unexplained subfertility [218]. 
The rotational method of volume calculation is well suited to solid 
organs such as the uterus and ovary, with the shell feature enabling 
calculation of vascular indices within tissues such as the endometrium. 
Within respect to the anorectum, which is a tubular structure, there is no 
method available within VOCAL II to measure and accurately mark the 
cranial and caudal limits of the ROI, thereby allowing accurate and 
reproducible assessment of the vascular indices. 
The anorectal angle sphere was therefore used as a marker of 
vascularity in the anorectum, rather than as a true measurement of volume 
or vascularity. The high intraobserver ICCs obtained from studies one and 
two confirm that the transperineal 3D volume acquisition and the placement 
of the anorectal angle sphere are reliable tests. The ICC values were lower 
for the FI measurements than for those of volume, VI or VFI. FI is the 
average colour value of all colour voxels, representing average colour 
intensity. Other investigators have reported low FllCCs for measurements 
of ovarian vascularity [219-221]. 
It is likely that the fluctuations in blood flow cause greater changes in 
the colour voxels than the gray-scale index, which remains nearly constant. 
The variation in the measurements of colour indices maybe partly due to the 
artifacts produced by power Doppler. Amso et al. quantified power Doppler 
--
energy images on 2D real-time scanning and observed a significant image-
to-image variation [222]. 
Nelson et al. categorized power Doppler artifacts relating to gain and 
motion [223]. In this study there were pre-defined settings for each scan, 
which should have excluded any effects caused by gain. Motion artifact is 
caused by external movement, which causes colour in places where there is 
no flow, showing streaks and pseudo-vessels in the image. It is feasible that 
smooth muscle contractions in the rectal wall caused motion artifact that was 
not obvious on evaluation of the 3D volume during acquisition. 
Unfortunately there was no option available for testing either the 
interobserver reliability of obtaining the datasets or of analysing the 3D-PDA 
data. This was related both to available funding, and the time required to 
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analyse the data. The approximate duration of data analysis for the entire 
study was three months. 
It is promising that no significant changes of volume or vascularity 
indices were identified amongst the group of healthy volunteers over a five-
week period. There are limitations to study three including small group size, 
and the lack of a gold-standard outcome measure to compare to. 
At each ultrasound appointment, the volunteer was questioned about 
possible haemorrhoidal symptoms. Prior to the first ultrasound, the entire 
group completed the symptom questionnaire and scored zero in all parts of 
section 3 (see appendix 8-1, figs 8-7 and 8-8). 
The results of study 4 are also encouraging; the patients' volume and 
vascular indices were significantly higher than those of the volunteers, 
particularly the volume and FI (r > 0.5). It is acknowledged however that 
these were essentially pilot studies and no attempt was made to control for 
differences between patients and volunteers. The numbers included in the 
study are too small to assess for effect of grade of haemorrhoid, or other 
surgical factors such as previous treatment. Apart from the small numbers in 
each group, other factors that may account for the higher volumes and 
vascular indices in patients include hormonal factors [224]. 
Aigner et al. used transperineal 2D US and duplex Doppler to 
evaluate the supplying branches of the superior rectal artery in groups of 
patients with haemorrhoids and healthy volunteers [225-228]. All the studies 
involved measurement of the calibre and peak velocities of the supplying 
vessels, and in each study, these were significantly lower in the healthy 
volunteer group compared to the patient group. 
The investigators stated that did not study the middle or inferior rectal 
arteries and their branches, as they did not supply the corpus cavernosum 
recti [226]. This decision was also based on their macroscopic evaluation of 
five cadaveric rectal specimens in which the middle rectal artery was not 
identified. This conflicts with the findings of Thomson, who found that the 
middle rectal artery contributed to the blood supply of the anal canal in 76% 
(n = 50) of anorectal specimens [8]. 
Despite the factors described above, and although the acquisition of 
Doppler information was different to 3D-power Doppler angiography (PDA), 
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there are similarities in the findings of the current study and those of Aigner 
et al. All vascularity measures were lower in age-matched healthy volunteers 
compared to patients. 
The final aim of this study was to assess the effect of rubber band 
ligation treatment on the vascularity of the haemorrhoidal zone. Significant 
changes were identified post rubber band ligation with a decrease in volume, 
VI and VFI. Aigner et al. failed to show a difference between pre-treatment 
and post-treatment measures of supplying vessel calibre and maximum 
velocity, in all grades of haemorrhoids and following PPH treatment [225, 
227]. Therefore the authors concluded that PPH has little impact on the 
cause of haemorrhoids (hypertrophied arterial supply of the anorectal 
vascular plexus), thus explaining the higher recurrence rates in comparison 
to conventional haemorrholdectomy [59, 229, 230]. 
Although the current study showed a decrease in volume, VI and VFI 
post rubber band ligation, the results should be interpreted with caution due 
to the small numbers involved. It should be noted that the anorectal sphere 
is possible a more global measure of vascularity as power Doppler signal 
from arterial, arteriovenous communications and the submucosal venous 
plexus are all included depending on the relative size of the sphere, the 
length of the anal canal and the exact position of the haemorrhoids with 
relation to the anorectal angle. 
The choice of the anorectal sphere was dictated by the options 
available in VOCAL II; discussion with the designers of the software could 
lead to other options for setting a ROI, or indeed placing a grid system over 
the multiplanar display to allow accurate positioning of a ROL 
At the start of the thesis research period, a literature search 
performed in December 2004 using the terms "anal", "cushions", 
"haemorrhoids", "measurement", and "ultrasound" produced only one 
publication with direct reference to ultrasound assessment of anal cushions 
or haemorrhoids [226]. Since that time there have been two different 
approaches to assessing anal cushions or haemorrhoids: the cushion to 
canal ratio calculated from transvaginal 2D analysis of the mid anal canal 
[207,209,210], and 2D transperineal Doppler analysis of the feeding 
vessels to the haemorrhoidal zone [225-228, 231]. Further larger studies are 
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required to assess the impact on our understanding of the pathogenesis of 
haemorrhoids and the clinical role of these approaches. No other group has 
performed 3D transperineal PDA of the haemorrhoidal zone; this approach 
requires further studies to evaluate its role in the understanding of 
pathogenesis, but the preliminary results overlap with the findings of other 
groups. A role for vascular congestion in the haemorrhoidal zone requires 
further debate and investigation. 
144 
4 SURGICAL NUCLEAR PROBES 
4.1 INTRODUCTION 
Nuclear medicine has the potential to offer a different approach to the 
possibility of semi-quantifying the haemorrhoid complex. Before reviewing 
radionuclide studies where a quantitative approach is utilized, a general 
overview was carried out. This provided a summary of the types of study 
that could be undertaken using radionuclides, and aided in determination of 
the most suitable methodology. 
4.1.1 Nuclear Imaging Modalities 
4.1.1.1 Gamma Camera 
The gamma camera, invented in the late 1950s by Hal Anger [232], is 
used to generate a two-dimensional projected image of a three-dimensional 
distribution of radioactivity. The gamma camera or scintillation camera is 
based on a large scintillation crystal coupled to an array of photomultiplier 
tubes to record the distribution of gamma-emitting radiopharmaceuticals. 
The main components are a large scintillation crystal, often sodium iodide 
(Nal) doped with a small amount of thallium, a bank of photomultiplier tubes 
which detect the scintillation light emitted from the Nal crystal, and a 
collimator in front of the Nal crystal to localize radiation. 
The collimator is normally made out of a plate of lead or tungsten in 
which a large array of apertures are placed close to each other with a 
narrow septal thickness. The collimator mechanically confines the direction 
of incident photons reaching the scintillation crystal, thereby providing a 
means of localizing the site of the emitting sources. The scintillation crystal 
is highly efficient at converting the incident gamma rays or photons into 
visible radiation. These photons deposit energy within the scintillation crystal 
by a photoelectric or a Compton scattering interaction. 
In a photoelectric interaction, the entire energy of the photon is 
transferred to an electron and the photon ceases to exist. In a Compton 
scattering interaction, only a partial amount of the photon's energy is 
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transferred to an electron, and the photon continues to travel at an angle to 
its initial direction. Approximately 10% of the incident photon's energy 
deposited in the scintillation crystal is converted into visible light photons 
(»3eV energy). These visible light photons are guided towards the 
photocathodes of the photomultiplier tubes, where they are converted into 
an electrical signal at the anode of each photomultiplier tube. The 
amplitudes of the signals from each anode are then examined by either an 
analogue or digital positioning circuitry to estimate the x and y coordinates of 
the scintillation event on the crystal. The apertures of the collimator 
physically restricts the gamma radiation, thereby ensuring that the x and y 
coordinate of the events on the scintillation crystal matches the x and y 
coordinates of the two-dimensional projection image of the object of interest. 
Most clinical examinations are carried out with a parallel hole 
collimator (apertures parallel to each other) since it provides a good 
combination of resolution and sensitivity for most regions of the body with no 
-
geometrical distortion. The spatial resolution of scintillation imaging is 
determined by the intrinsic resolution of the camera and the resolution of the 
collimator. The intrinsic resolution indicates the ability of the camera to 
locate the point at which the incoming photon interacts with the scintillation 
crystal. This is approximately 2 - 3 mm in modern scintillation cameras. The 
collimator's contribution to the resolution can be much larger. The collimator 
resolution depends on its design; shape, diameter and length of apertures; 
and the distance between the region being imaged and the collimator. 
Typically, the collimator resolution is 1 cm at a distance of 10 cm from the 
region of interest, although detail in the image ultimately depends upon 
uptake of the radiopharmaceutical. 
4.1.1.2 Geiger-Muller Probes 
Nuclear medicine originated with the use of probe detectors, primarily 
for tumour localization; the majority of current research concentrates on 
probes used intra-operatively; but the first relevant probe work used external 
detectors. In 1942 Marinelli and Goldschmidt [233] used a hand-held Geiger-
Muller (G-M) tube to compare phosphate-32 (32P ) labelled sodium 
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phosphate uptake in melanoma, mycosis fungoides and normal skin. Uptake 
and turnover was higher in melanoma than in normal skin. It was also noted 
that probe counts were higher over bone than elsewhere. This demonstrated 
that probes detect counts from surrounding tissue, not just from the volume 
immediately adjacent to the detector. This will be considered later in the 
discussion on probe design. 
In 1946 Low-Beer et al [234]., correctly classified 24 of 25 breast 
lesions in preoperative patients as benign or malignant using a hand-held G-
M tube with 32P. Axillary and supraclavicular lymph nodes were also 
evaluated, but the results were equivocal. It is now well accepted that 
external imaging is unsatisfactory with respect to localizing soft-tissue 
tumours smaller than 2 cm in diameter [235, 236]. 
Selverstone et aI., were the first to report the intra-operative use of a 
probe in 1949 [237]. Cylindrical G-M tubes, 3 and 5mm in diameter, were 
employed to localize and in some cases demarcate cerebral tumours. The 
patients were given 32P-buffered sodium phosphate prior to operation. 
Tumours were correctly localized in 29 of 33 cases. There were two false-
negative cases in which the probe was not adequately employed. The probe 
gave a false-positive result in one, a case of diffuse gliomatosis, and a true-
negative result in another. This study demonstrated the issues with using 
32P as a tumour-seeking tracer. Its maximum beta particle range is in the 
range of 2 - B mm in soft tissue [236, 23B], and therefore the probe must be 
within this distance of the tumour. 32P is a non-specific tracer, and any 
cause of increased metabolic activity such as inflammation, will cause false-
positive results. Finally, the radiation dose from 32P is not insignificant. 
The early work with 32P and G-M counters worked because the GM 
tube had very high detection efficiency for beta particles, and the relative 
high energy of the beta particles allowed penetration of up Bmm of tissue to 
reach the G-M tube. The success of this approach was limited in part by the 
absorbed dose per unit activity for 32P. It is 300 - 600 times greater than 
that of the currently most frequently used isotope, technetium-99m (99mTc). 
Between 1.2 and 2.4 MBq of 32P is equivalent in dose to the 740 MBq of 
99mTc that is typical in diagnostic nuclear medicine. This meant that there 
would be very low count rates from the tumour or larger doses would need 
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to be administered. In the early work with 32P [237], 37 - 148 MBq doses 
were injected for intra-operative probe-assisted surgery. It should be added 
that these studies were carried out before guidelines had been established 
for medical applications of radiation. 
4.1.1.3 Scintillation Detectors 
G-M counters have low sensitivity to gamma rays, and therefore other 
alternatives have been examined. The only readily available solution for a 
gamma ray-sensitive probe in the 1950s was the scintillation detector. Harris 
et aI., reported the use of a thallium-activated caesium iodide scintillation 
detector coupled to a rigid Lucite light pipe with iodine-131 (1311) to localize 
thyroid tissue and recurrent thyroid carcinoma in patients undergoing neck 
exploration [239]. Unlike G ~ M M counters the gamma ray-detector probe is not 
limited by distance from the volume of interest, but it is limited by its 
detection of distant background activity. Thus, a large volume of low activity 
may obscure a small tumour with increased radionuclide activity, and a more 
distant hot source may be interpreted as a nearby tumour. 
Woolfenden et aI., used a 2.5 mm x 9 mm Nal detector passed 
through the channel of a fibreoptic bronchoscope to assess the bronchial 
tree for cobalt-57 bleomycin activity in lung tumours [240]. Sensitivity, 
specificity, accuracy and predictive values were compared for the Nal 
detector, chest X-ray film and bronchoscopy alone in a group of 34 patients. 
The Nal detector performed satisfactorily, but was limited by its inability to 
detect tumours smaller than 6mm adjacent to the detector leading to the 
lowest sensitivity of the three modalities. This is a result of the activity level 
in the tumour and the tumour-to-background activity ratio. 
4.1.1.4 Solid State Detectors 
The reduction in the use of G-M tubes and scintillation detectors was 
due in part to the introduction of solid state detectors, which are essentially 
solid versions of gas-filled ionization chambers. They have several 
advantages over G-M detectors, including better energy resolution allowing 
reduction of the background count. They can be manufactured in very small 
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sizes and in a variety of shapes, and therefore they can be used for counting 
radioactivity in small superficial lesions such as those of the skin and eye. 
Also they may be introduced through catheters into body cavities such as 
those of gastrointestinal and genitourinary tracts, the cardiac chambers and 
great vessels, or they may be implanted into tissue through trochar needles 
[241]. They can take narrow entry windows to allow the counting of very low 
energy beta and gamma rays [242] 
The earliest use of solid state probes was as direct replacements for 
G-M tubes to detect 32P in eye tumours [243, 244]. Pircher et aI., examined 
32P uptake in melanomas of the anterior hemisphere of the eye and in 
lesions of the skin [243]. In four cases of skin lesions metastatic from 
carcinoma of the breast, the investigators were able to show a decrease in 
differential uptake of 32P one week after initiation of radiotherapy, albeit 
statistical significance was not assessed. 
The possibility for miniaturization was demonstrated by Lauber, who 
-
placed a detector inside a needle with an outside diameter of 1.1 mm and 
multiple detectors inside a 1.5mm diameter needle [245]. 
Marcus evaluated lithium-drifted silicon probes [Si (Li)] for gamma-ray 
detection of 87m-strontium and 99mTc-polyphosphate in healing periodontal 
lesions, and 67-gallium citrate in prostatic cancer [246]. Problems with the 
study included the low stopping power for Si (Li) for gamma rays and the 
lack of tumour specificity of 67 -gallium citrate. 
Further w'ork on periodontal lesions was reported by Garcia et aI., 
who used a cadmium telluride (CdTe) probe; the counting efficiency of CdTe 
for 99mTc was comparable to that of a rectilinear scanner with aNal (TI) 
crystal [247]. Lennquist et aI., used a CdTe probe with iodine-125 in thyroid 
cancer surgery [248]. 
Scintillation and semiconductor probes have been used inside the 
body for a variety of applications other than tumour detection. Most of these 
involve localization of abnormalities that are already known to be present. 
The most common intra-operative application has been in the localization of 
osteoid osteoma, not visible with naked eye examination of the surgical field, 
which concentrates 99mTc [249-251]. Kirchner et aI., demonstrated the 
reliability of the procedure after follow-up in 12 cases [252]. The nidus of the 
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tumour is successfully removed, and normal bone tissue is spared. Perkins 
and Hardy [253] presented a case series of 68 procedures undertaken over 
15 years. This included excision of osteoid osteoma, osteoblastoma, 
hamartoma, Brodie's abscess, chronic bone infection, ectopic parathyroid 
adenoma and metastatic neuroblastoma. In the majority of cases a CdTe 
probe was used, in conjunction with 99mTc-hydroxymethylene 
diphosphonate for bony lesions, 201TI-thallous chloride for examination of 
ectopic parathyroid adenoma, and 1231-MIBG for examination of metastatic 
neuroblastoma. In all these cases, the lesions were successfully excised 
with confirmation of complete excision. 
Aslam et aI., used 1231-MIBG pre-operatively in two children with 
neuroblastoma [254]. 1231-MIBG is a low-energy emitter, and therefore 
extensive shielding of the detector was not required. It was more appropriate 
in children because of the lower radiation dose. 
4.1.2 Radiopharmaceuticals 
The rate of colloid transport and movement through lymphatic 
pathways is strongly related to the particle size of the colloid [255, 256]. 
Particles larger than 0.004 - 0.005 mm are preferred, as smaller particles 
have been reported to penetrate the capillary membranes and therefore may 
be unavailable to migrate through the lymphatic channel. Particles that are 
smaller than 0.1 mm show the most rapid disappearance from the interstitial 
space into the lymphatic vessels, and yet have significant retention in the 
lymph node. Larger colloid particles, approximately 500mm, showed a much 
slower rate of clearance from the interstitial space with significantly less 
accumulation in the lymph node. 
A gold-198 colloid [257] has been evaluated. It has a relatively 
uniform particle size of 3 - 5 mm, with a 2.7 day physical half-life and emits 
a 412 keV gamma photon and beta particles. This radionuclide delivers a 
high radiation dose at the injection site, and the (412 keV) gamma photon is 
not suitable for scintillation camera imaging. 
Various 99mTc-labelied colloids and albumin agents have also been 
assessed. 99mTc nanocolloid, a labelled human albumin colloid, is used in 
Europe. Ninety five per cent of the colloidal albumin particles that comprise 
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this agent are smaller than 0.8 mm [258]. Although 99mTc human serum 
albumin successfully images flow, it is not particulate in nature and shows 
poor retention within the lymph nodes [255], and therefore delayed images 
or gamma probe intra-operative explorations may miss the sentinel node. 
4.1.3 Choice of Radionuclide 
An important consideration in the methodology and choice of nuclear 
medicine imaging modality is the selection of radionuclide, and therefore the 
radiation energies, with which it is used. Ideal characteristics of a 
radionuclide in a diagnostic arena include: 
• Gamma radiation suitable for imaging (in terms of energy and 
abundance ). 
• A half-life of appropriate length, long enough to allow optimal 
localization and imaging but not unnecessarily long such that an 
unsuitable radiation dose is given. 
• Absence of particulate emissions to substantially reduce the radiation 
dose. 
• High specific activity (a high radioactivity-to-mass ratio provides 
sufficient gamma radiation with negligible mass effect i.e. the 
radionuclide behaves as a tracer of physiologic function. 
• Absence of pharmacologic and toxic effects. 
• A biodistribution suitable for the intended procedure, i.e. localization 
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only in the tissue of interest. 
• Availability at a reasonable cost. 
• If the radionuclide is to be prepared on-site, the procedure should be 
as simple as possible and there should be a radiopharmaceutical 
quality control program implemented on site. 
4.1.4 Radionuclides and y-Cameras 
Radionuclides used in gamma camera imaging include technetium-
99m, indium-111, iodine-123, iodine-131, thallium-201, gallium-67 and 
selenium-53 [259]. 99mTc is the most widely used as it has favourable 
emission energy of 140 keV, is cheap, easily available and can be bound to 
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many ligands. The half-life of 6.02 hours is excellent for same-day imaging, 
but is inadequate if imaging is requires for a period of 24 hours or more. 
1111n is more expensive, but has a favourable emission spectrum (173 keV 
and 247 keV), good binding characteristics and a longer half-life allowing 
delayed imaging. 
131 1 has a long half-life of 8 days and can be bound to many ligands 
including proteins. It emits a gamma photon (364 keV) which is only 
moderately favourable for imaging, and also emits a beta particle resulting in 
increased patient radiation absorbed dose, hence its use as a therapeutic 
radiopharmaceutical in thyroid and other cancers. 1231 has a more suitable 
profile, with a favourable half-life and gamma-emission energy, resulting in 
better imaging and a reduced radiation dose to the patient, but is much more 
expensive. 
67Ga is used when delayed imaging is necessary. It has a complex 
emission spectrum, which leads to some loss of image quality. 53Se has 
limited use with its long half-life of 50 days, leading to high radiation doses 
and poor counting statistics. 
4.1.5 Radionuclides and y-Probes 
The major factors affecting the choice of radionuclide are photon 
energy and physical half-life. For accurate localization, e.g. with sentinel 
lymph node detection, it is more appropriate to use low-energy radionuclides 
[260, 261]. The effect of attenuation of the low energy gamma photon by 
tissue is minimal since the gamma probe is in direct contact with tissue of 
interest during the procedure. Low radioactivity concentration in distant 
organs will improve detection efficiency of the gamma probe when used with 
a low-energy radionuclide. The use of a lower energy photon emitter also 
reduces the problem of radiation exposure to staff. 
The use of high-energy radionuclides reduces the specificity of the 
procedure, such as scattered radiation from sites of high normal uptake, 
such as the liver [262]. Medium to high-energy emitters such as 1111n and 
1311, require increased shielding around the detector element making the 
probe heavy and bulky, thereby reducing acceptability to the user [263]. 
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Virtually all current lymph node-avid radiopharmaceuticals are 
labelled with 99mTc, whereas tumour-avid radiopharmaceuticals, such as 
monoclonal antibodies and antibody fragments, may be labelled with 99mTc, 
1111n, 1251, 1231 or 1311. Most available probe detectors appear to have 
reasonably high intrinsic efficiency for 1231, 1251 (35 keV), 99mTc, and other 
low-energy photon emitters [264]. 
The use of 131 1 and 1111n is not ideal because of their high-energy 
spectrum, and although the use of 1251 is attractive from a physical point of 
view, it would appear to be contraindicated for routine use because of its 
high patient radiation absorbed dose. 
Most intra-operative procedures have been carried out using 99mTc. 
It is a safe, inexpensive readily available radionuclide with excellent imaging 
characteristics, which can be readily bound to many proteins. Given the 
above attributes it seems necessary to consider 99mTc before any other 
radionuclide for gamma probe studies. 
4.1.6 Functional Studies 
Other chapters in this thesis focus on imaging modalities where 
anatomical structure is the basis on which measurements are taken. Nuclear 
medicine investigations essentially measure organ perfusion and functional 
uptake of a suitable tracer. All of the studies mentioned so far have focused 
on localization of pathology, but organ function has also been studied. 
4.1.6.1 Dua//sotope Techniques 
Quantitative approaches to measuring vascular permeability in adult 
respiratory distress syndrome have been examined in the intensive care 
setting. Cardiologists and nuclear medicine physicians have measured 
cardiac output and ejection fraction [265]. 
The principle of such studies is to use two radiolabelled tracers that 
act in different ways at the site of interest. In 1957 Aviado and Scmidt [266] 
summarized a series of investigations in which they used diffusible 131 1_ 
albumin and non-diffusible 32P-labelled red blood cell tracers to study the 
development of pulmonary oedema in dogs. Emissions from the radiotracers 
were measured with a Geiger counter inserted into the pleural space. 
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Technical limitations only allowed the use of one radiotracer per 
animal, however the authors did observe an increase in 131 1 counts in lung 
occurring agonally, at a time when 32p counts were known to fall. This may 
have reflected increased extravasation of plasma albumin into the lung 
parenchyma. 
Potchen and Welch [267] suggested a modification of the two-tracer 
approach to study regional lymph transport of proteins. A pulse-height 
analyser distinguished between gamma emissions from a diffusible 131 1_ 
albumin and a non-diffusible 51Cr-RBC tracer administered simultaneously. 
The rate of albumin accumulation in leg muscles of intact animals was only 
assessed indirectly. 
Basran et aI., studied lung vascular permeability in ten patients with 
ARDS [268]. The authors a'nticipated that monitoring in patients on intensive 
care units would have to occur simultaneously to therapeutic procedures, 
such as drug administration. Therefore anticipated changes in circulating 
-
blood distribution were corrected for by simultaneously monitoring the 
distribution of 99mTc-labelied red blood cells. Radiolabelled 113mln-transferrin 
was used as the protein marker. The study used a Nal thallium activated 
crystal-probe detector system; with a dual channel analyser to detect and 
record 99mTc and 113mln counts simultaneously and separately. 
Indium count rates recorded over the lung field provided a measure of 
the circulating and extravascular radiolabelled transferrin. To correct for 
normal clearance from the circulation and for radioactive decay, the lung 
count rates were divided by the cardiac blood pool count rates. If there were 
no accumulation of protein, the indium rates of lung count rates to heart 
count rates would remain constant throughout the study. Extravasation 
within the lung would result in the increase of this ratio with time. To allow for 
changes in thoracic blood distribution radioactive decay and loss of 
transferring to other extravascular compartments, it was necessary to 
correct using a marker that is confined to the intravascular space, such as 
99mTc-labelied red blood cells. Simultaneous recordings over the lung and 
cardiac blood pools, and dividing the indium ratio by the technetium ratio, 
allows the investigator to calculate the lung transferring index: 
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The rate of change of the lung transferrin index provides a plasma 
protein accumulation (PPA) index for the lung. PPA index values were 
compared between an ARDS group (1.83) and a healthy volunteer group 
(0.1). ARDS patients were clearly distinguished from the volunteers (p < 
0.001 ). 
Bedside probe studies have proven to be useful in the management 
of patients in intensive care. Perkins et aI., demonstrated the value of 
assessing renal and hepatobiliary function, gastric emptying and lung 
vascular permeability in an adult intensive care unit [269]. 
4.1.6.2 Washout Techniques 
Although myocardial perfusion imaging is now generally performed 
using positron emission tomography (PET) or single photon emission 
computed tomography (SPECT), earlier researchers assessed myocardial 
viability using thallium-201 scintigraphy, using gamma cameras [270] as well 
as gamma-detecting probes [271]. Viability of myocardium is assessed by 
measuring the washout rate of 201TI from the myocardium after intravenous 
administration. The distribution of 201TI within the myocardium is a complex 
mechanism. Interventions such as ischaemia with reperfusion, ouabain and 
hypoxia have only modest effects on 201TI uptake and retention by the 
myocardium. Under clinically relevant conditions the principle factor 
determining the rate of 201TI washout from the myocardium appears to be 
the rate of decline in 201Tlieveis in the blood. Marked decreases or 
increases in myocardial blood flow have little impact on net loss of isotope 
from the heart. 
Differential thallium washout, known as redistribution, occurs in 
clinical scans because regions with normal perfusion lose thallium, faster 
than regions in which flow is reduced. The lower initial concentration in the 
low flow region permits extraction and retention of thallium for longer against 
rapidly declining levels in the blood. In contrast a normally perfused region 
obtains a higher initial concentration of the radioisotope and thus is less able 
to maintain those levels as blood activity falls. Therefore thallium 
redistribution is widely regarded as evidence of myocardial viability. 
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4.1.7 Choice of Methodology 
4.1.7.1 y-Camera versus Intraoperative Probe 
A single-head g camera was available for research purposes, at the 
time of planning the study protocol, in the Medical Physics department at 
Queen's Medical Centre. The main concern with using the g camera was the 
issue of resolution, the ability to distinguish the haemorrhoidal zone from the 
surrounding tissue. Spatial resolution depends on the intrinsic resolution of 
the g camera, the resolution of the collimator and the regional uptake of 
radiopharmaceuticals. 
A literature search failed to find any studies of g camera imaging of 
the rectum or anal canal where an attempt is made to quantify the volume of 
a section of the lower gastrointestinal tract. Although small volumes of tissue 
are visible as discrete entities, for example in lymph node scintigraphy, no 
attempt i ~ ~ made to measure size or volume, only to distinguish between 
normal and tumour-laden lymph nodes. 
The advantage of the intraoperative probe is that it is small and can 
be positioned on the haemorrhoid itself via a proctoscope. Its field of view is 
much smaller than that of the g camera, such that it should be able to 
distinguish between haemorrhoid and surrounding tissue, purely on the 
basis of the positioning of the probe. Given the importance of the directional 
prope.rties of the detector, care must be taken in the positioning of the probe. 
4.1.7.2 Dual Isotope versus Washout Method 
Although these methods are discussed as options for the 
methodology of assessing change in haemorrhoids before and after 
treatment, they are measuring different entities, and therefore it is pertinent 
to discuss what should be measured when assessing the success of 
treatment. 
These issues are discussed in the haemorrhoid symptom index 
chapter. After review of the literature, it becomes clear that success of 
treatment is assessed subjectively by the surgeon and the patient. Most 
classification systems divide the disease into stages of increasing severity 
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as denoted by degree of prolapse. Lunniss and Mann [70] relate increasing 
severity of prolapse to increasing size of the haemorrhoids, which again is 
assessed subjectively. 
With respect to assessing change in the haemorrhoid complex after 
treatment, it is logical to attempt to measure size or volume of the 
haemorrhoids before and after treatment. 
Given that the washout technique measures perfusion, resulting in a 
t1/2 measurement for a radioisotope in the region of interest, it is essential to 
consider what perfusion is, and its relationship to the volume or size of the 
region of interest. 
In physiology perfusion is the delivery of arterial blood to a capillary 
bed in the biological tissue. Tissue perfusion can be defined as the volume 
of blood that flows through a unit quantity of tissue and can be expressed in 
the unit ml blood /100g tissue. In this case distribution of radioisotope to the 
region of interest is the result of both blood flow delivery of radioisotope and 
-
extraction of the radioisotope by the biological tissue. 
Application of the washout technique to assessing change before and 
after treatment of haemorrhoids increases the complexity of the study by 
performing two sets of measurements. Even if a radioisotope with a short 
half-life were used such as 99mTc (6.02 hours), the study would have to be 
carried out on two separate days, to allow time for the 99mTc to decay. The 
results will be affected by variation in positioning of the patient and 
positioning of the probe. There is also the logistical consideration of having 
patients returning on consecutive days to the medical physics department. 
The dual isotope technique is Simpler to carry out. Patients would 
only need to attend on one occasion, and changes in the experimental set-
up would be less of an issue i.e. positioning of the patient. The dual isotope 
technique is also semi-quantitatively measuring volume, since the number of 
gamma photons measured is related to the number of blood components 
labelled by radioisotope in the set region of interest. 
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4.1.8 Radioisotope Choice 
99mTc was chosen as it is safe, inexpensive, readily available and has 
excellent imaging characteristics. 1231 was also an attractive option as it is 
also a low energy emitter (27 keV & 159 keV) and obviously has a different 
peak energy profile from 99mTc. At the time of planning the methodology, 1231 
was difficult to purchase and more expensive than the alternative option of 
1111n. Although the gamma probe is not ideally suited to the 1111n profile, the 
dual isotope technique was still the most attractive method for investigating 
change in haemorrhoids after treatment, and therefore this was decided to 
be the best compromise. 
4.1.9 Labelling Issues 
Fundamental to the procurement of high-quality blood pool studies, 
whether f9r nuclear cardiac imaging studies or gastrointestinal 
haemorrhage, is the use of a suitable radiopharmaceutical that remains 
within the vascular space. There are three major categories of 
radiopharmaceutical available for blood pool imaging: labelled red blood 
cells (RBCs), labelled human serum albumin (HSA) and labelled sulphur 
colloid (SC). 
In the main 99mTc SC was used in scintigraphy of gastrointestinal 
haemorrhage, w ~ e r e e its advocates theorized an improved contrast between 
the exponentially diminishing background activity and areas of extravasated 
radiopharmaceutical. 99mTc SC, with a half-life of two minutes in patients with 
normal liver function, is rapidly extracted from the circulation. Thus, 
detectable activity with this agent is removed from the circulation in 5 - 10 
minutes. Advocates recommended repeated administrations of 370 MBq 
doses as a way of expanding the time frame of this radiopharmaceutical. 
The radiation exposure to the liver and spleen is substantial. Each 370 MBq 
of 99mTc SC delivers 3.4 rad to the liver. Given the radiation exposure and 
that no advantage has been found for 99mTc SC over 99mTc RBCs, either 
clinically or in experimental models, it is inappropriate to consider using this 
radiopharmaceutical. 
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Imaging of the cardiac blood pool has been compared using 99mTc 
HSA and 99mTc RBCs. Thrall et aI., analysed the relative distributions of 
99mTc RBCs and 99mTc HSA on end-diastolic frames of gated blood-pool 
studies and on whole-body anterior pinhole images [272]. 99mTc RBCs 
demonstrated greater relative percentage localization in the cardiac blood 
pool, higher target-to-background ratios in the left ventricle, and less liver 
concentration. Several other investigators have suggested that 99mTc RBCs 
might be superior to 99mTc HAS because of the in vivo stability of 99mTc 
RBCs and the observation that albumin leaks from the vascular space with 
time [273, 274]. Such leakage reduces effective tracer activity and the 
target-to-background ratio. 
4.1.10 Methods of.Labelling Ted Blood Cells with 99mTc 
The ability of 99mTc pertechnetate to become attached to RBCs that 
have been exposed to stannous ion has been known for almost four 
decades [275]. The labelling methods outlined in the literature involved in 
vitro methods using stannous chloride, with repeated centrifugations and 
washing steps before and after addition of 99mTc-pertechnetate. The 
procedure was cumbersome and time-consuming. Stannous pyrophosphate 
was introduced as the reducing agent, which increased labelling efficiency 
and reduced the number of manipulations required in the labelling sequence 
[276]. Clinical application was limited until the introduction of a relatively 
simple in vitro kitfor 99mTc RBC labelling by Smith and Richards in 1975 
[273]. 
In 1974, McRae et aI., observed that the tissue distribution of 99mTc 
pertechnetate in rats was altered for up to thirteen weeks following 
administration of stannous ion [277]. The tin prolonged the clearance of 
technetium from the blood. Chandler and Shuck observed similar effects; 
they noticed increased intravascular radioactivity on brain scans performed 
with pertechnetate following 99mTc pyrophosphate bone scan [278]. These 
observations led Pavel et al [279]., and Stokely et al [274]., to suggest that 
red blood cells could be intentionally labelled in vivo by intravenous injection 
of stannous pyrophosphate 20 minutes to 24 hours before the administration 
of 99mTc. Pavel et aI., administered the stannous ion 20 minutes before the 
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99mTc pertechnetate, reported in vivo labelling efficiency of 96%, which 
persisted for up to 60 minutes after 99mTc pertechnetate injection [279]. 
4.2 AIMS 
The hypothesis states that radionuclide probe investigations can 
identify a semi-quantitative reduction in haemorrhoidal volume following 
rubber band ligation of haemorrhoids. Comparison between volume 
reduction and change in symptom scores will also be made. 
Prior to the clinical evaluation of patients, the surgical probe needed 
evaluation to ensure accuracy and reproducibility of radionuclide counts, 
which is presented in phase I. The clinical evaluation of patients with 
haemorrhoids is presented in phase II. 
4.3 METHOD PHASE I 
4.3.1 Evaluation of Equipment 
Before starting the recruitment phase of this project, two second-hand 
probes had been acquired by the Medical Physics department at Queen's 
Medical Centre. The department already owned one surgical probe; but it 
could not be used for the haemorrhoid research, as it had to be kept in 
reserve for any potential clinical work. Therefore the probes' operational 
characteristics were examined, to determine suitability for the haemorrhoid 
research. This was carried out with the help of a trainee medical physicist. 
In order to distinguish between 99mTc and 1111n, different energy 
windows are set on the CTC4 electronics box. This particular model does 
not provide a display of the energy spectrum, and therefore it was ,not 
possible to check visually whether the photopeak coincides with the pre-set 
photopeak energy window. As the results were critically dependent on the 
accurate and reproducible performance of radionuclide counting, it was 
essential to assess the performance of the probes with a known amount of 
radiopharmaceutical. 
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4.3.2 Equipment 
Each of the second-hand probes was compared to the working 
surgical probe. Low activity (- 1 MBq) point sources of 99mTc and 1111n in 
syringes were placed on a piece of benchkote. The control probe and one of 
the second-hand probes were clamped 1 cm above the source, as shown in 
figure 4-1. The energy window was set by two potentiometers, calibrated in 
arbitrary units from 0.0 to 10.0. The energy range switch determined 
whether the range was 0 - 200 keV for use with 99mTc, or 0 - 1 MeV for use 
with 1111n. 
To reduce radiation exposure, the source was shielded by lead 
blocks. After use the sources were disposed of in the relevant shielded 
sharps bin. The surgical probe equipment consists of three main items, as 
shown in figure 4-7: the handheld probe, the counting electronics and a 
count rate meter. All are manufactured by Radiation Monitoring Devices 
(WatertO\yn, MA, USA). The handheld probe contains a solid-state cadmium 
telluride detector surrounded by tungsten for collimation. The remainder of 
the probe was made from surgical stainless steel and. contained the pre-
amplifier electronics. The probe was connected to a CTC4 electronics box, 
which enabled the user to set the counting window to be used. There is also 
an option to display the number of counts detected in a given time period. 
The box shown on top of this was the count rate meter that displayed the 
counts detected per second in the selected window. 
There were two different sizes of probe tip available for use with the 
probe as shown in figure 4-7. The left hand probe contains a Smm diameter 
detector, whereas the right hand one contains a 10mm diameter detector. 
The tungsten collimation can clearly be seen on both the probes. The 
smaller detector improves the ability to localise the source of y-ray.s, 
whereas the larger detector increases the sensitivity of the probe; hence the 
choice of detector was dependent upon its intended use as well as 
ergonomic considerations. 
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4.3.3 Examination of the Surgical Nuclear Probes 
Dead time was examined by placing each probe immediately 
adjacent to the source and obtaining a 10 second count. This was repeated 
at set distances up to 20 cm from the source. The measurements were 
found to obey the inverse square law in both probes, and therefore neither 
probe had any significant dead time when used with low activity sources. 
This was checked with both 99mTc and 1111n. 
Probe 1 and the working surgical probe were clamped at a set 
distance above a 1 MBq source of 99mTc. The energy window was set at its 
lowest setting (0 - 3 keV), and the counts detected by each probe in a 10 
second period were recorded; this was repeated three times for each energy 
window. The fixed width energy window was increased in steps of 3 keV, 
and for each step the aforementioned process was repeated, until 
measurements had been recorded over the whole energy range (0 - 198 
keV). T h ~ ~ whole process was repeated with probe 2. 
As the electronics boxes were interchangeable, the experiments were 
repeated, as set out in table 5-1 (experiments 2 and 4), in an attempt to 
distinguish whether any problems were due to either the probe or the 
electronics box. 
The detected counts were corrected for decay. Interpreting the results 
of experiments 1 - 4 using 99mTc dictated that only probe 2 needed 
comparison to t ~ . e e surgical probe for 1111n. In order to detect the second peak 
of 1111n, the energy range had to be changed to 0 - 1 MeV and the window 
width widened to 10 keV. This led to some loss of energy resolution in the 
results. 
4.4 RESUL TS PHASE I 
The results are displayed in figures 4-2 to 4-6. The mean of the three 
counts recorded per energy window is plotted against the detected energy. 
Each figure compares the energy spectrum of one of the second-hand 
probes to that of the working surgical probe. 
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Figure 4-1 Testing of the working surgical probe. 
The radiation source was placed behind the lead blocks. The electronic boxes are 
seen on the right of the image. 
Experiment Spectrum Combination A Combination B 
Analysed Probe Box Probe Box 
1 ~ ~ m T c c Surgical Surgical 1 1 
2 ~ ~ ~ T c c Surgical 1 1 Surgical 
3 99mTc Surgical Surgical 2 2 
4 99mTc Surgical 2 2 Surgical 
5 "'In Surgical Surgical 2 2 
-
Table 4-1 Combination of probe and box experiments. 
This allowed comparison of both components of probes 1 and 2 with the surgical 
probe, which was known to be accurate and reproducible . 
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No improvement is identified in the energy spectrum when the boxes are 
interchanged between the surgical probe and probe 1. 
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99mTc peaks are identified with the boxes interchanged between the surgical probe and 
probe 2. 
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Both probes demonstrated two peaks corresponding to the photon energies emitted by 111 1n 
(173 keV and 246 keV). 
Figure 4-7 CTC4 electronics box and y-probes. 
On the right, the smaller detector improves the ability to localise the source of y-rays, 
whereas the larger detector increases the sensitivity of the probe. 
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4.5 CONCLUSIONS PHASE I 
The 99mTc spectrum for probe 1 and box 1 does not show an obvious 
peak for 99mTc, instead showing Compton scattering that gradually drops as 
the energy increases until an abrupt drop at around 140keV. There is no 
improvement in the energy spectrum when the electronic boxes are 
switched between probe 1 and the surgical probe, and therefore probe 1 
must be damaged in some way. 
The 99mTc spectrums for probe 2, with either box 2 or the surgical box, 
show obvious peaks for 99mTc. There are two peaks on the 1111n spectrum, 
which compares favourably with that produced by the surgical probe. 
The high counts detected at the lower end of the energy spectrum for 
all experiments are the result of noise. A peak is visible on some of the 
spectra at - 50 keV which is consistent with Compton scattering. 
As a result of the aforementioned experiments, probe 2 and its box was 
used for the haemorrhoid research, because adequate spectra had been 
obtained for both 99mTc and 1111n, comparing favourably with those obtained 
using the surgical probe. 
4.6 METHOD PHASE /I 
4.6.1 Ethics 
Ethical approval was gained from the designated NHS research 
ethics committee, and the research & development committee at Queen's 
Medical Centre also gave concurrent approval. A certificate to administer 
radioactive medicinal products was approved by the Administration of 
Radioactive Substances Advisory Committee (ARSAC). 
4.6.2 Inclusion Criteria 
Patients were considered for recruitment to the study if they had 
haemorrhoidal disease that required rubber-band ligation treatment. Either 
gender was considered. An age limit was set such that only patients over the 
age of 55 years were considered. 
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4.6.3 Exclusion Criteria 
Patients were excluded from the study based on the following criteria: 
rectal bleeding that had not been investigated; any other colorectal 
pathology; and pregnancy. Pregnant patients were excluded on the basis 
that we were only investigating patients over the age of 55 years. 
4.6.4 Study Group 
Patients were recruited from a general surgical clinic and had 
undergone clinical assessment and investigations as necessary before 
being asked to participate in the study. The study was explained to each 
recruit in detail, which was reinforced by an information sheet that was taken 
home. Patients gave permission to be contacted by telephone. Patients 
were contacted and given the opportunity to ask further questions. At this 
point patients were given an appointment for the study, which was confirmed 
by letter. All patients gave informed consent. A copy was given to the 
patient, another copy filed in the hospital medical record and another kept 
for research documentation. 
4.6.5 Procedure 
Corrections were applied for background counts and radioactive 
decay. The basic procedure was that counts were measured over 50 second 
periods, howeve'r a variety of time intervals and durations were assessed. 
Each patient was asked to complete the haemorrhoid PROM prior to the 
study, four and eight weeks after rubber band ligation. 
The procedure steps were: 
• The patient was asked to empty their bladder immediately before 
starting the procedure. 
• A 16G butterfly was sited in a vein of the right hand or arm of each 
participant. 
• A mark was made over the right radial artery. 
• The patient was placed in the left lateral position. 
• The patient was examined using a proctoscope, documenting the 
position and degree of the haemorrhoids. 
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• The proctoscope was marked with indelible ink to mark the 
corresponding position of the haemorrhoids. The proctoscope was 
inserted into the anal canal in the same position each time. This was 
verified by ensuring that the handle of the proctoscope was in 
alignment with the natal cleft. 
• Markings at 0.5cm intervals were also made with indelible ink along 
the barrel of the proctoscope, and therefore depth of insertion was 
kept constant by placing the distal edge of the proctoscope at the 
dentate line. The length from the anal margin to the dentate line was 
recorded in each patient. Each time that the proctoscope was 
reinserted into the anal canal, this distance was used to maintain the 
accuracy of positioning the probe. 
• Non-radioactive stannous pyrophosphate was injected via a metal 
needle at a dose of 0.5mg/ kg (for in vivo radiolabelling of red blood 
cells) and flushed with 10mls of 0.9% saline. 
• Wait 10 minutes. 
• 10 MBq 99mTc -pertechnetate was injected intravenously and flushed 
with 10mls 0.9% saline. 
• The energy range was set at 10% below and above the value for the 
99mTc peak as measured by the phase I experiments. 
• Wait 5 minutes. 
• The p r o b ~ ~ was positioned directly over the distal aspect of each 
haemorrhoid, and 50-second counts were recorded manually. 
• 50-second counts were then recorded over the reference points: 12 
o'clock position 3 cm from the anal verge, and over the right radial 
artery. 
• Rubber-band ligation of the haemorrhoids was carried out using 
suction banding equipment. 
• 5 MBq of 1111n -chloride was injected and flushed with 10mls normal 
saline. 
• The energy range was set at 10% above and below the value for the 
1111n peak as measured by the previous probe experiments. 
• Wait 10 minutes. 
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• The probe was re-positioned to monitor counts for 50 seconds over 
each haemorrhoid and at each reference point. 
A venous blood sample was taken after completion of the experiment to 
check the extent of labelling. 
4.6.6 Calculation of Index of Volume Change 
The index of volume change (Ivc) is defined by the following equation: 
Equation 4·1 Index of volume change. 
H is the count from the haemorrhoids. R is the count from the reference 
point. 
Therefore if Ivc has a value of ~ ~ 1, this would indicate that no change in 
volume has occurred after rubber band ligation. If Ivc has a value < 1, this 
would indicate a reduction in volume. 
4.6.7 Radiation Dosimetry 
The effective dose for the procedure from 10 MBq of 99mTc was 0.1 
mSV and from 5MBq of 1111n was 1.0 mSV. This gave a total dose of 1.1 
mSV per patient;' equivalent to less than 6 months exposure from 
background radiation [280]. 
4.7 RESULTS PHASE II 
4.7.1 Study Group Characteristics 
Twelve patients were recruited to the study over a 12-month period. 
There were 7 males and 5 females aged between 56 and 81 years. Of 
these, three of the females changed their minds about taking part in the 
study. In each case this was because of concerns about the radiation dose. 
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Of the remaining nine patients, one did not complete the study. In this 
case there was a fault with the charging of the counting electronics box. 
Therefore there were eight patients who completed the study, of which 
seven were male and one female aged between 56 and 75 years. 
Adjustments were made to the method after the first experiment and 
therefore there are results for seven patients. 
4.7.2 Initial Results 
The results of the first participant (NM2) (see table 5-2) are discussed 
separately, because modifications were made to the protocol as a 
consequence of carrying out the first experiment and the results obtained. 
The left half of table 5-2 shows the actual results obtained during the 
experiment. The top half shows the 99mTc counts, and the times at which 
they were obtained, over the reference point and haemorrhoids. The bottom 
half shows the same for the 11111n counts. The right half of the table shows 
from left to right: 
• correction for decay from the time of injection of the radioisotope 
(highlighted in yellow). 
• mean of the corrected counts obtained from the reference point 
(highlighted in green) and from the haemorrhoids (highlighted in dark 
pink). 
• the counts per second (cps) for the reference point (highlighted in 
blue) and each haemorrhoid (highlighted in orange). 
• the haemorrhoid cps divided by the reference point cps (highlighted in 
light pink). 
The indium values in the final column are divided by the corresponding 
technetium values to give the result of the index of volume c h a n g ~ ~ for each 
haemorrhoid. In this participant the results are set out in table 5-3. 
The counts obtained from the reference point were quite low and varied 
quite significantly particularly for 1111n. There was a significant degree of 
variability between the counts for each haemorrhoid, both for 99mTc and 
1111n. The variation in counts between haemorrhoids could have been due to 
a genuine difference in the size, but it could also have been due to small 
changes in the position of the probe. 
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Therefore, two changes were made to the protocol. It had been 
hoped that one count over each haemorrhoid would be enough to obtain 
interpretable results, in order to minimize the time that the proctoscope was 
in the anal canal. Due to statistical considerations, it seemed essential to 
obtain three counts over each haemorrhoid. The other change was to move 
the reference point from the radial artery to the skin overlying the common 
carotid artery in the right carotid triangle. Again this reference point was 
marked prior to starting the study. 
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ACTUAL TIME wmTc lllin 
HRS I'UNS Tl/2 6 .030 67.200 
""'Te INJECTION 11 3 DECAY FACTOR 0. 115 0 .0 10 
IUln INJECTION 11 45 
TECHNETIUM 
\ CORRECTED 
REFERENCE CTS ""'Te CTS CTTIME ACTUA.L TIME TIME DIFF (Hrs) "'''TeCTS MEAN OFCTS CoRA CTS/ a '11M! 
1 88 SO 11 23 0.333 91.437 8 1.881 1.638 
2 83 SO 11 24 0.350 86.407 
3 6S SO 11 25 0.367 67.798 \ 
HROID POSN "mTe CTS CTTIME ACTUAL TIME "mTe CTS ~ 0 I l C 1 S S CORR _1- '11M! HROIDLREF 
12 604 SO 11 27 0.400 632.420 ,. ·632.420 12.&48 7.724 
9 458 SO 11 29 0.433 481.391 ., ··..411.391 9.628 5.879 
5 448 SO 11 30 0.450 471.784 . 47L7B4 9.436 5.762 
INDIUM CORRECTED 
REFERENCE CTS lUln CTS CTTIME ACTUAL TIME lU ln CTS MEAN OFCTS CORA asI a '11M! 
1 223 SO 11 S6 0.183 223.422 121.582 , 2.432 
2 92 SO 11 58 0.217 92.206 
3 49 SO 11 59 0.233 49.118 
HROID POSN l11ln CTS CTTIME ACTUAL TIME lU ln CTS ~ 0 I l c : n n CoRA CTS1$!r 'llM1! HROID/REF 
12 1052 SO 12 4 0.317 1055.442 I.e 55.442 21.109 8.681 
9 796 SO 12 6 0.350 798.879 IaD_ 15.978 6.571 
5 1209 SO 12 7 0.367 1213.581 1 13.581 24.272 9.982 
Table 4-2 Results from first patient (NM2). 
Technetium counts are presented in the top half and indium counts in the lower half of the table . Corrected values are presented in the right half of the table. 
The index is calculated from the values in the columns highlighted in light pink. 
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Haemorrhoid Banded lye 
12 Yes 1.12 
5 No 1.12 
9 No 1.73 
.. . . . . Table 4·3 Initial results from the first participant. No change m the mdex of 
volume change was identified. 
PliO Oeg Lab Haem 1 RBL Haem 2 RBL Haem 3 RBL 
(%) lYe lYe lYe 
NM1 3 10.6 0.37 Y 0.77 Y 1.10 N 
NM3 1 93.9 0.72 Y 0.97 Y 1.12 N 
NM4 2 38.4 1.06 Y 1.44 Y 1.13 N 
NM5 1 42.7 0.41 Y' 0.27 Y 0.34 N 
NM6 2 82.8 1.45 Y 1.67 Y 1.38 N 
NM11 2 66.4 0.63 Y 0.51 N 0.76 N 
-
NM12 3 66.5 0.49 Y 0.89 Y 0.59 N 
Table 4-4 Summary of the outcome for the participants examined under the 
modified protocol. 
Deg - degree Lab - Extent of red blood cell labelling 
Haem - haemorrhoid 
PliO OEG Lumps Bleeding lotal 
., 
NM1 3 -2 0 -3 
NM3 1 ONe ONe ONe 
NM4 2 -1 0 -29 
NM5 1 -5 0 -6 
NM6 2 -1 -5 -7 
NM11 2 ONe ONe ONe 
NM12 3 0 -3 1 
QOL QOL Dee 
Pain Other in lye 
-3.2 -0.1 Yes 
ONe ONe Yes 
-4.1 -3.4 No 
-1.9 -2.3 Yes 
-1.4 -1.9 No 
ONe ONe Yes 
-0.9 0.4 Yes 
Table 4·5 Summary of change in the symptom score prior to and after rubber 
band ligation. 
ONe - Did not complete haemorrhoid PROM. 
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4.8 SUMMARY OF RESUL TS 
Modifications to the initial protocol increased the number of counts over 
the reference points and the haemorrhoids for both 99mTc and 1111n. There 
was less variability between the three counts obtained over the four 
measured points. 
Overall only the results of two patients (NM1 and NM3) completely 
fulfilled the expectations of the hypothesis i.e. that there would be an Ivc of 
less than 1 for the ligated haemorrhoids and also an Ivc for the 
haemorrhoids that were not ligated. 
In three patients (NM5, NM11 and NM12) there was a reduction of Ivc 
for all three haemorrhoids, not just the two that were ligated. In the 
remaining two patients (NM4 and NM6) there was no reduction in Ivc for any 
of the haemorrhoids whether ligated or not. 
There was a large degree of variability in the extent of red blood cell 
labelling by 99mTc -pertechnetate, from 10.6 to 93.9%. It is noted that in only 
one (NM4) of the three patients with labelling of less than 65%, was there a 
failure to show a change in the following rubber band ligation. 
There was no obvious relationship between Ivc and the change in 
symptom scores, whether one assessed the individual items, the total 
scores or the quality of life scores. Formal statistical analysis was not 
performed as the number of participants involved was too small to attain any 
.. 
meaningful significance. 
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4.9 DISCUSSION 
The choice of methodology was partly based on equipment available 
for use at the time of planning the study, which was the y-camera or the 
surgical solid state cadmium telluride detector. The total spatial resolution of 
a gamma camera is approximately 10mm depending on the model and 
purpose of use [281]. The spatial resolution of a gamma camera will also 
reduce the further the ROI is placed from the camera head. Given that the 
average length of the anal canal is 2.5 - 4cm depending on the 
measurement modality [282] and gender, the task of differentiating 
haemorrhoids from surrounding tissue is likely to be difficult. 
The choice of surgical probe overcomes the issue with spatial 
resolution because of its design and the ability to position it directly on the 
haemorrhoid or reference point. The dual radioisotope technique allows the 
investigator to indirectly semi-quantitatively measure volume change by 
-
acquiring counts from 99mTc labelled red blood cells pre rubber band ligation 
and 1111n bound transferrin, an intravascular protein, post rubber band 
ligation. The reference point measurements are used to correct for normal 
clearance from the circulation and for radioactive decay. 
This technique is attempting to calculate an index of volume change by 
measuring the counts from radioisotope bound components of blood, the 
presumption being that less blood components will reach the haemorrhoidal 
.. 
zone after rubber band ligation. The results of the technique showed a 
reduced Ivc for some of the participants, however there were several sources 
of possible error within this technique. 
Woolfenden and Barber [238] found that minor changes in the angle of 
surgical probes could have a significant effect on the count rate. These 
counts were arising from distant sources in the volume of tissue in front of 
the detector. A change of angle might bring a high-activity source, for 
example the kidney or urinary bladder, into view. Even when distant hot 
sources were not present, they found that changes in probe angle or 
position could cause changes in count rate because of differences in the 
volume of tissue assessed by the probe. All patients were asked to empty 
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their bladder prior to the beginning of the study to eliminate this possibility, 
however positioning of the probe was certainly difficult. 
Despite marking the position of the haemorrhoids and the dentate line 
on the distal end of the barrel of the proctoscope, it was difficult to maintain 
the barrel within the anal canal, which is unsurprising as counting time 
totalled 450 seconds prior to and post rubber band ligation for each patient. 
The morphology of the haemorrhoids obviously changed post rubber band 
ligation, with swelling of the ligated areas, thus making exact positioning of 
the probe more difficult. 
Another factor to be considered is the interaction of the x- and y-ray 
energies emitted by radionuclides with matter by the photoelectric effect and 
Compton scatter. Compton-scattered photons that are scattered in a 
patient's body and then absorbed·in the detector appear to originate from a 
direction different to that of the incident photon. This represents one of the 
major difficulties in accurate spatial localization and high-contrast detection 
of r a d i o n u c l i d e s ~ ~
Energy-selective counting is used to reject Compton-scattered photons 
and accept primary photons. For 140-keV technetium-99m y- rays, even 
sharply scattered photons would be included in the standard 20% photopeak 
energy window. Narrowing the energy window to ±1 0%, as was the case in 
the described methodology, will result in less scattered radiation being 
detected but at the cost of significantly reduced sensitivity [264], thus 
explaining the requirement for three counts at each measured region. 
The low levels (S 65 % [283]) of red blood cell binding identified in 
three of the patients (NM1, NM4 and NM5), could explain some of the 
variation in the results. Although in vitro RBC labelling is recommended for 
use in cardiac imaging, many centres prefer to use in vivo tagging because 
of its ease of use and the reduction in time consumption [284]. Since the 
description of the method for in vivo red blood cell labelling by Pavel et aI., 
[279], it has been widely applied all over the world, using different stannous 
compounds for the tinning procedure, with reported labelling values from 
60% to 90% [285]. 
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Recommendations from Hambye et aI., were followed in this 
methodology including the use of weight appropriate doses of stannous 
pyrophosphate and a metal needle for its injection. None of the patients 
were on heparin [286] or chemotherapeutic agents [287], however two (NM1 
and NM4) of the three patients were taking cardiac medication (digoxin and 
nifedipine), which have been shown to interfere with in vivo red blood cell 
labelling [288]. 
If the results from the three patients with poor red blood cell labelling 
are set aside and the remaining participants are evaluated, the values 
obtained cannot be explained on the basis of which haemorrhoids were 
ligated. 
For the purpose of Ivc calculation, it is assumed that all externally detected 
radioactivity originated from the haemorrhoids. In Gorin's [289] sheep model 
of pulmonary oedema and calculation of transvascular protein flux, using 
diffusible 113mln-transferrin and non-diffusible 99mTc -RBC, there was an 
assumption thaf all the externally detected activity originated from the lung. 
By studying pneumonectomy patients using Na 1251, other investigators 
showed that up to 30 % of counts originated in the chest wall, which would 
be expected with a small highly diffusible, low-energy tracer [290]. Although 
there are obvious differences between placing an external detector on the 
chest wall and within the anal canal, the underlying principle is applicable to 
this technique. 
Accuracy of measurement is also affected by the fact that a 
proportion of the gamma radiation will be absorbed before it can be 
detected, the extent of which is proportional to the gamma ray energy, tissue 
path length and tissue densities. 
From a logistical point of view, this study was difficult to organize and 
there were surprising numbers of patients who declined to take part in the 
study. This included the three patients who initially entered the study before 
changing their minds. Despite the patient information sheet and the 
investigator explaining that the dose involved was very small, half that of the 
UK yearly background dose, there appeared to be genuine reluctance to 
receive any radioactive dose whatsoever. 
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The underlying principles of the dual radioisotope technique are 
simple, and had the study produced reliable results this technique would 
have been an elegant way of demonstrating volume change after a surgical 
or even future pharmacological intervention. 
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5 MAGNETIC RESONANCE IMAGING 
5.1 INTRODUCTION 
5.1.1 Physics of Magnetic Resonance Imaging 
The nucleus of the hydrogen atom is a single positively charged 
proton. As a fundamental particle, the proton spins on its own axis, 
generating its own magnetic field, which is known as its magnetic moment. If 
the proton is placed in an external magnetic field, it experiences torque and 
the protons attempt to align themselves parallel and anti-parallel to the 
magnetic field, The torque causes the protons to precess around the 
direction of the magnetic field. The precessional frequency of the proton is 
proportional to the external magnetic field strength, and is described by the 
Lamor equation. 
Wo = yBo 
Equation 5·1 The Lamor equation where Wo is the Lamor frequency, 
V is the gyromagnetic ratio and Bo is the strength of the external magnetic field. 
The protons can only precess in one of two orientations known as 
states: spin-up or parallel and spin-down or anti-parallel. The spin-down 
state requires slightly more energy than the spin-up state, and protons 
interchange between the two by gaining or losing a photon, a packet of 
electromagnetic radiation. In the human body there are millions of protons, 
and in a set external magnetic field strength, there will be a set distribution 
between the spin-up and spin-down states. In a 1.5 Tesla (T) scanner for 
every million protons in the spin-down state, there will be a million and fqur 
in the spin-up state. For a large number of protons the distribution is 
described by the Boltzmann distribution, and from this the net magnetization 
Mo can be calculated as depicted in equation 5.2 below. 
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Equation 5-2. The net magnetization Mo. 
P is proton density, y is the gyromagnetic ratio, h is Planck's constant divided by 
2n, Bo is the strength of the external magnetic field, KB is the Boltzmann constant 
and T is body temperature. 
Water contains 6.67 x 1022 protons mr1, and from equation 5-2, at body 
temperature and 1.5T, Mo is calculated at 0.02I..1Tmr1. The calculated 
magnetization of the body is very small compared to the main magnetic field, 
and therefore almost impossible to measure while it is at equilibrium, lying 
parallel to Bo. 
If the body's magnetization is tipped through 90° into the transverse 
plane, a detector which only measures magnetic field in the transverse plane 
will be able to r ~ c o r d d a significant signal. This is achieved by applying a 90° 
radiofrequency (RF) pulse, which must be at the Lamor frequency. The flip 
angle (a) is determined by the strength of the RF magnetic field (B1) and the 
duration of the pulse (tp). As time is a crucial factor in magnetic resonance 
imaging (MRI), the strength of the pulse is altered to produce different flip 
angles. 
The RF pulse also brings the spins into phase coherence, such that 
they all point to the same position on the precession circle. With Mo in the 
transverse plane, it can be measured by detecting the voltage it induces in 
the receive coil, which can only detect magnetization perpendicular to Bo. 
The amplitude of the signal undergoes Free Induction Decay (FlO), 
dropping exponentially to zero, because the protons rapidly dephase with 
respect to each other. As soon as the protons have been flipped into the. 
transverse plane, they start to relax back to the equilibrium position when 
the RF pulse is switched off. Relaxation involves dephasing of the spins and 
realignment along the z-axis as the protons lose energy absorbed from the 
RF pulse. 
The spins dephase due to small differences in their precessional 
frequencies. The main factor causing FlO is the inhomogeneity in the 
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external magnetic field. A second factor is the interaction between spins as 
they move within the tissues. This is known as spin-spin interaction and is 
denoted by the T2 relaxation time, which is independent of the magnet and 
its field strength. 
As two protons come close together, they experience a change in the 
magnetic field strength, which changes their precessional frequency. 
Therefore each proton will dephase with respect to the Lamor frequency. 
When the two protons move apart, they both return to precessing at the 
Lamor frequency, but the newly acquired phase angle is irreversible. Over 
time there will be thousands of proton-proton interactions until all the protons 
are out of phase with each other. The transverse magnetization vector 
decays exponentially to zero, and T2 is the time taken for it to drop to 37% 
of its original value. 
Although transverse magnetization decays, there is no loss of energy 
in spin-spin interaction. To lose energy the protons interact with the 
surrounding tissue known as the lattice. The lattice can absorb energy and 
disperses it via blood flow. The protons lose the extra energy by attaining 
thermal equilibrium with the lattice. This is known as spin-lattice relaxation 
characterised by T1 , the time taken for magnetization to recover to 63% of 
its equilibrium value. T1 increases proportionally with field strength. In 
human tissues T1 is always longer than T2. 
The time difference between T1 and T2 is essential to the formation 
of the MR image. There is always a series of repeated RF and gradient 
pulses, with a repetition time (TR). In a simple spin echo sequence, 90°-TR-
90° -TR, provided the TR is at least five times longer than the longest T1 of 
the imaged tissues, Mz will have recovered to Mo. All tissues will have 
returned to equilibrium before the next 90° RF pulse. Signal in the 
transverse plane will depend only on proton density. 
5.1.2 Magnetic Resonance Equipment 
The magnet is the main component of the magnetic resonance (MR) 
system. The static magnetic field is inherently non-uniform. Its homogeneity 
is optimized by a process called shimming. Pieces of steel or electric coils 
are incorporated into the magnet to improve uniformity. 
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Magnetic field strength is measures in tesla (T). Strengths vary from 
0.02 - 8T, however most clinical systems operate in the 0.5 - 3.0T range. 
The advantages of higher field strengths are a better signal to noise ratio 
(SNR) and increased chemical shift artefact. Improvement in SNR can be 
traded for increased spatial resolution or decreased imaging time. 
There are four types of MR magnet, the most up-to-date version of 
which is the superconducting magnet. They are composed of certain 
materials which at temperatures approaching absolute zero 
(-273.16°C, OK) have zero electrical resistance. Electric current in a loop of 
superconducting wire, held below its transition temperature will continue to 
circulate indefinitely. 
The MR signal that provides diagnostic information is produced within 
the patient's tissue in response to·RF pulses. These are produced by a 
transmitter coil, which surrounds the whole or a part of the body. A body coil· 
is usually built into the construction of the magnet. 
The MR signals -produced in the body are detected using a receiver coil. The 
MR signals are very weak and sensitive to electrical interference. Special 
shielding known as a Faraday cage is built into the magnet room. 
5.1.3 Obtaining the Magnetic Resonance Image 
All magnetic resonance (MR) images are produced using a pulse 
sequence, which contains radiofrequency (RF) pulses and gradient pulses. 
The timing and duration of these pulses are precisely controlled to obtain 
images of tissues with specific characteristics. 
The most important properties of magnetic resonance imaging (MRI) 
are the proton density (PO), the spin-lattice relaxation time (T1) and spin-
spin relaxation time (T2). PO relates to the number of hydrogen atoms in a 
particular volume. Relaxation times refer to the time taken for a tissue to . 
return to equilibrium after an RF pulse. Contrast of an MR image is 
determined by the PO, T1 and T2. High POs produce high signal intensities 
and appear bright on the image. In T2-weighted images, tissues with long T2 
have high signal intensities. In contrast, T1-weighted images and tissues 
with long T1 have low signal intensities. 
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There are two main types of pulse sequence, spin echo (SE) and 
gradient echo (GE). SE sequences use two RF pulses to produce the echo, 
which measures the signal intensity. T1, T2 or PO weighted images can be 
acquired with SE sequences dependent on the TR and TE used. SE images 
are of higher quality but acquisition time is generally longer. 
GE sequences use a single RF pulse followed by a gradient pulse to 
create the echo, which measures signal intensity. Again T1, T2 or PO 
weighting is obtained by changing the TR and TE. Generally the TR is much 
shorter than in SE imaging, and therefore scan times are much shorter. GE 
images are affected by the external magnetic field, which affects the spin-
spin relaxation or T2 time, which becomes shorter. This combination is 
known as T2*. 
T1-weighted images are obtained 'by using short TR and TE times to 
enhance the T1 differences between tissues. Fluid appears dark, fluid-based 
tissues are grey and fat-based tissues are very bright. T1-weighted images 
are often called "anatomy" images. 
T2-weighted images are generally obtained following a SE pulse 
sequence, and require longer acquisition times due to the long TR. Fluid 
appears very bright, water and fat-based tissues are of intermediate signal. 
T2 images are often considered to be "pathology" scans. Oedema is often 
associated with pathology, and will appear bright against the darker normal 
tissue. 
PO images are formed by creating a second echo at a shorter TE during a 
T2 SE acquisition. This produces an image at the same slice location and 
within the same scan time, but with PO weighting. 
A gradient refers to an additional spatially linear variation in the static 
field strength in the z direction (Bo). An x-gradient (Gx) adds to or subtract 
from the magnitude of the static field at different points along the x-axis. The 
protons resonate faster or slower than the Lamor frequency depending upon 
their position. Faster or slower precession is detected as higher or lower 
frequencies in the MR signal. Therefore frequency measurements may be 
used to distinguish between MR signals at different positions in space. 
Slice selection is the process by which MR signals are restricted to a 
two-dimensional plane or slab within the patient. The operator can control all 
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the position, width and orientation of the slice. A specially designed RF 
excitation pulse is applied at the same time as a gradient. The special RF 
pulse contains a narrow range of frequencies of RF centred about the Lamor 
frequency. The presence of the gradient causes the resonant frequency to 
vary with position. 
Gradient pulses are applied in a controlled fashion to form a pulse 
sequence. An RF pulse is applied simultaneously with a slice selective 
gradient. The RF pulse stimulates the MR interactions in tissues, which 
leads to the MR signal. By combining the RF excitation with a gradient, the 
MR interactions are restricted to a two-dimensional plane, slab or slice. Any 
physical gradient Gx, Gy, Gz or combinations of these can be used, 
producing transverse, sagittal, coronal or oblique slices. 
Next phase encoding is applied in a direction orthogonal to the slice 
selection. This encodes the MR signal in the phase encode direction. The 
frequency-encode or readout gradient is applied in the third direction. Finally 
the MR signal is-then acquired, which actually occurs during the frequency-
encode gradient and after phase encoding. 
The whole sequence is repeated for each line of data, corresponding 
to a different value of phase encode gradient until the k-space matrix is 
filled. Once the data is acquired a two-dimensional Fourier transformation is 
applied. The data, already encoded as spatial frequencies, is converted into 
an image. 
5.1.4 Contrast Agents 
MR imaging is considered to be very sensitive, making pathology very 
conspicuous, but not very specific. It is poor at distinguishing different 
pathologies. Contrast agents help to improve the specificity by producing an 
extra sequence of images with differing contrast; they also increase SNR 
improving image quality. 
The most commonly used contrast agents are based on gadolinium, 
which has a strong paramagnetic susceptibility. When it is injected, it initially 
is taken up into the arterial system, but rapidly redistributes into the 
extracellular fluid space. It is then gradually excreted via the kidneys. It 
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shortens T1 in tissues where it accumulates, such that on post-contrast T1-
weighted images these tissues have enhanced signal. 
The super-paramagnetic iron oxide (SPIO) group of contrast agents 
reduce the T2 of tissues in which they accumulate, causing lower signal 
intensities on T2 and T2* weighted images post contrast. 
Gadolinium does affect T2 as well as T1 , and similarly SPIOs have a T1-
shortening effect as well as reducing T2 and T2*. The exact effect of 
contrast depends on their concentration in the tissue of interest, and also on 
the imaging sequence being used. At high concentrations and sequences 
with long TEs, gadolinium may reduce the signal intensity of the tissues due 
to shortening of T2. 
5.1.5 History of Abdominal a ~ d d Pelvic MRI 
Before discussing the possible methods of assessing volume and 
blood flow within haemorrhoids using MRI, it is important to discuss the 
advent of medical MRI and its progression since the 1980s. 
Early MR evaluation of the abdomen [291] used systems with a 0.1ST 
resistive magnet or a 0.3T -superconducting magnet. A whole body coil was 
used, allowing transverse, sagittal and coronal image acquisition. Slice 
thickness varied between 11 and 1Smm with a resolution of two line pairs 
per cm in the plane. Acquisition time varied between 4 and 9 minutes per 
slice. 
Different pulse techniques were used to acquire images of different PO, T1 
and T2 weighting. Focal liver abnormalities such as metastatic deposits, 
haem angiomas and cysts were imaged with both MRI and computed 
tomography (CT). In nineteen out of twenty-two cases MRI detected all liver 
lesions. 
Failure to depict the focal lesion in the three cases was thought to' be 
related to the long scanning times required for T2 weighted imaging, poor 
spatial resolution and poor SNR when compared to T1 weighted imaging. 
Other early research [292, 293] evaluated the quality of images of the pelvic 
organs in males and females, as well as the T1 and T2 relaxation times of 
tissues, such as the myometrium and endometrium. MR anatomical 
appearances were described on T1 and T2 sequences. Basic evaluation of 
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bladder and prostate tumour appearances on T1 and T2 sequences were 
described, and compared to clinical and CT appearances. 
At this point MR technology was limited in the spatial resolution 
available, and certainly could not distinguish between different layers of the 
rectal wall for example. 
Improvements in hardware, spatial and contrast resolution and faster 
scanning techniques meant that by the 1990s, MR was being evaluated for 
the clinical assessment of anal fistulae [294-296] and faecal incontinence. A 
few studies have evaluated and compared the use of a body wrap-around 
coil [297, 298] to endoanal coil imaging [296], however the majority of 
researchers used endoanal coils because of insufficient spatial resolution for 
differentiating the individual small muscles of the anal sphincter [299-301]. 
Typical signal intensities ot-the submucosa, internal anal sphincter, 
conjoined longitudinal muscle and external anal sphincter were 
characterised on T1, T2, short tau inversion recovery and post contrast 
sequences, as detailed in table 5-1 [302]. Correlation with cadaveric cross-
sections confirmed the morphology of the sphincters, and correlation with 
clinical and surgical findings confirmed that endoanal MR could accurately 
assess anal fistulae. Although the use of rigid endoanal coils allows high-
resolution thin MR images, there is compression of the epithelium and 
subepithelial tissue [303]. 
Submucosa Internal Conjoined External 
Anal Longitudinal Anal 
Sphincter Muscle Sphincter 
T1 1-1- -+ + + 
T1 & 1-1- 1- + + 
Contrast 
T2 1-1- 1- + + 
STIR 1-1- 1- + + 
Table 5·1 Typical signal intensities from the layers of the anorectum 
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PO-weighted GRE and T2-weighted TSE MR images clearly 
demonstrate normal anal anatomy and disease [295, 296, 304], including 
faecal incontinence and anorectal tumours. Fat suppression techniques 
such as fat saturation, spectral inversion recovery and short tau inversion 
recovery (STIR) may help to increase the level of confidence in difficult 
cases, facilitating identification of small amounts of fluid [305]. 
In anorectal tumour imaging, contrast between tumour and the rectal 
wall is optimal on T2-weighted TSE images. PO-weighted GRE images are 
too susceptible to motion artefact caused by rectal contractions. 
Characterization of tumour extension into perirectal fat or anal sphincter is 
best achieved with T1-weighting. The use of contrast can help determine 
tumour extent [305]. Dynamic MR imaging has been advocated to improve 
the differentiation between T2 and T3 tumour. 
Imaging planes used are off-axis orientated orthogonal or parallel to 
the coil and anorectum, thereby reducing partial volume effects. The axial 
plane is optimar in the evaluation of anorectal disease. Longitudinal 
sequences allow better appreciation of the craniocaudal extent of disease 
[306]. A radial sequence has the theoretical advantage that all sections are 
perpendicular to the coil and anorectum resulting in fewer partial volume 
effects. Superior evaluation, in terms of multiplanar capability, of the external 
anal sphincter has increased the understanding of the external anal 
sphincter anatomy. 
5.1.6 Relaxometry 
Much of the early work carried out by MR researchers focused on 
measurement of relaxation times in vitro and in vivo. The working theory was 
that normal tissue and pathologies could be characterized on the basis of 
relaxation times. This has proved to be impossible for a number of reasons. 
There is a substantial overlap of T1 and T2 values due to biological 
variability. As shown in table 5-2 [307, 308], grey matter, white matter and 
cerebrospinal fluid have distinct T1 and T2 values, which allows for good 
anatomical imaging. Various brain lesions including tumours [309], infarction 
and multiple sclerosis plaques have T2 values in a narrow range (170 - 200 
msec), which is distinct from the T2 values of grey and white matter, but not 
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uniquely distinctive from each other [310,311]. MRI is very sensitive but less 
specific based on relaxation times only, unless other features such as 
contrast uptake, presence of oedema, degree of vascularity and blood 
breakdown products are taken into account. 
Tissue T1 (msec) T2 (msec) 
White Matter 832 110 
Grey Matter 1331 80 
CSF 3700 
Fat 382 68 
Muscle 898 29 
Liver 809 34 
Spleen 1328 61 
Table 5·3 Selection of T1 and T2 values for tissues at 3.0T. 
All values are measured in vivo from human tissues. 
So far tissues have been considered to have single T1 and T2 values. 
In practice the situation is usually more complex. Tissues are formed of 
various components including parenchymal cells, the interstitial space and 
the microvascular space. Relaxation characteristics of each of these may 
differ significantly from each other, and thus the measured T1 and T2 will be 
a weighted.average of the components. 
When considering relaxation mechanisms, water molecules reside in 
three states: free, bound and structured. Water molecules, free in solution, 
consist of a uniform number of protons moving over a wide range of 
frequencies. There will only be a small number moving at the Lamor 
frequency, so T1 relaxation is relatively inefficient and T1 times are long. 
Similarly only a small number are moving at very low frequencies, and 
therefore T2 relaxation time is also inefficient leading to long T2 values. 
With water molecules bound to larger macromolecules through the 
formation of a hydration layer, there are a large number of protons moving at 
very low frequencies because the binding to macromolecules restricts their 
motion. T2 relaxation is very efficient and T1 relaxation inefficient. 
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Protons can also be in the intermediate stage, between bound and 
free states. There are a large number of protons moving at the Lamor 
frequency, and T1 relaxation will be the most efficient. T2 relaxation is 
intermediate between bound (short T2) and free (long T2). The measured T1 
and T2 relaxation times will be a weighted average of the three states. 
As well as mixing of tissues at the cellular level, there is mixing of the tissue 
types within a voxel due to the relatively low spatial resolution of MRI. 
T1 has a marked dependence on the field strength BO, which is described by 
the mathematical relationship in equation 5.3. 
Tl oc B ~ ~
Equation 5-3 The relationship between field strength and the T1 relaxation 
time. 
The constant b lies in the 0.3 - 0.4 range. 
As there .are many different MR scanners with carrying field strengths, 
it is difficult to directly compare relaxation measurements from different sites 
or models. T2 is largely independent of field strength. The observed MR 
signal, and therefore the T1 and T2 relaxation time can be influenced by 
magnetization transfer. This occurs when there is fast exchange between 
bound and free protons. The bound or restricted pool has such a short T2 
relaxation time that the molecules are invisible to standard MR imaging, as 
their signals decay before the echo can collect the signal. However the 
bound pool has a broad resonance and therefore can be excited by an RF 
pulse at a frequency several kilohertz away from the free water frequency, 
which therefore has no effect on the free protons. 
Exchange of protons between the bound and free pools means that 
saturated magnetization from the invisible bound pool will move into the free 
pool, this reducing the total MR signal that can be observed. 
Apart from biological variability, multi-exponential behaviour 
(exchange between states), tissue mixing, field strength dependence and 
magnetization transfer there are a number of other sources of error in 
relaxometry. These include poor sequence parameter choice, particularly 
too short a TR for a PO-weighted image, inhomogeneous RF pulses, 
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contrast effects in multiple slice acquisitions arising from selective pulses 
intended for other pulses and slice profile distributions. All of these problems 
dictate that T1 and T2 measurement is not at present a useful tool. 
5.1.7 Dynamic contrast enhanced imaging 
Development of DCE imaging arose in response to the development 
of antiangiogenic agents, which are selectively targeted to the endothelial 
cells of tumour neovasculature. Unlike traditional cytotoxic drugs, these new 
agents induce a rapid shutdown of tumour blood supply. Their cytostatic 
nature precludes normal tumour size measurement as a marker for 
response evaluation [312]. It has been used in multiple oncological settings 
including tumour grading and clinical outcome prediction [313, 314]. 
In solid tumours the neovasculature is abnormal in structure with 
defects in the walls that make them more permeable than normal vessels. 
Low molecular weight contrast agent molecules will leak into the interstitial 
-
space, and interaction with adjacent water protons will increase the tissue 
longitudinal relaxation time, generating a brighter signal in T1 weighted 
images [315], producing a more rapid and intense washout of contrast. 
The change in contrast agent concentration can be described by a variety of 
model-free parameters [316, 317] or fitted to a pharmacokinetic model [318], 
which enables quantification of tumour vascular heterogeneity [313]. 
5.2 AIM· 
The aim of this study is to evaluate the feasibility of using MRI and in 
particular DCE-MRI to evaluate vascular measures in haemorrhoidal 
disease. 
5.3 METHOD 
5.3.1 Ethics 
Ethical approval to image fifteen patients was gained from the 
Nottingham Research Ethics Committee 2 (part of the Central Office for 
Research Ethics Committee). Concurrent approval was also given by the 
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Research & Development Department at Nottingham University Hospital 
NHS Trust. Approval was given by the University of Nottingham Medical 
School Ethics Committee to scan four healthy volunteers. 
5.3.2 Inclusion and Exclusion Criteria 
Patients were considered for recruitment to the study if they had 
haemorrhoidal disease that required rubber-band ligation treatment. Either 
gender was considered. Healthy volunteers were considered for recruitment 
to the study provided that there was no history of gastrointestinal disease. 
Patients were excluded from the study if they had rectal bleeding that had 
not been investigated or any other colorectal pathology. Patients were also 
asked specifically about MRI exclusion criteria, including a known metal 
implant or pacemaker, known allergy to intravenous contrast, pregnancy or 
claustrophobia (see appendix 10.4). 
5.3.3 Recruitment 
Patients were recruited from a general surgical clinic and had 
undergone clinical assessment and investigations as appropriate, to exclude 
other colorectal pathology, before being asked to participate in the study. 
Patients underwent digital rectal examination, proctoscopy and rigid 
sigmoidoscopy to allow confirmation of haemorrhoids, and exclude any anal 
or rectal pathology. 
The study was e.?<plained to each potential recruit in detail, which was 
reinforced by an information sheet that was read at the time of assessment. 
A safety check was carried out to ensure that the potential participants did 
not have a contraindication to undergoing MRI. An explanation of the rubber 
band ligation process was given. 
Some patients preferred to have more time to consider either takillg 
part in the study or having rubber band ligation performed. Patients gave 
permission to be contacted by telephone, and were contacted two to three 
days later. They were given the opportunity to ask further questions. If the 
patient did not wish to take part in the study but wished to proceed with 
rubber band ligation, they were offered an appointment to return to the 
department of surgery. If the patient had consented to taking part in the 
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study, they were asked to complete the consent form and questionnaire at 
home and bring the paperwork to the appointment. 
All patients and healthy volunteers gave informed consent. A copy was 
given to the patient, another copy filed in the hospital medical record and 
another kept for research documentation. Both patients and healthy 
volunteers completed a safety screening form prior to entry into the study 
(see appendix 8.3). 
5.3.4 Equipment 
All patients and healthy volunteers were imaged at the Sir Peter 
Mansfield Magnetic Resonance Centre. They were scanned on a Philips 
Medical Systems™ Intera Achieva 3T machine, with a phased array body 
coil centred at the hips. An intravenous cannula was inserted into the 
antecubital fossa for administration of gadolinium-based contrast. Each 
patient was weighed and a dose of 0.1 mmolkg-1 of Prohance ™ 
(Gadoteridol) was calculated. The gadolinium was hand injected through a 
20G cannula with an approximate flow rate of 1.1 ml/sec, followed by 20mls 
of saline flush. The first sequence was acquired without contrast, followed by 
acquisition at 30, 60, 90 and 120 seconds. 
5.3.5 Determination of Sequences 
Four healthy volunteers and two patients were each scanned once to 
establish the best seq,uences for imaging the anal canal. The details of each 
and a summary of the sequences trialled are summarised in table 5-3. Axial 
and sagittal planes were acquired; the sagittal images were used to plan the 
axial imaging such that true axial views were obtained, orthogonal to the 
anal canal. 
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ID Age Gender Degree T1 T2 PD STIR SE GE T1C 
MV1 36 F 0 ,/ ,/ ,/ ,/ ,/ 
MV2 46 F 0 ,/ ,/ ,/ ,/ 
M3 52 F 2 ,/ ,/ ,/ 
M4 37 F 2 ,/ ,/ ,/ ,/ 
MV4 30 F 0 ,/ ,/ ,/ ,/ 
MV3 22 M 0 ,/ ,/ ,/ ,/ 
Table 5-2 Overview of demographics and sequences tria lied on each patient 
and volunteer in phase 1. 
5.3.6 Protocol for Imaging Patients and Healthy Volunteers 
The final choice of sequences consisted of a high-resolution sagittal 
T2 to allow planning of the axial sequences, followed by a true axial T2 
weighted sequence, a DeE axial T1 weighted sequence, and lastly another 
axial T2 sequence. These are summarised in table 5-4. Six patients were 
scanned with the finalised protocol, one of who withdrew after the first scan. 
The remaining five patients were scanned immediately prior to and two days 
after rubber band ligation. 
ID Age Gender Degree 
M5 35 M 2 
M6 46 
.. F 1 
M8 33 M 3 
M9 54 F 1 
M11 66 F 2 
Table 5-3 Demographics of patients in phase II of MRI study. 
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Property 5agT2 Axial T2 Axial T1 
TE 80 55 10 
TR 1910.5 1500 164.3 
Angle 90 90 90 
Slice Thickness (mm) 1.5 2.0 2.0 
Slice Spacing (mm) 1.6 2.2 3.0 
NSA 4 8 4 
ETL 14 7 3 
Matrix 256 x 256 256 x 256 256 x 256 
Duration (secs) 114.6 702 557.1 
No of slices 14 16 6 
Table 5-4 Summary of finalised sequences used for assessing patients and 
healthy volunteers. 
The same axial T? sequence was repeated immediately after the axial DeE T1 sequence. 
5.3.7 Image Analysis 
Analyses of regions of interest were carried out on OsiriXTM, version 
4.0 (32-bit), on a 15-inch MacBook Pro (Intel Core Duo). OsiriXTM is 
an image processing software application dedicated to DICOM images 
produced by imaging equipment. It is fully compliant with the DICOM 
standard for image communication and image file formats. It is able to 
receive images transferred by DICOM communication protocol from 
any PACS or imaging modality. It has been specifically designed for 
navigation and visualization of multi modality and multi-dimensional images. 
Each dynamic image was evaluated for signal intensity values. The 
regions encapsulated by the lAS and by the submucosa were selected'for 
signal intensity calculations obtained with the oval ROls (see figs 5-1 and 5-
2). Time-intensity curves were constructed from signal intensity values 
calculated at the 30-second intervals over the 120-second duration. To 
compare the relative enhancement differences between pelvic tissues, 
additional measurements were taken from a major artery and a reference 
muscle (gluteus maximus) in all patients in each slice. 
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The percentage of enhancement for each time-intensity curve was 
calculated from the formula: 
E = (lmax-1pre) x 100 
Ipre 
Equation 5-4 Calculation of percentage enhancement from time-intensity 
curve. 
Imax is the peak signal intensity during the post contrast dynamic sequence. Ipre is the signal 
intensity at the base of the curve [319]. 
The acceleration rate on a time-intensity curve was used as a measure of 
perfusion of the imaged anorectum. This is defined as the steepest slope of 
gadolinium uptake and is expressed by the following equation: 
(lend - Ipre)x 100 
AR= - - . - - - - ~ ~ - - - - - -
Ipre X (Tend - T prev) 
Equation 5-5 Calculation of acceleration rate on a time-intensity curve. 
lend and Ipre are the values on the time-intensity curve at the corresponding time points Tend 
and T prey [320] 
To compensate for differences in contrast injection rate and variations in 
vasculature the ratio Ih was used where IH is the signal intensity of the 
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haemorrhoids, IA is the signal intensity of a reference artery, and 60 refers to 
the time-point at which the measurements were taken. 
5.4 RESULTS 
5.4.1 Choice of Sequences 
Attempts to image patients and volunteers using gradient echo technique 
failed to produce images with adequate detail of the submucosa (comp.are 
fig 5-1 to 5-2), and therefore spin echo images were used, which have a 
longer duration of acquisition, but better spatial resolution. T2 weighted 
imaging produced anatomical images, whilst T1 images were required for 
the DeE imaging. 
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5.4.2 Qualitative Evaluation of Imaging 
All T1-DCE and T2-images were evaluated for the presence of 
artefact. The submucosa-lAS and the IAS-EAS interfaces were either 
recorded as adequate or inadequate for ROI analysis. Pre and post rubber 
band ligation images were synchronised within OsiriXTM and viewed 
simultaneously for objective differences within the submucosa. 
Motion artefact affected the pre and post rubber band ligation images 
of M11 and the post rubber band ligation images of M8. Peristalsis artefact 
was identified on the pre-RBL images of M6, however this did not preclude 
ROI analysis. The submucosa-lAS and the IAS-EAS interfaces were easily 
discerned in the lower and mid-anal canal (fig 5-2) allowing easy placement 
of the ROls (fig 5-3), however as the axial plane of imaging approached the 
anorectal angle the interfaces became less distinct (fig 5-4) in all patients. 
Review of the T2 weighted images also demonstrated a high signal 
trefoil appearance within the centre of the low signal submucosa, which is 
likely to represent the mucosal folds of the anal canal. This was evident in 
the single healthy volunteer (fig 5-5) and all the patients that were scanned 
under the finalised protocol (fig 5-6). 
The DCE images were difficult to assess initially; there was no inherent 
tissue contrast identified at the first time-point, which made placement of an 
ROI virtually impossible (fig 5-7). However this issue was overcome by 
propagating ROls from images of the same slice acquired at 60 or 90 
"" 
seconds, which is possible within the OsiriX TMsoftware (fig 5-8). 
No discernible difference was identified between pre and post rubber band 
ligation images on T2 images (fig 5-9 & 5-10), however comparing the 
patient (M8) with third-degree haemorrhoids to the other patients showed a 
difference on the final post contrast T2 images (fig 5-11 & 5-12). There was 
an area of high signal intensity identified at the 6 o'clock position, which was 
also identified on the post rubber band ligation images (fig 5-13). 
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5.4.3 Semi-Quantitative Analysis of DeE Imaging 
Although all slices were analysed a representative selection of the data is 
presented. The most proximal of the six slices (slices 5 and 6) are 
presented, as these are in closest proximity to the anorectal angle, an easily 
identifiable landmark. No results are presented for the patient M5, as there 
was an error with the timing of the MR acquisition in relation to the contrast 
such that the upward slope of the time-intensity curve was not acquired at 
all. 
It became clear on evaluating the time intensity curves (see fig 5-14 and 5-
15) of all scanned patients that the contrast enhancement curve had not 
demonstrated a complete plateau, however this did not preclude the 
calculation of values for E, AR or Ih . The values for the lAS ROI are 
. la60 
presented below in tables 5-6 to 5-8. 
Comparison of the healthy volunteer's time intensity curve (fig 5-16) 
demonstrated a faster attainment of peak contrast enhancement at 30 
seconds, compared to that of 90 seconds for the pre and post rubber band 
ligation curves. 
Unsurprisingly due to the small numbers involved, the Wilcoxon signed rank 
test showed no significant difference between pre and post rubber band 
ligation values of the lAS ROI values of E (T = 15.00 P = .742), AR of the 
time intensity curve (T = 10.00 P = .313) or of ;h (T = 14.50 P = .491) . 
. , a60 
Similar results were identified for the submucosal ROI signal intensity 
values. 
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PTID SLICE 5 SLICE 6 
Pre-RBL 2/7 Pre-RBL 2/7 
M5 - - - -
M6 85.71 137.84 125.27 92.6 
M8 118.42 85.98 74.19 111.0 
M9 183.53 155.68 182.76 240 
M11 186.27 25.76 229.17 114.29 
MV11 121.62 - 146.77 -
Table 5-5 Percentage enhancement E within lAS ROI 
PTID Deg SLICE 5 SLICE 6 
Pre-RBL 2/7 Pre-RBL 2/7 
M5 2 - - - -
M6 1 2.95 2.3 1.39 1.54 
M8 3 0.99 2.87 0.82 1.88 
M9 1 6.12 1.3 3.05 2.0 
M11 2 3.1 0.43 7.64 1.29 
MV11 - 1.01 - 1.22 -
Table 5-6 Acceleration rate of time intensity curve for the lAS ROI. 
PTID SLICE 5 SLICE 6 
Pre-RBL 217 Pre-RBL 2/7 
M5 - - - -
M6 0.36 0.46 0.40 0.56 
M8 0.36 0.43 0.38 0.44 
M9 0.32 0.28 0.47 0.38 
M11 0.21 0.15 0.22 0.14 
MV11 0.22 - 0.23 
-
Table 5-7 Ih - for the lAS ROI. 
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Figure 5-1 Spin echo based image demonstrating poor 
spatial and contrast resolution. 
Figure 5-2 T2 weighted image of lower anal canal. 
The submucosa-lAS and IAS-EAS interfaces are well demonstrated . 
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Figure 5-3 Demonstration of placement of ROls. 
T2 weighted image. 
Figure 5-4 Axial image of proximal anal canal. 
Images are from the same patient as in figs 5-1 and 5-2. 
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Figure 5-5 High signal intensity of mucosal folds in a healthy 
volunteer. 
Figure 5-6 High signal intensity of mucosal folds in a patient. 
Similar appearance in a patient with second-degree haemorrhoids at mid-
anal canal level. 
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Figure 5-7 T1 weighted image DeE. 
Proximal slice from a patient prior to rubber band ligation at start of DeE 
scanning. 
Figure 5-8 Image acquired at 60 seconds post contrast 
injection. 
The same slice as in fig 5-5 now shows contrast-enhanced delineation 
between the submucosa and lAS, thereby allowing placement of ROls and 
propagation to other slices. 
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Figure 5-9 Pre-RBL appearance of patient with 1 st degree 
haemorrhoids. 
Figure 5-10 Post-RBL appearance of patient with 1 
degree haemorrhoids 
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Figure 5-11 Proximal slice from pre-RBL patient with 
haemorrhoids. Figure 5-12 Proximal slice from pre-RBL patient with 3
rd degree 
haemorrhoids. 
An area of high signal intensity is identified at the six o'clock position. 
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Figure 5-13 Axial slice from post-RBL patient with third-degree haemorrhoids and concurrent position on sagittal image 
The green line on the left image denotes the exact position of the axial slice. The area of high signal intensity is unchanged visually from that in fig 5-12. 
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Figure 5-14 Time intensity curve for M6 prior to RBL. 
Each gridline on the x-axis represents a 30-second interval. 
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Figure 5-15 Time intensity curve for M6 2 days after RBL. 
No significant difference was identified between the measures of perfusion 
pre and post rubber band ligation . 
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Figure 5-16 Time intensity curve of a healthy volunteer. 
This demonstrates attainment of peak enhancement at 30 seconds, which 
is of shorter duration than in the pre or post RBL time intensity curves 
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5.5 DISCUSSION 
The aim of this study was to evaluate the feasibility of both acquiring 
MR images of haemorrhoids and the evaluation of perfusion calculations as 
a possible parameter for haemorrhoidal vascularity. There is an extensive 
amount of research on the role of both endoanal and external phased array 
MRI in the evaluation of faecal incontinence and perianal fistulae. This is 
supported by numerous studies on the morphology of anal sphincters in 
patients and healthy volunteers [283, 297, 298, 305, 306, 321]. There is, 
however, no formal evaluation of the submucosal layer in any of these 
studies. Review of images from groups evaluating the role of external 
phased array MRI of the anal sphincter complex [322-324], show that the 
submucosa is isointense in comparison to the hypointense lAS. There was 
no morphological detail such as the hyperintense mucosal folds identified in 
this study. This is likely to be related to the use of a 3T magnet, with its 
increased intrinsic SNR proportional to the main magnetic field strength, 80 
(equation 5-1). The SNR is not however twice of that obtained in a 1.5T 
magnet due to factors such as increased longitudinal relaxation time [307, 
325] and decreased transverse relaxation time [307]. Nevertheless 
qualitative analysis of the images demonstrated improved morphological 
detail such as the mucosal folds. 
Four patients and two volunteers were scanned to evaluate the most 
appropriate sequences for imaging the submucosal layer of the anal canal. 
80th the spatial and contrast resolution was superior on spin echo imaging, 
compared to gradient echo imaging. Adjustments to the trialled sequences 
were related to the increased specific absorption rate (SAR), a measure of 
the energy deposition within the human body. SAR increases by a fact9r of 4 
with doubling of the magnetic field strength, and although the energy 
deposited is still non-ionizing, the increased SAR requires careful monitoring 
[326]. Consequent protocol adjustments such as an increase in the TR, a 
decrease in the number of slices or a decrease in the flip angle are 
frequently necessary [326]. These factors explain the long durations 
required for the chosen sequences. 
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There were a number of limitations in this study, which should be taken 
into account. The qualitative analysis demonstrated that images were 
affected by artefact due to motion, peristalsis and flow. Although these 
artefacts did not preclude the placement of the lAS and submucosa ROls, 
accuracy of replicating this process in the images acquired after rubber band 
ligation is likely to have been affected. This could be improved by 
administration of an anti-spasmodic such as buscopanTM (Boehringer 
Ingelheim, GmbH) in possible future studies. 
Following on from the last point, there will have been errors relating to 
the placement of the orthogonal planes on the planning sagittal sequence 
(fig 5-13). Measurement errors are related to the inherent discriminatory 
capability of the imaging method, as well as the ability of the observer to 
perform a consistent reading [298]. Due to the pilot nature of this study and 
the small sample size, formal evaluation of reproducibility was not 
performed. Difficulty with placement of the ROls was noted for the proximal 
slices at the anorectal angle; this was likely to be related to the change in 
orientation of the orthogonal plane at the anorectal angle. In possible future 
studies modification of the technique may include acquiring two sets of axial 
images, orthogonal to the mid and distal anal canal, and orthogonal to the 
proximal anal canal at the anorectal angle. 
Technical limitation of the DCE MRI component of the study was 
demonstrated on review of the time intensity curves, where the contrast 
enhancement curve had not yet completed a full plateau. If further 
investigation of DCE-MRI is to be performed, further evaluation of the T1 
sequence parameters will be necessary to reduce acquisition time. 
It was possible and simple to evaluate three model-free parameters 
describing the DCE-MRI dynamic curve, however no meaningful statistical 
analysis could be performed due to the small number of patients involved. 
The choice to use the model-free parameters is related to the simplicity of 
application and calculation. 
In the research field of recurrent rectal cancer, investigators have 
emphasised the need to evaluate diagnostic criteria for categorization of 
recurrent tumour [327, 328]. Therefore qualitative analysis of pre and post 
210 
rubber band ligation images was performed in this study. The appearance of 
pre and post rubber band ligation images did not differ, with no difference in 
overall or focal signal intensity identified. It is acknowledged that analysis of 
signal intensity was not performed, however this choice is related to the 
errors inherent in relaxometry, including biological variability, multi-
exponential behaviour, tissue mixing, field strength dependence and 
magnetization transfer. 
Pre rubber band ligation T2 images from the patient with third-degree 
haemorrhoids showed a focal area of high signal at the six o'clock position. 
This appearance became slightly more prominent on the second set of T2 
post DeE image acquisition, and was still present at the time of post rubber 
band ligation image acquisition. It was documented at the time of MR 
examination that the patient was in considerable discomfort prior to rubber 
band ligation, and one possible interpretation of this appearance is that of 
thrombosis present within the haemorrhoidal venous plexus. 
At the time of writing (January 2012) the investigator is not aware of 
any MRI studies performed by other groups to examine anal canal cushions 
or haemorrhoids. This was a feasibility study, and I would recommend the 
following alterations to the study protocol: the use of buscopan to reduce 
motion and peristalsis artefact; longer duration of acquisition of DeE images; 
acquisition of two sets of axial images, orthogonal to the mid-to-distal anal 
canal and orthogonal to the proximal anal canal as it approaches the 
anorectal angle; and I'astly to image patients with third and fourth-degree 
haemorrhoids. 
There are multiple parameters available for evaluation of DeE MRI 
images, and if there are greater numbers of patients involved, then these 
could be compared formally. It is noted that the model-free parameters have 
shown poor reproducibility and do not distinguish the effects of blood flow, 
blood volume or contrast agent leakage [329]. Nevertheless, given that 
haemorrhoidal vascularity has not been evaluated in any great depth, simple 
measures, which can be easily replicated by multiple groups, are likely to 
represent a more pragmatic approach to further research. 
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6 DISCUSSION 
6. 1 Development of objective measures of haemorrhoidal 
disease and response to treatment. 
At the start of the research period the underlying theme to the 
proposed investigations was that if new surgical treatments, DGHAL and 
PPH purported to affect haemorrhoids by interrupting arterial supply, then it 
might be possible to replicate the effect pharmacologically. A literature 
review at this time demonstrated a paucity of research evaluating changes in 
vascularity as a cause of haemorrhoids, despite enthusiastic and extensive 
publication of trials evaluating the effectiveness of DGHAL and PPH. 
There has been very little objective assessment of the relationship 
between development of symptoms and the change from normal anal 
cushions to pathological haemorrhoids. Little is known of the natural history 
or symptom progression of patients with haemorrhoids. Although there has 
been enthusiastic uptake of PPH and DGHAL, this has not been mirrored by 
investigation of pathogenesis or objective evaluation of outcome. 
The testing of pharmacological agents often requires a biomarker; 
which can be defined as a characteristic that is objectively measured and 
evaluated as an indicator of a normal biological process, pathological 
process or pharmacological response to a therapeutic intervention [330]. 
The requirement for objective outcome measures or biomarkers in the 
evaluation of treatment of haemorrhoids is clear; there are no validated or 
even standardised methods for evaluation of treatment efficacy, as 
discussed in the introduction to chapter two. 
Therefore the primary aim of the thesis is to investigate and develop 
different modalities to assess efficacy of treatment, with a view to producing 
a biomarker of haemorrhoidal disease. A secondary aim is to evaluate 
whether pathological change in vascularity of the normal anal cushions is at 
least partly responsible for the development of haemorrhoidal disease. 
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6.1.1 Haemorrhoid PROM 
At the time of starting the thesis research period, there had been no 
significant discussion of how surgeons should compare the success of 
different treatment modalities for haemorrhoidal disease. The advent of PPH 
and DGHAL stimulated re-evaluation of the role of abnormal vascularity in 
the pathogenesis of haemorrhoids. 
Patient reported outcome measures and quality of life measures have 
become a significant, and sometimes essential, part of assessment of 
treatment efficacy in clinical trials, in a variety of clinical settings. 
There are a wide variety of measures reported in the literature, which are 
used to compare treatment modalities and verify successful outcome. These 
include surgeon-assessed clinical outcomes such as symptoms and 
proctoscopic appearance, complications and requirement for re-intervention, 
patient satisfaction and return to work, and recurrence rates at varying post-
operative time intervals. 
In the early stages of the thesis research period, it became clear that 
there is no consensus on a gold standard criterion for evaluation of the 
efficacy of any treatment modality. Therefore validation of any outcome 
measure was always going to be difficult. It was postulated that health-
related quality of life could be correlated to responses to individual items and 
a total score, allowing self-validation. This has been used in the early stages 
of development of other PROMs to assess validity. 
The development of the haemorrhoid PROM comprised an initial 
phase of item selection, reduction and scaling. Analysis of the responses to 
the initial symptom index (HSI-1) was used to develop a second PROM. 
Differences included reduced number of items, different scaling, altered 
formatting to improve ease of use, and the use of visual analogue scales to 
assess HRQL. 
The choice of a general surgical outpatient clinic for recruitment of 
patients was inherent to the nature of the study, i.e. evaluation of a 
treatment. One hundred and fifteen patients with first to third degree 
haemorrhoids were recruited to the study. Early on in the study, 
reproducibility was assessed by asking the first twenty-two participants to 
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complete a second PROM, once the first had been completed and returned. 
The intraclass correlation was 0.987 (0.970 - 0.995). Reliability was further 
assessed by analysing internal consistency. Values of Cronbach's a were 
higher than 0.80 for all items at all time-points. This indicates that the 
covariance of the items reflects an underlying dimension that may be more 
important than any single item. 
Validity was assessed in several ways: completion by healthy 
volunteers, and correlation of the item and total scores to the quality of life 
scores. Healthy volunteers scored a mean value of 1.58 compared to 
patients who scored a mean value of 22.04 prior to, 18.53 four weeks after 
and 11.37 eight weeks after rubber band ligation. 
Spearman's rho for correlation of the total score to quality of life score 
affected by pain ranged between 0.629 and 0.720 depending on the time-
point of assessment, and for correlation to quality of life affected by other 
symptoms ranged between 0.569 and 0.744. Correlation values of less than 
0.300 were obtained for the bleeding and itch! irritation items, which suggest 
that these items are less important to the overall construct. Removal of 
these items did not make a significant difference to the overall correlation of 
the total score to the quality of life scores. 
Responsiveness was verified by demonstrating a significant decrease 
with a moderate size effect in the total score, and in most individual items 
apart from the pain and soiling items. Further proof of validity was 
demonstrated by coni'paring patients who did and did not require further 
treatment. At no point in the study was reference made to the scores with 
respect to making decisions about the requirement for further treatment. 
A significant decrease with medium to high size of effect was identified for all 
items, except itch! irritation. As this item did not correlate well with quality of 
life scores either, it is suggested that in any future work, the investigator 
considers removal of this item completely or analysis of validity with the item 
included and excluded from the total score. 
Evaluation of the patient group by degree of haemorrhoid 
demonstrated significant differences between first-degree haemorrhoids and 
second or third-degree haemorrhoids. Patients with first-degree 
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haemorrhoids demonstrated low responsiveness for pain, lumps, sensation 
of incomplete emptying and mucus/ slime. This pattern of response is in 
keeping with currently used classification systems, however the decrease in 
score of the bleeding item for first, second and third-degree haemorrhoids 
does not correlate well with Goligher's classification [331]. 
Acceptability of the PROM can be evaluated by the recruitment rate, 
which was good (80.6%) and moderate retention rate (72.2%) for each time-
point. It is suggested that if future studies are carried out, then only the 8-
week questionnaire is sent out to reduce the burden on the patient. 
Statistical analysis of missing data was handled in a consistent manner for 
every study, and data was excluded in a list-wise manner. This may explain 
the low values for the correlation of some items to the quality of life scores. 
Although most of the requirements [332] for a clinically appropriate 
PROM have been fulfilled, it is acknowledged that there were limitations to 
the study. Most importantly patients were not directly involved in the item 
selection process. The study group was relatively small, and with respect to 
validity, further studies are required. Nevertheless the haemorrhoid PROM 
has fulfilled many of the appraisal criteria to merit further development and 
analysis. 
This study evaluated patients with first to third degree haemorrhoids 
requiring rubber band ligation as the chosen method of treatment, and 
therefore although there is promising evidence of validity, it cannot be used 
directly in the evaluation of fourth-degree haemorrhoids. Recruitment to all 
studies proved difficult, which may be related to the strict adherence to 
exclusion criteria. The study population was relatively small, and further 
analysis of validation sets of patients is required before the PROM can be 
applied to a clinical setting, Future work should focus on direct involvement 
of patients in further generation of quality of life related items. Expansion of 
the study population to include fourth-degree haemorrhoids will require 
modification of the PROM to include relevant items. 
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6.1.2 3D PDA - Anorectal Angle Sphere Measurements of 
Vascular Indices. 
An endoanal approach was rejected as a possible route to imaging 
haemorrhoids because of the compressive effect of the probe. Duplex 
Doppler was rejected as a means of analysing vascularity because of 
Doppler angle reliance, operator dependent error and aliasing. It should also 
be noted that there was no significant ultrasound training available for the 
investigator, and that this was also a factor in rejecting the duplex Doppler 
approach to analysing vascularity. The decision to use power Doppler was 
also based on the fact that all vessels, including arteriovenous 
communications and the venous plexus would be assessed. 
The other pragmatic decision was related to the probes available for 
use with the GE 730 Expert based at Nurture, the fertility treatment centre 
based at University Hospital Nottingham. An abdominal probe (RAB 2-5) 
and an e n d o v ~ g i n a l l probe (RIC 5-9) were available for use. The frequency 
range of the abdominal probe is 2.0 - 5.0 MHz, which was too low for the 
application of interest. Several of the healthy volunteers were also scanned 
with the abdominal probe, and the 3D grey-scale datasets and power 
Doppler datasets were found to be of much lower quality in comparison to 
those obtained with the endovaginal probe. An issue with the endovaginal 
probe was the ergonomics of supporting the probe on the perineum whilst 
the datasets were acquired. 
Transperineal 3D ultrasound was established as a reliable method of 
acquiring images of the anal canal that did not compress the haemorrhoids 
or anal cushions. Evaluation of all datasets showed that the anorectal angle 
was captured within the acquired volume. Optimum power Doppler settings 
were established prior to starting the clinical part of the study. 
Early on in the study, it was important to decide the means of 
evaluating the 3D power Doppler information available within the scanned 
volumes. Delineating a region of interest by rotating it around an axis was 
not feasible as the cranial and caudal limits could not be defined accurately. 
Therefore the anorectal angle sphere was assessed for feasibility and 
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reliability. Once the centre-point of the sphere had been positioned.at the 
anorectal angle, the sphere was automatically generated by VOCAL. 
Therefore there is less of a margin for the introduction of 
measurement error, which was evaluated by studies 1 and 2. These studies 
established the reliability of obtaining the 3D-PDA volumes from patients 
and healthy volunteers. Very high intraclass correlations were obtained for 
volume and vascular indices when analysing a single dataset and three 
datasets acquired within the same scanning session. 
At this stage in the research, reliability of the transperineal technique 
and the anorectal angle sphere measurement technique had shown high 
reliability. The establishment of validity as discussed previously is inherently 
a difficult task, with the lack of an available gold standard. Therefore 
construct validity had to be assessed; in these circumstances based on the 
theory of a vascular element to the pathogenesis. It was postulated that the 
vascular indices of healthy volunteers should not change significantly over 
time, and thafthe vascular indices of patients should be higher than those of 
healthy volunteers. 
There was no significant difference between patients and healthy 
volunteers with respect to age or current medication use. Study 3 assessed 
the possible change in the vascular indices of healthy volunteers over time. 
Friedman's ANOVA did not identify any significant difference between the 
values, and therefore further analysis with the Wilcoxon signed rank test was 
not performed. Study' 4 compared the vascular indices of healthy volunteers 
to patients at all time-points. The Mann-Whitney test identified that the pre-
rubber band ligation patients' sphere volumes and vascular indices were 
significantly higher than those of the healthy volunteers. 
Responsiveness of the volume and vascular indices was analysed 
over an eight week time period. Although significant decreases were 
identified between day 1 and day 14 scores, the study size limited its 
strength to assess responsiveness. 
Aigner et aI., assessed the branches of the superior rectal artery with 
duplex Doppler, and was able to show significant differences between an 
age and gender matched groups of patients and healthy volunteers [228]. 
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This group was unable to show a statistically significant difference between 
pre and post DGHAL measurements, which was thought to be related to 
failure to ligate all branches of the superior rectal artery, thus explaining the 
recurrence rates for DGHAL. To the best of the author's knowledge, this 
group has not published any data on the reliability of measurement of the 
flow and diameter of vessels assessed, and this may represent an 
alternative explanation for failure to show a difference between patients and 
volunteers. 
6.1.3 Surgical Nuclear Probe 
The nuclear medicine study evaluated the feasibility of measuring a 
change in volume of haemorrhoids following rubber band ligation. The 
underlying principle of the dual radioisotope technique was simple: g-rays 
emitted by the 99mTc labelled red blood cells and counted by the surgical 
probe represented volume prior to rubber band ligation; and similarly counts 
from 1111n labelled transferring represented post rubber band ligation 
volume. Calculations were corrected for decay and reference counts 
corrected for normal clearance from the circulation. 
Consistent results were not identified across the study participants, 
and there are various sources of error that could account for this. Patient 
related characteristics included cardiac medication that affected in vivo 99mTc 
labelling of the red blood cells. Reproducibility of positioning the patient and 
placing the probe on the haemorrhoids is difficult to verify. Changes in the 
morphology of the haemorrhoids following rubber band ligation would also 
make accurate probe positioning difficult. Error relating to the measurement 
of the photons should also be considered, including v-rays that are absorbed 
before they can be detected and Compton-scattered v-rays contributing to 
the acquired counts. 
6.1.4 Dynamic Contrast Enhanced Magnetic Resonance Imaging 
This study firstly evaluated the feasibility of imaging anal cushions 
and haemorrhoids with enough spatial and contrast resolution to allow for 
potential image analysis. Having identified appropriate sequences, DCE-MRI 
and signal intensity curves were used to assess potential measures of 
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vascularity. Software analysis of images and regions of interest were simple 
to perform. 
Qualitative analysis of images from healthy volunteers and patients did 
not show any discernible differences. Similarities included the high signal 
mucosal folds on T2 weighted images. The only difference identified was 
that of high signal change within the submucosa of one patient with third-
degree haemorrhoids, who from the history taken and examination 
performed obviously had thrombosis of an internal haemorrhoid. 
6.2 Choice of Modality for Future Studies 
Overall comparison of the three imaging modalities is difficult because 
they are all measuring differeni-factors, relating to vascularity. However the 
surgical nuclear probe is not recommended as a modality to be further 
assessed, even if one discounts the issues with reliability. Of the three 
studies, the sorgical nuclear probe was the most difficult to recruit to, with 
poor patient understanding of relative risks of radiation doses. The 
procedure itself was of relatively long duration with periods of inconvenience 
or discomfort when the proctoscope is inserted. The feasibility study failed to 
demonstrate consistent results in the patients where in-vivo 99mTc-red 
blood cell labelling had been adequate. 
To a certain extent, the choice of outcome measure has to be a 
pragmatic one. Many centres do not have access to ultrasound equipment 
capable of 3D volume acquisition, and post-procedural analysis of Doppler 
data. The same applies to a certain extent with 3T MRI however these 
magnets have become much more common in the last few years. 
The Doppler technique has been shown to be reliable, and the significant 
differences between patient and healthy volunteers are suggestive of 
validity. Although statistically significant differences were identified in the 
analysis of responsiveness, the study size precludes use of this study 
clinically without further analysis of validity and responsiveness. 
It is important to remember that these indices are unitless and do not 
represent true measurements of flow, vascularity or perfusion. They may still 
be used, however, to differentiate between patient populations or quantify 
219 
the effect of a treatment in the same way that resistance and pulsatility 
indices are. If one accepts that power Doppler quantification has a clinical 
role then one of the most important issues to address in its application is 
standardisation of measurements. 
The effect of machine settings on the power Doppler signal has been 
recognised by most authors who report the maintenance of settings 
throughout the study period. However, power Doppler is not only highly 
dependent upon the machine settings but is also significantly affected by 
attenuation. 
Ensuring consistency of the power Doppler settings is insufficient, 
therefore, if variation in the patient population is not considered. The effect 
of haematocrit on the power Doppler signal might be considered to be 
relatively constant across a patient population, but the effect of signal 
attenuation by excess subcutaneous tissue and fat can have an effect on the 
acquired Doppler signal. Attenuation will also be aggravated if the object of 
interest is at a considerable depth from the transducer, which may explain 
the difficulties with imaging male patients. Time-gain-compensation can be 
used, but has limitations and may be unable to compensate for large 
changes in depth encountered in some patients. 
Once the sequences had been finalised, the DCE-MRI study was 
relatively easy to perform. As this was a feasibility study, further work is 
required to establish reliability and validity, including reproducibility of T2 
weighted image acquisition by repeated scanning of the patient or volunteer, 
intra-observer and inter-observer reliability of region of interest deployment, 
and assessment of other model-free parameters and possibly 
pharmacokinetic models. 
The time required to analyse the data was much shorter in 
comparison to the Doppler study. Disadvantages of the modality include the 
exclusion criteria inherent to MRI, such as patient-related factors including 
the presence of pacemakers, neurosurgical coils and claustrophobia. 
Estimates of patient refusal for MRI due to claustrophobia vary between 4% 
[333] and 37% [334]. 
220 
Whether future investigators choose to evaluate 3D power Doppler 
ultrasound, duplex Doppler ultrasound or DCE-MRI or other unexplored 
modalities, it is essential that other markers of outcome such as the 
haemorrhoid PROM, be used in parallel to allow evaluation of correlation, 
and possible confirmation of validity. 
6.3 Examination of the vascular theory of pathogenesis 
Prior to the advent of DGHAL and PPH, the accepted theory of 
pathogenesis is that haemorrhoids arise as a consequence of degeneration 
of stromal or submucosal connective tissue and of the supportive smooth 
muscle network arising from the internal anal sphincter and the conjoined 
longitudinal muscle [2, 13]. Venous obstruction due to straining [335], 
constipation [34], pregnancy [52] or portal hypertension [336] is another well 
accepted pathological factor [52]. The final proposed theory of pathogenesis 
is hyperplasia of the arteriovenous communications in the submucosa, or 
the corpus cavernosum recti [10]. 
There is an unusual and extensive vascular network within the 
haemorrhoidal zone composed of a varying branching network of the 
superior, middle and inferior rectal arteries, the direct arteriovenous 
communications and the distinctive sacculated submucosal venous plexus 
[337]. How these components are related to the pathogenesis of 
haemorrhoids is unknown. Anal cushions are considered to be normal 
structures and part of the anal continence mechanism [17] by forming a 
compliant plug in the anal canal. As the cushions reduce and increase in 
size for the purposes of defaecation, it is logical to consider that pathological 
change in the vascular network is at least partly responsible for the onset of 
haemorrhoids. 
Part of this thesis studied the effect of treatment on indirect vascularity 
measures, and differences between patients and healthy volunteers. 
Although significant differences were measured, vascularity measures were 
not assessed over time to identify if the measures were stable without 
treatment or without any change in the level of disease. Patients and healthy 
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volunteers were not formally age-matched, although there was no 
statistically significant difference between the two groups. 
Therefore although the three-dimensional power Doppler angiography 
technique is promising, one can only continue to speculate that pathological 
change in the vascular network has a role in the pathogenesis of 
haemorrhoids. 
222 
7 Bibliography 
1. Dirckx, J.H., The biblical plague of "hemorrhoids". An outbreak of 
bilharziasis. Am J Dermatopathol, 1985. 7(4): p. 341-6. 
2. Thomson, W.H., The nature of haemorrhoids. Br J Surg, 1975. 62(7): 
p.542-52. 
3. Johnson, J., The development of the rectum in the human embryo. 
Am J Anat, 1914. 16: p. 1-53. 
4. Miles, W.E., Observations upon internal piles. Surg Gynecol Obstet, 
1919.29: p. 497-506. 
5. Parnaud, E., M. Guntz, A. Bernard, and J. Chome, [Normal 
macroscopic and microscopic anatomy of the hemorrhoidal vascular 
system]. Arch Fr Mal App Dig, 1976.65(7): p. 501-14. 
6. Widmer, 0., [Rectal arteries in man; entrance, caliber, distribution, 
anastomosis and supply area]. Z Anat Entwicklungsgesch, 1955. 
118(5): p. 398-416. 
7. Loder, P.B., M.A. Kamm, R.J. Nicholls, and R.K. Phillips, 
Haemorrhoids: pathology, pathophysiology and aetiology. [Review] 
[159 refs]. British Journal of Surgery, 1994.81(7): p. 946-54. 
8. Kaufman, H.D., The Haemorrhoid syndrome1981 , Turnbridge Wells, 
Kent: Abacus Press. x, 156 p. : ill. 
9. Quenu, E., Etude sur les veinesdu rectum et de I'anus. Soc. Anat, 
1893: p. 601-609. 
10. Stelzner, F., J. Staubesand, and H. Machleidt, [The corpus 
cavernosum recti--basis of internal hemorrhoids]. Langenbecks Arch 
Klin Chir Ver Dtsch Z Chir, 1962.299: p. 302-12. 
11. Schmidt, H. and J. Staubesand, [Roentgenologic proof of the corpus 
cavernosum recti]. Fortschr Geb Rontgenstr Nuklearmed, 1972. 
116(3): p. 297-305. 
223 
12. Thulesius, O. and J.E. Gjores, Arterio-venous anastomoses in the 
anal region with reference to the pathogenesis and treatment of 
haemorrhoids. Acta Chirurgica Scandinavica, 1973. 139(5): p. 476-8. 
13. Haas, P.A, T.A. Fox, Jr., and G.P. Haas, The pathogenesis of 
hemorrhoids. Diseases of the Colon & Rectum, 1984. 27(7): p. 442-
50. 
14. Gibbons, C.P., E.A Trowbridge, J.J. Bannister, and N.W. Read, Role 
of anal cushions in maintaining continence. Lancet, 1986. 1 (8486): p. 
886-8. 
15. Lestar, B., F. Penninckx, H. Rigauts, and R. Kerremans, The internal 
anal sphincter can not close the anal canal completely. Int J 
Colorectal Dis, 1992. 7(3): p. 159-61. 
16. Penninckx, F., B. Lestar; and R. Kerremans, The internal anal 
sphincter: mechanisms of control and its role in maintaining anal 
continence. Baillieres Clin Gastroenterol, 1992.6(1): p. 193-214. 
17. Lestar,-B., F. Penninckx, and R. Kerremans, The composition of anal 
basal pressure. An in vivo and in vitro study in man. Int J Colorectal 
Dis, 1989. 4(2): p. 118-22. 
18. Read, M.G., N.W. Read, W.G. Haynes, T.C. Donnelly, and AG. 
Johnson, A prospective study of the effect of haemorrhoidectomy on 
sphincter function and faecal continence. British Journal of Surgery, 
1982. 69(7): p. 396-8. 
19. Haas, P.A and T.A Fox, Jr., Age-related changes and scar 
formations of perianal connective tissue. Dis Colon Rectum, 1980. 
23(3): p. 160-9. 
20. Haqqani, M.T. and B.D. Hancock, Internal sphincter and 
haemorrhoids: a pathological study. Journal of Clinical Pathology, 
1978.31(3): p. 268-70. 
21. Hiltunen, K.M. and M. Matikainen, Anal manometric findings in 
symptomatic hemorrhoids. Dis Colon Rectum, 1985. 28( 11): p. 807-9. 
22. Arabi, Y., J. Alexander-Williams, and M.R. Keighley, Anal pressures 
in hemorrhoids and anal fissure. Am J Surg, 1977. 134(5): p. 608-10. 
224 
23. Creve, U. and A Hubens, The effect of Lord's procedure on anal 
pressure. Dis Colon Rectum, 1979. 22(7): p. 483-5. 
24. Hancock, B.D. and K. Smith, The internal sphincter and Lord's 
procedure for haemorrhoids. Br J Surg, 1975.62(10): p. 833-6. 
25. Lane, R.H. and G. Casula, Proceedings: Anal pressure before and 
after haemorrhoidectomy. Br J Surg, 1976. 63(2): p. 158. 
26. Read, N.W., D.C. Bartolo, M.G. Read, J. Hall, W.G. Haynes, and AG. 
Johnson, Differences in anorectal manometry between patients with 
haemorrhoids and patients with descending perineum syndrome: 
implications for management. Br J Surg, 1983.70(11): p. 656-9. 
27. Shafik, A, The pathogenesis of hemorrhoids and their treatment by 
anorectal bandotomy. J Clin Gastroenterol, 1984.6(2): p. 129-37. 
28. Hancock, B.D., Internal sphincter and the nature of haemorrhoids. 
Gut, 1977.18(8): p. 651-5. 
29. Ho, Y.H., F. Seow-Choen, and H.S. Goh, Haemorrhoidectomyand 
-
disordered rectal and anal physiology in patients with prolapsed 
haemorrhoids. British Journal of Surgery, 1995. 82(5): p. 596-8. 
30. Keighley, M.R., Y. Arabi, and J. Alexander-Williams, Proceedings: 
Anal pressures in haemorrhoids and anal fissure. British Journal of 
Surgery, 1976.63(8). 
31. Sun, W.M., R.J. Peck, AJ. Shorthouse, and N.W. Read, 
Haemorrhoids are associated not with hypertrophy of the internal anal 
sphincter, but with hypertension of the anal cushions. British Journal 
of Surgery, 1992.79(6): p. 592-4. 
32. Sun, W.M., N.W. Read, and AJ. Shorthouse, Hypertensive anal 
cushions as a cause of the high anal canal pressures in patients with 
haemorrhoids. British Journal of Surgery, 1990.77(4): p. 458-62: 
33. Bender, F.H., H., Continuous determination of blood flow in human 
skin by a heat conductivity measuring device. Pflugers archiv 
European journal of physiology, 1956.263(5): p. 603-14. 
34. Burkitt, D.P., Varicose veins, deep vein thrombosis, and 
haemorrhoids: epidemiology and suggested aetiology. British Medical 
Journal, 1972.2(813): p. 556-61. 
225 
35. Hyams, L. and J. Philpot, An epidemiological investigation of 
hemorrhoids. Am J Proctol, 1970.21(3): p. 177-93. 
36. Hunt, A.H., A contribution to the study of portal hypertension.1958, 
Edinburgh: Churchill Livingstone. 
37. Bernstein, W.C., What are hemorrhoids and what is their relationship 
to the portal venous system? Dis Colon Rectum, 1983.26(12): p. 
829-34. 
38. Hosking, S.W., H.L. Smart, A.G. Johnson, and D.R Triger, Anorectal 
varices, haemorrhoids, and portal hypertension. Lancet, 1989. 
1 (8634): p. 349-52. 
39. Heaton, N.D., M. Davenport, and E.R Howard, Incidence of 
haemorrhoids and anorectal varices in children with portal 
hypertension. Br J Surg, '1993.80(5): p. 616-8. 
40. Gass, D.C. and J. Adams, Hemorrhoids; etiology and pathology. Am 
J Surg, 1950.79(1): p. 40-3. 
41. Thomson, W.H.F., The nature of haemorrhoids. Br J Surg, 1975.62: 
p.542-552. 
42. Parks, A.G., The surgical treatment of haemorrhoids. British Journal 
of Surgery, 1956.43(180): p. 337-51. 
43. Stelzner, F., [Anorectal diseases--introduction and pathophysiology). 
Langenbecks Archiv fur Chirurgie, 1972.332: p. 405-10. 
44. Johanson, J.F. and A. Sonnenberg, The prevalence of hemorrhoids 
and chronic constipation. An epidemiologic study. Gastroenterology, 
1990. 98(2): p. 380-6. 
45. Gazet JC, RW., Rickett JWS., The prevalence of haemorrhoids. Proc 
R Soc Med, 1970. 63: p. 78-80. 
46. Haas, P.A., G.P. Haas, S. Schmaltz, and T.A. Fox, Jr., The 
prevalence of hemorrhoids. Diseases of the Colon & Rectum, 1983. 
26(7): p. 435-9. 
47. Grucela, A., H. Salinas, S. Khaitov, RM. Steinhagen, S.R Gorfine, 
and D.B. Chessin, Prospective analysis of clinician accuracy in the 
diagnosis of benign anal pathology: comparison across specialties 
and years of experience. Dis Colon Rectum, 2010. 53(1): p. 47-52. 
226 
48. Johanson, J.F. and A Sonnenberg, Temporal changes in the 
occurrence of hemorrhoids in the United States and England. Dis 
Colon Rectum, 1991.34(7): p. 585-91; discussion 591-3. 
49. Bleday, R, J.P. Pena, D.A Rothenberger, S.M. Goldberg, and J.G. 
Buls, Symptomatic hemorrhoids: current incidence and complications 
of operative therapy. Dis Colon Rectum, 1992.35(5): p. 477-81. 
50. Pares, D., M. Iglesias, M. Pera, M. Pascual, A Torner, T. Baro, S. 
Alonso, and L. Grande, Expression of estrogen and progesterone 
receptors in the anal canal of women according to age and 
menopause. Dis Colon Rectum, 2010. 53(12): p. 1687-91. 
51. Park, Y., D.J. Hunter, D. Spiegelman, L. Bergkvist, F. Berrino, P.A 
van den Brandt, J.E. Buring, G.A Colditz, J.L. Freudenheim, C.S. 
Fuchs, E. Giovannucci, RA Goldbohm, S. Graham, L. Harnack, AM. 
Hartman, D.R Jacobs, I. Kato, V. Krogh, M.F. Leitzmann, M.L. 
McCullough, AB. Miller, P. Pietinen, T.E. Rohan, A Schatzkin, W.C. 
Willett,-A Wolk, A Zeleniuch-Jacquotte, S.M. Zhang, and S.A. Smith-
Warner, Dietary Fiber Intake and Risk of Colorectal Cancer. JAMA: 
The Journal of the American Medical Association, 2005. 294(22): p. 
2849-2857. 
52. Keighley, M.RB., Surgery of the anus, rectum & colon. 3rd ed2008, 
Philadelphia: Saunders Elsevier. 
53. Morinaga, K., K. Hasuda, and T. Ikeda, A novel therapy for internal 
hemorrhoids: "ligation of the hemorrhoidal artery with a newly devised 
instrument (Moricorn) in conjunction with a Doppler flowmeter. 
American Journal of Gastroenterology, 1995.90(4): p. 610-3. 
54. Bursics, A, K. Morvay, P. Kupcsulik, and L. Flautner, Comparison of 
early and 1-year follow-up results of conventional hemorrhoidectomy 
and hemorrhoid artery ligation: a randomized study. International 
Journal of Colorectal Disease, 2004.19(2): p. 176-80. 
55. Longo, A Treatment of hemorrhoids disease by reduction of mucosa 
and hemorrhoidal prolapse with a circular suturing device: a new 
procedure. in Endoscopic Surgery. 1998. Rome, Italy. 
227 
56. Maw, A., K.-W. Eu, and F. Seow-Choen, Retroperitoneal sepsis 
complicating stapled hemorrhoidectomy: report of a case and review 
of the literature. Diseases of the Colon & Rectum, 2002. 45(6): p. 
826-8. 
57. Molloy, RG. and D. Kingsmore, Life threatening pelvic sepsis after 
stapled haemorrhoidectomy.{see comment). Lancet, 2000. 355(9206): 
p.810. 
58. Ripetti, V., M. Caricato, and A. Arullani, Rectal perforation, 
retropneumoperitoneum, and pneumomediastinum after stapling 
procedure for prolapsed hemorrhoids: report of a case and 
subsequent considerations.{see comment). Diseases of the Colon & 
Rectum, 2002. 45(2): p. 268-70. 
59. Nisar, P.J., A.G. Acheson, K.R Neal, and J.H. Scholefield, Stapled 
hemorrhoidopexy compared with conventional hemorrhoidectomy: . 
systematic review of randomized, controlled trials. Diseases of the 
Colon"& Rectum, 2004. 47(11): p. 1837-45. 
60. Ortiz, H., J. Marzo, and P. Armendariz, Randomized clinical trial of 
stapled haemorrhoidopexy versus conventional diathermy 
haemorrhoidectomy. BrJ Surg, 2002. 89(11): p. 1376-81. 
61. Lyseng-Williamson, K.A. and C.M. Perry, Micronised Purified 
Flavonoid Fraction: A Review of its Use in Chronic Venous 
Insufficiency, Venous Ulcers and Haemorrhoids. Drugs, 2003. 63(1): 
p.71-100. 
62. Godeberge, P., Oaf/on 500 mg in the treatment of hemorrhoidal 
disease: a demonstrated efficacy in comparison with placebo. 
Angiology, 1994.45(6 Pt 2): p. 574-8. 
63. Misra, M.C. and R Parshad, Randomized clinical trial of micronized 
f/avonoids in the early control of bleeding from acute internal 
haemorrhoids.[see comment}. British Journal of Surgery, 2000. 87(7): 
p.868-72. 
64. Myers, B. and W. Donovan, Cryosurgery of the anus. South Med J, 
1977.70(1): p. 17-8. 
228 
65. Zmora, 0., P. Colquhoun, S. Abramson, E.G. Weiss, J. Efron, A.M. 
Vernava, 3rd, J.J. Nogueras, and S.D. Wexner, Can the procedure for 
prolapsing hemorrhoids (PPH) be done twice? Results of a porcine 
model. Surg Endosc, 2004.18(5): p. 757-61. 
66. Plapler, H., Hemorrhoids: an experimental model in monkeys. Acta 
Cir Bras, 2006. 21 (5): p. 354-6. 
67. Mosby, Mosby's Medical Dictionary, 2009, Elsevier. 
68. Preamble to the Constitution of the World Health Organization. in 
International Health Conference. 1946. New York: World Health 
Organization. 
69. Goligher, J., Haemorrhoids or piles., in Surgery of the Anus Rectum 
and Colon, J. Goligher, Editor 1980, BALLI ERE TINDALL: London. p. 
96. 
70. Lunniss, P.J. and C.v. Mann, Classification of internal haemorrhoids: 
a discussion paper. Colorectal Dis, 2004. 6(4): p. 226-32. 
71. Thomson, J., R. Leicester, and L. Smith, Haemorrhoids, in 
Coloproctolgy and the pelvic floor, M. Henry and M. Swash, Editors. 
1992, Butterworth-Heinemann Ltd: Oxford. p. 373-393. 
72. Longo, A Treatment of hemorrhoids disease by reduction of mucosa 
and hemorrhoidal prolapse with a circular suturing device: a new 
procedure. 1998. Rome, Italy. 
73. Gaj, F. and A. Trecca, Hemorrhoids and rectal internal mucosal 
prolapse: one' or two conditions? A national survey. Tech Coloproctol, 
2005. 9(2): p. 163-5. 
74. Gaj, F. and A Trecca, [New "PA TE 2006" system for classifying 
hemorrhoidal disease: advantages resulting from revision of "PA TE 
2000 Sorrento'}. Chir Ital, 2007. 59(4): p. 521-6. 
75. Gaj, F., A Trecca, A Serio, F. Scardamaglia, and M. Carboni, 
Improving the classification of hemorrhoids: results of an Italian 
multicentric study on 1494 patients. Ambulatory Surgery, 2000. 8(2): 
p.67-69. 
76. Fukuda, A, T. Kajiyama, H. Kishimoto, H. Arakawa, H. Someda, M. 
Sakai, H. Seno, and T. Chiba, Colonoscopic classification of internal 
229 
hemorrhoids: usefulness in endoscopic band ligation. J Gastroenterol 
Hepatol, 2005. 20(1): p. 46-50. 
77. Morgado, P.J., J.A. Suarez, L.G. Gomez, and P.J. Morgado, Jr., 
Histoclinical basis for a new classification of hemorrhoidal disease. 
Dis Colon Rectum, 1988.31(6): p. 474-80. 
78. Garratt, A., L. Schmidt, A. Mackintosh, and R. Fitzpatrick, Quality of 
life measurement: bibliographic study of patient assessed health 
outcome measures. BMJ, 2002. 324(7351): p. 1417-. 
79. EORTC, EORTC Investigator's Handbook, 2009. p. A2. 
80. Johnson, J.R. and R. Temple, Food and Drug Administration 
requirements for approval of new anticancer drugs. Cancer Treat 
Rep, 1985.69(10): p. 1155-9. 
81. Acquadro, C., R. Berzon, D. Dubois, N.K. Leidy, P. Marquis, D. 
Revicki, and M. Rothman, Incorporating the patient's perspective into 
drug development and communication: an ad hoc task force report of 
the Patient-Reported Outcomes (PRO) Harmonization Group meeting 
at the Food and Drug Administration, February 16, 2001. Value in 
Health, 2003. 6(5): p. 522-31. 
82. Lenderking, W., Task Force report of the Patient-Reported Outcomes 
Harmonization Group: too much harmony, not enough melody? Value 
in Health, 2003. 6(5): p. 503-4. 
83. Taillefer, M.-C., G. Dupuis, M.-A. Roberge, and S. LeMay, Health-
Related Quality of Life Models: Systematic Review of the Literature. 
Social Indicators Research, 2003. 64(2): p. 293-323. 
84. Health, U.S.D.o., F.D.A.C.f.D.E. Human Services, Research, 
F.D.A.C.f.B.E. Human Services, F.D.A.C.f.D. Human Services, and 
H. Radiological, Guidance for industry: patient-reported outcome 
measures: use in medical product development to support labeling 
claims: draft guidance. Health & Quality of Life Outcomes, 2006. 4: p. 
79. 
85. Kirshner, B. and G. Guyatt, A methodological framework for 
assessing health indices. J Chronic Dis, 1985.38(1): p. 27-36. 
230 
86. Ware, J.E., Jr. and C.D. Sherbourne, The MOS 36-item short-form 
health survey (SF-36). I. Conceptual framework and item selection. 
Med Care, 1992.30(6): p. 473-83. 
87. Hunt, S.M., J. McEwen, and S.P. McKenna, Measuring health status: 
a new tool for clinicians and epidemiologists. J R Coli Gen Pract, 
1985.35(273): p. 185-8. 
88. Bergner, M., R.A. Bobbitt, W.B. Carter, and B.S. Gilson, The 
Sickness Impact Profile: development and final revision of a health 
status measure. Med Care, 1981.19(8): p. 787-805. 
89. Meenan, R.F., J.H. Mason, J.J. Anderson, A.A. Guccione, and L.E. 
Kazis, AIMS2. The content and properties of a revised and expanded 
Arthritis Impact Measurement Scales Health Status Questionnaire. 
Arthritis Rheum, 1992.35(1): p. 1-10. 
90. Alazraki, N.P., T. Styblo, S.F. Grant, C. Cohen, T. Larsen, and J.N: 
Aarsvold, Sentinel node staging of early breast cancer using 
Iymphoscintigraphy and the intraoperative gamma-detecting probe. 
Semin Nucl Med, 2000. 30(1): p. 56-64. 
91. Alazraki, N.P., T. Styblo, S.F. Grant, C. Cohen, T. Larsen, S. 
Waldrop, and J.N. Aarsvold, Sentinel node staging of early breast 
cancer using Iymphoscintigraphy and the intraoperative gamma 
detecting probe. Radiol Clin North Am, 2001. 39(5): p. 947-56, viii. 
92. Alex, J.C. and D.N. Krag, Gamma-probe guided localization of lymph 
nodes. Surg Oncol, 1993.2(3): p. 137-43. 
93. Patient-reported outcome and quality of Life Instruments Database, 
2001 - 2009, MAPI Research Institute. 
94. Eypasch, E., J. Williams, S. Wood-Dauphinee, BM Ure, C. 
Schm··ulling, and E.N.e. aI., Gastrointestinal Quality of Life Index: 
development, validation and application of a new 
instrument. Br J Surg, 1995. 82: p. 216-222. 
95. Boccasanta, P., P.G. Capretti, M. Venturi, U. Cioffi, M. De Simone, G. 
Salamina, E. Contessini-Avesani, and A. Peracchia, Randomised 
controlled trial between stapled circumferential mucosectomy and 
conventional circular hemorrhoidectomy in advanced hemorrhoids 
231 
with external mucosal prolapse. American Journal of Surgery, 2001. 
182(1): p. 64-8. 
96. Brown, S.R., K. Balian, E. Ho, Y.H. Ho Fams, and F. Seow-Choen, 
Stapled mucosectomy for acute thrombosed circumferentially 
prolapsed piles: a prospective randomized comparison with 
conventional haemorrhoidectomy. Colorectal disease: the official 
journal of the Association of Coloproctology of Great Britain and 
Ireland, 2001. 3(3): p. 175-8. 
97. Cheetham, M.J., C.R. Cohen, M.A. Kamm, and R.K. Phillips, A 
randomized, controlled trial of diathermy hemorrhoidectomy vs. 
stapled hemorrhoidectomy in an intended day-care setting with 
longer-term follow-up. Diseases of the Colon and Rectum, 2003. 
46(4): p. 491-7. 
98. Correa-Rovelo, J.M., O. Tellez, L. Obregon, A. Miranda-Gomez, and 
S. Moran, Stapled rectal mucosectomy vs. closed hemorrhoidectomy: 
a randomized, clinical trial. Dis Colon Rectum, 2002. 45(10): p. 1367-
74; discussion 1374-5. 
99. Ganio, E., D.F. Altomare, F. Gabrielli, G. Milito, and S. Canuti, 
Prospective randomized multicentre trial comparing stapled with open 
haemorrhoidectomy. Br J Surg, 2001. 88(5): p. 669-74. 
100. Hetzer, F.H., N. Demartines, A.E. Handschin, and P.A. Clavien, 
Stapled vs excision hemorrhoidectomy: long-term results of a 
prospective rtlndomized trial. Arch Surg, 2002. 137(3): p. 337-40. 
101. Ho, Y.H., W.K. Cheong, C. Tsang, J. Ho, K.W. Eu, C.L. Tang, and F. 
Seow-Choen, Stapled hemorrhoidectomy--cost and effectiveness. 
Randomized, controlled trial including incontinence scoring, anorectal 
manometry, and endoanal ultrasound assessments at up to three 
months. Dis Colon Rectum, 2000. 43(12): p. 1666-75. 
102. Kairaluoma, M., K. Nuorva, and I. Kellokumpu, Day-case stapled 
(circular) vs. diathermy hemorrhoidectomy: a randomized, controlled 
trial evaluating surgical and functional outcome. Dis Colon Rectum, 
2003.46(1): p. 93-9. 
232 
103. Krska, Z., J. Kvasnieka, J. Faltyn, D. Schmidt, J. Svab, K. 
Kormanova, and J. Hubik, Surgical treatment of haemorrhoids 
according to Longo and Milligan Morgan: An evaluation of 
postoperative tissue response. Colorectal Disease, 2003.5(6): p. 
573-576. 
104. Lau, P.Y., W.C. Meng, and A.W. Yip, Stapled haemorrhoidectomy in 
Chinese patients: a prospective randomised control study. Hong 
Kong Med J, 2004. 10(6): p. 373-7. 
105. Mehigan, B.J., J.R. Monson, and J.E. Hartley, Stapling procedure for 
haemorrhoids versus Milligan-Morgan haemorrhoidectomy: 
randomised controlled trial.[see comment}. Lancet, 2000. 355(9206): 
p.782-5. 
106. Palimento, D., M. Picchio, U. Attanasio, A. Lombardi, C. Bambini, and 
A. Renda, Stapled and open hemorrhoidectomy: randomized 
controlled trial of early results. World J Surg, 2003. 27(2): p. 203-7. 
107. Pavlidls, T., B. Papaziogas, A. Sou paris, A. Patsas, I. Koutelidakis, 
and T. Papaziogas, Modern stapled Longo procedure vs. 
conventional Milligan-Morgan hemorrhoidectomy: a randomized 
controlled trial. Int J Colorectal Dis, 2002. 17(1): p. 50-3. 
108. Racalbuto, A., I. Aliotta, G. Corsaro, R. Lanteri, A. Di Cataldo, and A. 
Licata, Hemorrhoidal stapler prolapsectomy vs. Milligan-Morgan 
hemorrhoidectomy: a long-term randomized trial. Int J Colorectal Dis, 
2004. 19(3): p. 239-44. 
109. Rowsell, M., M. Bello, and D.M. Hemingway, Circumferential 
mucosectomy (stapled haemorrhoidectomy) versus conventional 
haemorrhoidectomy: randomised controlled trial. Lancet, 2000. 
355(9206): p. 779-81. 
110. Senagore, A.J., M. Singer, H. Abcarian, J. Fleshman, M. Corman, S. 
Wexner, and S. Nivatvongs, A prospective, randomized, controlled 
multicenter trial comparing stapled hemorrhoidopexy and Ferguson 
hemorrhoidectomy: perioperative and one-year results. Dis Colon 
Rectum, 2004. 47(11): p. 1824-36. 
233 
111. Shalaby, R and A. Desoky, Randomized clinical trial of stapled 
versus Milligan-Morgan haemorrhoidectomy. Br J Surg, 2001. 88(8): 
p.1049-53. 
112. Wilson, M.S., V. Pope, H.E. Doran, S.J. Fearn, and W.A. Brough, 
Objective comparison of stapled anopexy and open 
hemorrhoidectomy: a randomized, controlled trial. Dis Colon Rectum, 
2002.45(11): p. 1437-44. 
113. Beattie, G.C., RG. Wilson, and M.A. Loudon, The contemporary 
management of haemorrhoids. Colorectal Disease, 2002. 4(6): p. 
450-4. 
114. Collopy, B.T., Internal haemorrhoids: observations on their nature and 
classification in relation to their management. Australian & New 
Zealand Journal of Surgery, 1980.50(2): p. 167-9. 
115. Hardy, A., C.L.H. Chan, and C.RG. Cohen, The surgical 
management of haemorrhoids--a review. Digestive Surgery, 2005. 
22(1-2): p. 26-33. 
116. Johanson, J.F., Sonnenberg, A. , The prevalence of haemorrhoids 
and chronic constipation. An epidemiologic study. Gastroenterology, 
1990. 98: p. 380-6. 
117. Johanson, J.F. and A. Rimm, Optimal nonsurgical treatment of 
hemorrhoids: a comparative analysis of infrared coagulation, rubber 
band ligation, and injection sclerotherapy. American Journal of 
Gastroenterology, 1992. 87(11): p. 1600-6. 
118. MacRae, H.M. and RS. McLeod, Comparison of hemorrhoidal 
treatment modalities. A meta-analysis. Diseases of the Colon & 
Rectum, 1995.38(7): p. 687-94. 
119. Thomson, H., The anal cushions--a fresh concept in diagnosis. 
Postgraduate Medical Journal, 1979.55(644): p. 403-5. 
120. Keighley, N. and N. Williams, Haemorrhoidal disease, in Surgery of 
the Anus, Rectum and Colon, N. Keighley and N. Williams, Editors. 
2000, Harcourt Publishers Ltd. p. 307. 
121. Corman, M.L., Colon and rectal surgery. 3rd ed1993, Philadelphia: 
Lippincott. xxiii, 1221 p. 
234 
122. Mann, C.V., Surgical treatment of haemorrhoids2001, London; New 
York: Springer. x, 179 p. 
123. Morris, P.J. and W.C. Wood, Oxford textbook of surgery2000: Oxford 
University Press. 
124. Madoff, RD. and J.W. Fleshman, American Gastroenterological 
Association technical review on the diagnosis and treatment of 
hemorrhoids. Gastroenterology, 2004. 126(5): p. 1463-73. 
125. Pollner, M., The effects ofinterviewer gender in mental health 
interviews. J Nerv Ment Dis, 1998. 186(6): p. 369-73. 
126. Kline, P., The handbook of psychological testing. 2nd ed2000, 
London; New York: Routledge. vii, 744 p. 
127. Patrick, D.L., D.A Drossman, 1.0. Frederick, J. DiCesare, and K.L. 
Puder, Quality of life in persons with irritable bowel syndrome: 
development and validation of a new measure. Dig Dis Sci, 1998. 
43(2): p. 400-11. 
128. Blazeby, J.M., D. Alderson, K. Winstone, R Steyn, E. Hammerlid, J. 
Arraras, and J.R Farndon, Development of an EORTC questionnaire 
module to be used in quality of life assessment for patients with 
oesophageal cancer. The EORTC Quality of Life Study Group. Eur J 
Cancer, 1996. 32A(11): p. 1912-7. 
129. Fowler, F.J., Improving Survey Questions: Design and 
Evaluation1995: Sage Publications. 
130. Bradburn, N.M., S. Sudman, and E. Blair, Improving interview method 
and questionnaire design. The Jossey-Bass social and behavioral 
science series1979, San Francisco: Jossey-Bass. 
131. Nystrom, P.O., N. Qvist, D. Raahave, I. Lindsey, and N. Mortensen, 
Randomized clinical trial of symptom control after stapled anopexy or 
diathermy excision for haemorrhoid prolapse. Br J Surg, 2010. 97(2): 
p. 167-76. 
132. Amin, AI., O. Hallbook, AJ. Lee, R Sexton, B.J. Moran, and RJ. 
Heald, A 5-cm colonic J pouch colo-anal reconstruction following 
anterior resection for low rectal cancer results in acceptable 
evacuation and continence in the long term. Colorectal disease: the 
235 
official journal of the Association of Coloproctology of Great Britain 
and Ireland, 2003. 5(1): p. 33-7. 
133. Hallbook, o. and R Sjodahl, Surgical approaches to obtaining 
optimal bowel function. Semin Surg Oncol, 2000. 18(3): p. 249-58. 
134. DeVellis, RF., Scale development: theory and applications. Applied 
social research methods series, v. 262003, Thousand Oaks, Calif.: 
Sage Publications. 
135. Goldstein, G. and M. Hersen, Handbook of psychological 
assessment2007, Amsterdam [etc.]: Elsevier. 
136. Norman, G.R and D.L. Streiner, Biostatistics the bare 
essentials2008, Hamilton: Decker. 
137. Cortina, J.M., What is coefficient alpha? An examination of theory and 
applications. Journal of Applied Psychology, 1993.78(1): p. 98-104. 
138. Streiner, D.L. and G.R Norman, Health measurement scales: a 
practical guide to their development and use. 3rd ed. Oxford medical 
publications2003, Oxford; New York: Oxford University Press. xii, 
283 p. 
139. Bartko, J.J., The intraclass correlation coefficient as a measure of 
reliability. Psychol Rep, 1966. 19( 1): p. 3-11. 
140. Fitzpatrick, R, A. Fletcher, S. Gore, D. Jones, D. Spiegelhalter, and 
D. Cox, Quality of life measures in health care. I: Applications and 
issues in assessment. BMJ, 1992.305(6861): p. 1074-1077. 
141. Guyatt, G.H., D.H."Feeny, and D.L. Patrick, Measuring health-related 
qualityoflife. Ann Intern Med, 1993. 118(8): p. 622-9. 
142. Fitzpatrick, R, C. Davey, M.J. Buxton, and D.R Jones, Evaluating 
patient-based outcome measures for use in clinical trials. Health 
Technol Assess, 1998.2(14): p. i-iv, 1-74. 
143. Guyatt, G.H. and D.J. Cook, Health status, quality of life, and the 
individual. JAMA, 1994.272(8): p. 630-1. 
144. Dunlop, S.P., D. Jenkins, K.R Neal, J. Naesdal, M. Borgaonker, S.M. 
Collins, and RC. Spiller, Randomized, double-blind, placebo-
controlled trial of prednisolone in post-infectious irritable bowel 
syndrome. Aliment Pharmacol Ther, 2003. 18(1): p. 77-84. 
236 
145. Neal, K.R, L. Barker, and RC. Spiller, Prognosis in post-infective 
irritable bowel syndrome: a six year follow up study. Gut, 2002. 51(3): 
p.410-3. 
,146. Neal, K.R, J. Hebden, and R Spiller, Prevalence of gastrointestinal 
symptoms six months after bacterial gastroenteritis and risk factors 
for development of the irritable bowel syndrome: postal survey of 
patients. BMJ, 1997.314(7083): p. 779-82. 
147. Spiller, RC., D.J. Humes, E. Campbell, M. Hastings, K.R Neal, G.E. 
Dukes, and P.J. Whorwell, The Patient Health Questionnaire 12 
Somatic Symptom scale as a predictor of symptom severity and 
consulting behaviour in patients with irritable bowel syndrome and 
symptomatic diverticular disease. Aliment Pharmacol Ther, 2010. 
32(6): p. 811-20. 
148. Humes, D.J., J. Simpson, K.R Neal, J.H. Scholefield, and RC. 
Spiller, Psychological and colonic factors in painful diverticulosis. Br J 
Surg, 2008. 95(2): p. 195-8. 
149. Simpson, J., F. Sundler, D.J. Humes, D. Jenkins, J.H. Scholefield, 
and RC. Spiller, Post inflammatory damage to the enteric nervous 
system in diverticular disease and its relationship to symptoms. 
Neurogastroenterol Motil, 2009. 21(8): p. 847-e58. 
150. Lomas, J., L. Pickard, and A. Mohide, Patient versus clinician item 
generation for quality-of-life measures. The case of language-
disabled adults. Med Care, 1987.25(8): p. 764-9. 
151. Guyatt, G.H., L.B. Berman, M. Townsend, S.O. Pugsley, and L.W. 
Chambers, A measure of quality of life for clinical trials in chronic lung 
disease. Thorax, 1987.42(10): p. 773-8. 
152. Stewart, A.L., S. Greenfield, R.D. Hays, K. Wells, W.H. Rogers, S.D., 
Berry, E.A. McGlynn, and J.E. Ware, Jr., Functional status and well-
being of patients with chronic conditions. Results from the Medical 
Outcomes Study. JAMA, 1989.262(7): p. 907-13. 
153. McDowell, I. Measuring health a guide to rating scales and 
questionnaires. 2006. 
237 
154. Guyatt, G., S. Walter, and G. Norman, Measuring change over time: 
assessing the usefulness of evaluative instruments. J Chronic Dis, 
1987.40(2): p. 171-8. 
,155. Deyo, RA. and T.S. Inui, Toward clinical applications of health status 
measures: sensitivity of scales to clinically important changes. Health 
Serv Res, 1984. 19(3): p. 275-89. 
156. BORGAONKAR, M.R and E.J. IRVINE, Quality of life measurement 
in gastrointestinal and liver disorders. Gut, 2000.47(3): p. 444-454. 
157. Watanabe, H., D. Igari, Y. Tanahasi, K. Harada, and M. Saito, 
Development and application of new equipment for transrectal 
ultrasonography. J Clin Ultrasound, 1974.2(2): p. 91-8. 
158. Weaver, RP., M.J. Noble, and J.W. Weigel, Correlation of ultrasound 
guided and digitally directed fransrectal biopsies of palpable prostatic 
abnormalities. J Urol, 1991.145(3): p. 516-8. 
159. Law, P.J. and C.1. Bartram, Anal endosonography: technique and 
normal anatomy. [Review] [10 refs]. Gastrointestinal Radiology, 1989. 
14(4): p. 349-53. 
160. Bollard, R.C., A. Gardiner, S. Lindow, K. Phillips, and G.S. Duthie, 
Normal female anal sphincter: difficulties in interpretation explained. 
Diseases of the Colon & Rectum, 2002. 45(2): p. 171-5. 
161. Frudinger, A., S. Halligan, C.1. Bartram, A.B. Price, M.A. Kamm, and 
R Winter, Female anal sphincter: age-related differences in 
asymptomatic volunteers with high-frequency endoanal US. 
Radiology, 2002. 224(2): p. 417-23. 
162. Nielsen, M.B., J.F. Pedersen, C. Hauge, 0.0. Rasmussen, and J. 
Christiansen, Endosonography of the anal sphincter: findings in 
healthy volunteers. AJR American Journal of Roentgenology, 1999. 
157(6): p. 1199-202. 
163. Fritsch, H., E. Brenner, A. Lienemann, and B. Ludwikowski, Anal 
sphincter complex: reinterpreted morphology and its clinical 
relevance. Diseases of the Colon & Rectum, 2002. 45(2): p. 188-94. 
164. Konerding, M.A., O. Dzemali,A. Gaumann,W. Malkusch, and V.F. 
Eckardt, Correlation of endoanal sonography with cross-sectional 
238 
anatomy of the anal sphincter. Gastrointestinal Endoscopy, 1999. 
50(6): p. 804-10. 
165. Poen, AC. and R.J. Felt-Bersma, Endosonography in benign 
anorectal disease: an overview. Scandinavian Journal of 
Gastroenterology - Supplement, 1999. 230: p. 40-8. 
166. Sultan, A.H., M.A Kamm, C.N. Hudson, J.R. Nicholls, and C.1. 
Bartram, Endosonography of the anal sphincters: normal anatomy 
and comparison with manometry. Clinical Radiology, 1994. 49(6): p. 
368-74. 
167. Linney, AD. and J. Deng, Three-dimensional morphometry in 
ultrasound. Proc Inst Mech Eng [H], 1999.213(3): p. 235-45. 
168. King, D.L., D.L. King, Jr., and M.Y. Shao, Three-dimensional spatial 
registration and interactive display of position and orientation of real-
time ultrasound images. J Ultrasound Med, 1990.9(9): p. 525-32. 
169. Brunner, M., A Obruca, P. Bauer, and W. Feichtinger, Clinical 
application of volume estimation based on three-dimensional 
ultrasonography. Ultrasound Obstet Gynecol, 1995.6(5): p. 358-61. 
170. Maymon, R., A Herman, S. Ariely, E. Dreazen, I. Buckovsky, and Z. 
Weinraub, Three-dimensional vaginal sonography in obstetrics and 
gynaecology. Hum Reprod Update, 2000. 6(5): p. 475-84. 
171. Leotta, D.F., P.R. Detmer, and R.W. Martin, Performance of a 
miniature magnetic position sensor for three-dimensional ultrasound 
imaging. Ultrasound Med Bioi, 1997.23(4): p. 597-609. 
172. Prager, R.W., A Gee, and L. Berman, Stradx: real-time acquisition 
and visualization of freehand three-dimensional ultrasound. Med 
Image Anal, 1999.3(2): p. 129-40. 
173. Blaas, H.G., S.H. Eik-Nes, T. Kiserud, S. Berg, B. Angelsen, and B. 
Olstad, Three-dimensional imaging of the brain cavities in human 
embryos. Ultrasound Obstet Gynecol, 1995.5(4): p. 228-32. 
174. Riccabona, M., T.R. Nelson, and D.H. Pretorius, Three-dimensional 
ultrasound: accuracy of distance and volume measurements. 
Ultrasound Obstet Gynecol, 1996. 7(6): p. 429-34. 
239 
175. Gilja, O.H., T. Hausken, A. Berstad, and S. Odegaard, Measurements 
of organ volume by ultrasonography. Proc Inst Mech Eng [H], 1999. 
213(3): p. 247-59. 
176. Bordes, A., A.M. Bory, M. Benchaib, R.C. Rudigoz, and B. Salle, 
Reproducibility of transvaginal three-dimensional endometrial volume 
measurements with virtual organ computer-aided analysis (VOCAL) 
during ovarian stimulation. Ultrasound Obstet Gynecol, 2002. 19(1): 
p.76-80. 
177. Downey, D.B. and A. Fenster, Vascular imaging with a three-
dimensional power Doppler system. AJR Am J Roentgenol, 1995. 
165(3): p. 665-8. 
178. Ohishi, H., T. Hirai, R. Yamada, S. Hirohashi, H. Uchida, H. 
Hashimoto, T. Jibiki, and Y. Takeuchi, Three-dimensional power 
Doppler sonography of tumor vascularity. J Ultrasound Med, 1998. 
17(10): p. 619-22. 
179. Raine-Fenning, N., B. Campbell, J. Collier, M. Brincat, and I. 
Johnson, The reproducibility of endometrial volume acquisition and 
measurement with the VOCAL-imaging program. Ultrasound Obstet 
Gynecol, 2002. 19(1): p. 69-75. 
180. Pairleitner, H., H. Steiner, G. Hasenoehrl, and A. Staudach, Three-
dimensional power Doppler sonography: imaging and quantifying 
blood flow and vascularization. Ultrasound Obstet Gynecol, 1999. 
14(2): p. 139-43. 
181. Svennevig, J.L., (Transperineal puncture biopsy of the prostate). 
Tidsskr Nor Laegeforen, 1974.94(4): p. 232-3. 
182. Beer-Gabel, M., M. Teshler, N. Barzilai, Y. Lurie, S. Malnick, D. Bass, 
and A. Zbar, Dynamic transperineal ultrasound in the diagnosis of 
pelvic floor disorders: pilot study. Dis Colon Rectum, 2002. 45(2): p. 
239-45; discussion 245-8. 
183. Kim, 1.0., T.1. Han, W.S. Kim, and K.M. Yeon, Transperineal 
ultrasonography in imperforate anus: identification of the internal 
fistula. J Ultrasound Med, 2000.19(3): p. 211-6. 
240 
184. Kleinubing, H., Jr., J.F. Jannini, O. Malafaia, S. Brenner, and T.M. 
Pinho, Transperineal ultrasonography: new method to image the 
anorectal region. Dis Colon Rectum, 2000. 43(11): p. 1572-4. 
185. Peschers, U.M., J.O. Delancey, G.N. Schaer, and B. Schuessler, 
Exoanal ultrasound of the anal sphincter: normal anatomy and 
sphincter defects. Br J Obstet Gynaecol, 1997. 104(9): p. 999-1003. 
186. Riccabona, M., Potential of modern sonographic techniques in 
paediatric uroradiology. Eur J Radiol, 2002. 43(2): p. 110-21. 
187. Rubens, D.J., J.G. Strang, S. Bogineni-Misra, and I.E. Wexler, 
Transperineal sonography of the rectum: anatomy and pathology 
revealed by sonography compared with CT and MR imaging. AJR Am 
J Roentgenol, 1998. 170(3): p. 637-42. 
188. Schaer, G.N., O.R Koechli, B. Schuessler, and U. Haller, Perineal 
ultrasound for evaluating the bladder neck in urinary stress 
incontinence. Obstet Gynecol, 1995. 85(2): p. 220-4. 
189. Stewart, L.K., J. McGee, and S.R Wilson, Transperineal and 
transvaginal sonography of perianal inflammatory disease. AJR Am J 
Roentgenol, 2001. 177(3): p. 627-32. 
190. Teele, RL. and J.C. Share, Transperineal sonography in children. 
AJR Am J Roentgenol, 1997.168(5): p. 1263-7. 
191. Weber, T.M., B.S. Hertzberg, and J.D. Bowie, Transperineal US: 
alternative technique to improve visualization of the presenting fetal 
part. Radiology, 19"91. 179(3): p. 747-50. 
192. Wisser, J., G. Schar, J. Kurmanavicius, R Huch, and A. Huch, Use of 
3D ultrasound as a new approach to assess obstetrical trauma to the 
pelvic floor. Ultraschall Med, 1999.20(1): p. 15-8. 
193. Yagel, S. and D.V. Valsky, Three-dimensional transperineal 
ultrasonography for evaluation of the anal sphincter complex: another 
dimension in understanding peripartum sphincter trauma. Ultrasound 
Obstet Gynecol, 2006. 27(2): p. 119-23. 
194. Cornelia, L., B. Stephan, B. Michel, W. Antoine, and K. Felix, Trans-
perineal versus endo-anal ultrasound in the detection of anal 
241 
sphincter tears. Eur J Obstet Gynecol Reprod Bioi, 2002.103(1): p. 
79-82. 
195. Beer-Gabel, M., M. Teshler, E. Schechtman, and AP. Zbar, Dynamic 
transperineal ultrasound vs. defecography in patients with evacuatory 
difficulty: a pilot study. Int J Colorectal Dis, 2004.19(1): p. 60-7. 
196. Boote, E.J., AAPMIRSNA physics tutorial for residents: topics in US: 
Doppler US techniques: concepts of blood flow detection and flow 
dynamics. Radiographics, 2003. 23(5): p. 1315-27. 
197. Pourcelot, L., P. Arbeille, F. Lapierre, AC. Benhamou, J. Doffin, and 
J. Barsotti, Doppler spectrum analysis and vascular imaging in the 
diagnosis of extracranial carotid artery disease. Int Angiol, 1985. 4(1): 
p.59-68. 
198. Gosling, RG., G. Dunbar, D.H. King, D.L. Newman, C.D. Side, J.P. 
Woodcock, D.E. Fitzgerald, J.S. Keates, and D. MacMillan, The 
quantitative analysis of occlusive peripheral arterial disease by a non-
intrusive ultrasonic technique. Angiology, 1971.22(1): p. 52-5. 
199. Bude, RO. and J.M. Rubin, Power Doppler sonography. Radiology, 
1996.200(1): p. 21-3. 
200. Rubin, J.M., RO. Bude, P.L. Carson, RL. Bree, and RS. Adler, 
Power Doppler US: a potentially useful alternative to mean frequency-
based color Doppler US. Radiology, 1994.190(3): p. 853-6. 
201. Cheng, W.F., C.N. Lee, J.S. Chu, C.A Chen, T.M. Chen, W.Y. Shau, 
C.Y. Hsieh, and F.J. Hsieh, Vascularity index as a novel parameter 
for the in vivo assessment of angiogenesis in patients with cervical 
carcinoma. Cancer, 1999.85(3): p. 651-7. 
202. Guerriero, S., S. Ajossa, V. Mais, A Risalvato, M.P. Lai, and G.B. 
Melis, The diagnosis of endometriomas using colour Doppler energy 
imaging. Hum Reprod, 1998.13(6): p. 1691-5. 
203. Rubin, J.M., RO. Bude, P.L. Carson, RL. Bree, and RS. Adler, 
Power Doppler US: a potentially useful alternative to mean frequency-
based color Doppler US. Radiology, 1994. 190(3): p. 853-6. 
204. Church, C.C., E.L. Carstensen, W.L. Nyborg, P.L. Carson, L.A. 
Frizzell, and M.R Bailey, The risk of exposure to diagnostic 
242 
ultrasound in postnatal subjects: nonthermal mechanisms. J 
Ultrasound Med, 2008. 27(4): p. 565-92; quiz 593-6. 
205. O'Brien, W.O., Jr., C.X. Deng, G.R. Harris, B.A. Herman, C.R. Merritt, 
N. Sanghvi, and J.F. Zachary, The risk of exposure to diagnostic 
ultrasound in postnatal subjects: thermal effects. J Ultrasound Med, 
2008.27(4): p. 517-35; quiz 537-40. 
206. BMUS, Guidelines For The Safe Use Of Diagnostic Ultrasound 
Equipment. 2009. 
207. Nicholls, M.J., R. Dunham, S. O'Herlihy, P.J. Finan, P.M. Sagar, and 
D. Burke, Measurement of the anal cushions by transvaginal 
ultrasonography. Dis Colon Rectum, 2006. 49(9): p. 1410-3. 
208. Stewart, L.K. and S.R. Wilson, Transvaginal sonography of the anal 
sphincter: reliable, or not? AJR Am J Roentgenol, 1999. 173(1): p. 
179-85. 
209. Thekkinkattil, O.K., R.J. Dunham, S. O'Herlihy, P.J. Finan, P.M. 
Sagar, and -D.A Burke, Measurement of anal cushions in idiopathic 
faecal incontinence. Br J Surg, 2009. 96(6): p. 680-4. 
210. Zbar, A and R. Murison, Transperineal ultrasound in the assessment 
of haemorrhoids and haemorrhoidectomy: a pilot study. Techniques 
in Coloproctology, 2010.14(2): p. 175-179. 
211. Merz, E., Three-dimensional transvaginal ultrasound in gynecological 
diagnosis. Ultrasound Obstet Gynecol, 1999. 14(2): p. 81-6. 
212. Kremkau, F.W., Doppler principles. Semin Roentgenol, 1992.27(1): 
p.6-16. 
213. Rubin, J.M., Spectral Doppler US. Radiographics, 1994.14(1): p. 
139-50. 
214. Bude, R.O., J.M. Rubin, and R.S. Adler, Power versus conventional 
color Doppler sonography: comparison in the depiction of normal 
intrarenal vasculature. Radiology, 1994.192(3): p. 777-80. 
215. DiDio, L.J., C. Diaz-Franco, R. Schemainda, and AJ. Bezerra, 
Morphology of the middle rectal arteries. A study of 30 cadaveric 
dissections. Surg Radiol Anat, 1986.8(4): p. 229-36. 
243 
216. Poiseuille and W.H. Herschel, Experimental investigations upon the 
flow of liquids in tubes of very small diameter. Rheological 
memoirs1940, Easton, Pa. ix, 101 p. 
217. Ng, E.H., C.C. Chan, O.S. Tang, W.S. Yeung, and P.C. Ho, Factors 
affecting endometrial and subendometrial blood flow measured by 
three-dimensional power Doppler ultrasound during IVF treatment. 
Hum Reprod, 2006. 21(4): p. 1062-9. 
218. Raine-Fenning, N.J., B.K. Campbell, N.R. Kendall, J.S. Clewes, and 
I.R. Johnson, Endometrial and sub endometrial perfusion are impaired 
in women with unexplained subfertility. Hum Reprod, 2004. 19(11): p. 
2605-14. 
219. Jarvela, I.Y., P. Siadkevicius, A.H. Tekay, S. Campbell, and G. 
Nargund, Intraobserver and interobserver variability of ovarian 
volume, gray-scale and color flow indices obtained using transvaginal 
three-dimensional power Doppler ultrasonography. Ultrasound Obstet 
Gynecol, 2003. 21(3): p. 277-82. 
220. Merce, L.T., B. Gomez, V. Engels, S. Bau, and J.M. Bajo, 
Intraobserver and Interobserver Reproducibility of Ovarian Volume, 
Antral Follicle Count, and Vascularity Indices Obtained With 
Transvaginal 3-Dimensional Ultrasonography, Power Doppler 
Angiography, and the Virtual Organ Computer-Aided Analysis 
Imaging Program. Journal of Ultrasound in Medicine, 2005. 24(9): p. 
1279-1287. 
221. Rovas, L., P. Siadkevicius, E. Strobel, and L. Valentin, Intraobserver 
and interobserver reproducibility of three-dimensional gray-scale and 
power Doppler ultrasound examinations of the cervix in pregnant 
women. Ultrasound in Obstetrics and Gynecology, 2005. 26(2): p. 
132-137. 
222. Amso, N.N., S.R. Watermeyer, N. Pugh, S. O'Brien, and A. D'Angelo, 
Quantification of power Doppler energy and its future potential. Fertil 
Steril, 2001. 76(3): p. 583-7. 
223. Nelson, T.R., D.H. Pretorius, A. Hull, M. Riccabona, M.S. Sklansky, 
and G. James, Sources and impact of artifacts on clinical three-
244 
dimensional ultrasound imaging. Ultrasound Obstet Gynecol, 2000. 
16(4): p. 374-83. 
224. Elbanna, H.G., A.M. Abbas, K. Zalata, M. Farid, W. Ghanum, M. 
Youssef, W.M. Thabet, S. EI Awady, and M.H. EI-Sattar, Effects of 
ovarian failure on submucosal collagen and blood vessels of the anal 
canal in postmenopausal women. Int J Colorectal Dis, 2010. 25(4): p. 
477-83. 
225. Aigner, F., H. Bonatti, S. Peer, F. Conrad, H. Fritsch, R Margreiter, 
and H. Gruber, Vascular considerations for stapled 
haemorrhoidopexy. Colorectal Dis, 2009. 12: p. 452-458. 
226. Aigner, F., G. Bodner, F. Conrad, G. Mbaka, A. Kreczy, and H. 
Fritsch, The superior rectal artery and its branching pattern with 
regard to its clinical influence on ligation techniques for internal 
hemorrhoids. American Journal of Surgery, 2004.187(1): p. 102-108. 
227. Aigner, F., G. Bodner, H. Gruber, F. Conrad, H. Fritsch, R Margreiter, 
and H. BOrlatti, The vascular nature of hemorrhoids. Journal of 
gastrointestinal surgery: official journal of the Society for Surgery of 
the Alimentary Tract, 2006. 10(7): p. 1044-50. 
228. Aigner, F., H. Gruber, F. Conrad, J. Eder, T. Wedel, B. Zeiger, V. 
Engelhardt, A. Lametschwandtner, V. Wienert, U. Bohler, R 
Margreiter, and H. Fritsch, Revised morphology and hemodynamics 
of the anorectal vascular plexus: impact on the course of 
hemorrhoidal disease. Int J Colorectal Dis, 2009. 24(1): p. 105-13. 
229. Jayaraman, S., P.H.D. Colquhoun, and RA. Malthaner, Stapled 
hemorrhoidopexy is associated with a higher long-term recurrence 
rate of internal hemorrhoids compared with conventional excisional 
hemorrhoid surgery. Diseases of the Colon and Rectum, 2007. 50(9): 
p. 1297-1305. 
230. Shao, W.J., G.C. Li, Z.H. Zhang, B.L. Yang, G.D. Sun, and Y.Q. 
Chen, Systematic review and meta-analysis of randomized controlled 
trials comparing stapled haemorrhoidopexy with conventional 
haemorrhoidectomy. Br J Surg, 2008. 95(2): p. 147-60. 
245 
231. Ratto, C., A. Parello, L. Donisi, F. Litta, G. Zaccone, and G.B. 
Doglietto, Assessment of haemorrhoidal artery network using colour 
duplex imaging and clinical implications. British Journal of Surgery, 
2012.99(1): p. 112-118. 
232. Anger, H., Scintillation Camera. Rev. Sci. Instrum, 1958.29(1): p. 27. 
233. Marinelli, L.D. and B. Goldschmidt, The concentration of P32 in some 
superficial tissues of living patients. Radiology, 1942. 39: p. 454 -
463. 
234. Low-Beer, B.v.A., H.G. Bell, H.J. McCorkle, and RS. Stone, 
Measurement of radioactive phosphorus in breast tumors in situ; a 
possible diagnostic procedure. Radiology, 1946.47: p. 492 - 493. 
235. Hinkle, G.H., H. Abdel-Nabi, E.A. Miller, L.E. Schlanger, D.P. 
Houchens, M.O. Thurston, D,R Aitken, C.M. Mojzisik, J.O. Olsen, 
S.E. Tuttle, and et aI., Radioimmunodetection of implanted tumors 
with gamma probe. NCI Monogr, 1987(3): p. 83-7. 
236. Packer, S.,- Tumor detection with radiopharmaceuticals. Semin Nucl 
Med, 1984. 14(1): p. 21-30. 
237. Selverstone, B., W.H. Sweet, and C.V. Robinson, The Clinical Use of 
Radioactive Phosphorus in the Surgery of Brain Tumors. Ann Surg, 
1949. 130(4): p. 643-50. 
238. Woolfenden, J.M. and H.B. Barber, Radiation detector probes for 
tumor localization using tumor-seeking radioactive tracers. AJR Am J 
Roentgenol, 1989.153(1): p. 35-9. 
·239. Harris, C.C., RR Bigelow, J.E. Francis, G.G. Kelley, and P.R Bell, A 
Csl(TI)-CRYSTAL SURGICAL SCINTILLA TlON PROBE. Nucleonics 
(U.S.) Ceased publication; Vol: 14, 1956: p. Pages: 102 & 104-8. 
240. Woolfenden, J.M., W.S. Nevin, H.B. Barber, and D.J. Donahue, Lung 
cancer detection using a miniature sodium iodide detector and cobalt-
57 bleomycin. Chest, 1984.85(1): p. 84-8. 
241. Sasaki, Y., H.N. Wagner, Jr., M. lio, S. Murao, S. Takayanagi, and T. 
Kobayashi, Catheter Semiconductor Detector and its Application to 
Clinical and Experimental Medicine. Semiconductor Detectors in the 
Future of Nuclear Medicine., ed. P.B. Hoffer, R Beck, and A. 
246 
Gottschalk1971, New York: The Society of Nuclear Medicine. pp 144-
56. 
242. Knoll, G., Radiation detection and measurement. 2nd ed1989, New 
York: John Wiley. 
243. Pircher, F.J., B. Anderson, Sr., P.J. Cavanaugh, and K.W. Sharp, 
Experiences with a solid state detector for surface counting of 
phosphorus-32. J Nucl Med, 1967.8(6): p. 444-50. 
244. Larose, J.H., W.H. Jarrett, W.S. Hagler, J.M. Palms, and R.E. Wood, 
Medical Problems in Eye Tumor Identification. Ieee Transactions on 
Nuclear Science, 1971. NS18(1): p. 46-&. 
245. Lauber, A., Development of miniaturized solid state detectors for the 
measurement of beta and gamma radiation in superficial and deep 
parts ofliving tissue. Nuclear ~ n s t r u m e n t s s and Methods, 1972. 101 (3): 
p.545-550. 
246. Marcus, C.S. Silicon probes for physiological studies: experience, 
limitations, and perspectives. in Semiconductor detectors in medicine. 
1973. United States: U.S. Atomic Energy Commission. 
247. Garcia, D.A., G. Entine, and D.E. Tow, Detection of small bone 
abscesses with a high-resolution cadmium telluride probe. J Nucl 
Med, 1974. 15(10): p. 892-5. 
248. Lennquist, S., J. Persliden, and S. Smeds, Intraoperative scintigraphy 
in surgical treatment of thyroid carcinoma: evaluation of a new 
technique. World J""Surg, 1986.10(4): p. 711-7. 
249. Colton, C.L. and J.G. Hardy, Evaluation of a sterilizable radiation 
probe as an aid to the surgical treatment of osteoid-osteoma. 
Technical note. J Bone Joint Surg Am, 1983. 65(7): p. 1019-22. 
250. Ghelman, B., F.M. Thompson, and W.O. Arnold, Intraoperative 
radioactive localization of an osteoid-osteoma. Case report. J Bone 
Joint Surg Am, 1981.63(5): p. 826-7. 
251. Rinsky, L.A., M. Goris, E.E. Bleck, A. Halpern, and P. Hirshman, 
Intraoperative skeletal sCintigraphy for localization of osteoid-osteoma 
in the spine. Case report. J Bone Joint Surg Am, 1980.62(1): p. 143-
4. 
247 
252. Kirchner, B., A. Hillmann, G. Lottes, J. Sciuk, P. Bartenstein, W. 
Winkelmann, and O. Schober, Intraoperative, probe-guided curettage 
of osteoid osteoma. Eur J Nucl Med, 1993.20(7): p. 609-13. 
253. Perkins, A.C. and J.G. Hardy, Intra-operative nuclear medicine in 
surgical practice. Nuclear Medicine Communications, 1996.17(12): p. 
1006-15. 
254. Aslam, A., A.C. Perkins, and RD. Spicer, Peroperative (123)I-MIBG 
scan using a sterile probe for staging and resection of neuroblastoma 
in children. Journal of Pediatric Surgery, 1996.31(5): p. 719-20. 
255. Bergqvist, L., S.E. Strand, and B.R Persson, Particle sizing and 
biokinetics of interstitia"ymphoscintigraphic agents. Semin Nucl Med, 
1983.13(1): p. 9-19. 
256. Henze, E., H.R Schelbert, J.D. Collins, A. Najafi, J.R Barrio, and 
L.R Bennett, Lymphoscintigraphy with Tc-99m-labeled dextran. J 
Nucl Med, 1982.23(10): p. 923-9. 
257. Strand, S.E.-and B.R Persson, Quantitative Iymphoscintigraphy I: 
Basic concepts for optimal uptake of radiocolloids in the parasternal 
lymph nodes of rabbits. J Nucl Med, 1979.20(10): p. 1038-46. 
258. Alazraki, N.P., D. Eshima, L.A. Eshima, S.C. Herda, D.R Murray, J.P. 
Vansant, and A.T. Taylor, Lymphoscintigraphy, the sentinel node 
concept, and the intraoperative gamma probe in melanoma, breast 
cancer, and other potential cancers. Seminars in Nuclear Medicine, 
1997.27(1): p. 55-67. 
259. Evans, J.W. and A.M. Peters, Gamma camera imaging in 
malignancy. Eur J Cancer, 2002. 38(16): p. 2157-72. 
260. Sickle-Santanello, B.J., P.J. O'Dwyer, C. Mojzisik, S.E. Tuttle, G.H. 
Hinkle, M. Rousseau, J. Schlom, D. Colcher, M.O. Thurston, C. 
Nieroda, and et aI., Radioimmunoguided surgery using the 
monoclonal antibody B72.3 in colorectal tumors. Diseases of the 
Colon & Rectum, 1987.30(10): p. 761-4. 
261. Thurston, M.O., J.W. Kaehr, E.W. Martin, and E.W. Martin, 
Radionuclide of Choice for Use with an Intraoperative Probe. 
248 
Antibody Immunoconjugates and Radiopharmaceuticals, 1991. 4(4): 
p.595-601. 
262. Curtet, C., J.P. Vuillez, G. Daniel, G. Aillet, A. Chetanneau, J. Visset, 
M. Kremer, P. Thedrez, and J.F. Chatal, Feasibility study of 
radioimmunoguided surgery of colorectal carcinomas using indium-
111 CEA-specific monoclonal antibody. Eur J Nucl Med, 1990.17(6-
8): p. 299-304. 
263. Perkins, A, Peroperative nuclear medicine. Eur J Nucl Med, 1993. 
20(7): p. 573-5. 
264. Zanzonico, P. and S. Heller, The intraoperative gamma probe: basic 
principles and choices available. Semin Nucl Med, 2000. 30(1): p. 33-
48. 
265. Broadhurst, P., P. Cashman, J. Crawley, E. Raftery, and A Lahiri, 
Clinical validation of a miniature nuclear probe system for continuous 
on-line monitoring of cardiac function and ST-segment. J Nucl Med, 
1991.32(1 ):-p. 37-43. 
266. Aviado, D.M., Jr. and C.F. Schmidt, Pathogenesis of pulmonary 
edema by alloxan. Circ Res, 1957.5(2): p. 180-6. 
267. Potchen, E.J. and M.J. Welch, Radioisotopic assessment of 
extravascular albumin an an index of lymph transport. Lymphology, 
1968. 1 (2): p. 59-64. 
268. Basran, G.S., AJ. Byrne, and J.G. Hardy, A noninvasive technique 
for monitoring lung 'vascular permeability in man. Nucl Med Commun, 
1985.6(1): p. 3-10. 
269. Perkins, AC., P. Yeoman, AJ. Hindle, R.M. Vincent, M. Frier, R.J. 
Winter, and M.L. Wastie, Bedside nuclear medicine investigations in 
the intensive care unit. Nuclear Medicine Communications, 1997. 
18(3): p. 262-8. 
270. Berger, B.C., D.O. Watson, G.J. Taylor, G.B. Craddock, R.P. Martin, 
C.D. Teates, and G.A. Beller, Quantitative Thallium-201 Exercise 
Scintigraphy for Detection of Coronary Artery Disease. J Nucl Med, 
1981.22(7): p. 585-593. 
249 
271. Beller, G.A., H.H. Holzgrefe, and D.o. Watson, Intrinsic washout rates 
of thallium-201 in normal and ischemic myocardium after 
dipyridamole-induced vasodilation. Circulation, 1985. 71 (2): p. 378-
86. 
272. Thrall, J.H., J.E. Freitas, D. Swanson, W.L. Rogers, J.M. Clare, M.L. 
Brown, and B. Pitt, Clinical comparison of cardiac blood pool 
visualization with technetium-99m red blood cells labeled in vivo and 
with technetium-99m human serum albumin. Journal of Nuclear 
Medicine, 1978. 19(7): p. 796-803. 
273. Smith, T.D. and P. Richards, A Simple Kit for the Preparation of 
99mTc-Labeled Red Blood Cells. J Nucl Med, 1976.17(2): p. 126-
132. 
274. Stokely, E., R. Parkey, F. Bonte, K. Graham, M. Stone, and J. 
Willerson, Gated blood pool imaging following 99mTc stannous 
pyrophosphate imaging. Radiology, 1976.120(2): p. 433-434. 
275. Eckelman, W., P. Richards, W. Hauser, and H. Atkins, Technetium-
Labeled Red Blood Cells. J Nucl Med, 1971. 12(1): p. 22-24. 
276. Bardy, A, H. Fouye, R. Gobin, J. Beydon, G. de Tovar, C. 
Panneciere, and M. Hegesippe, Technetium-99m Labeling by Means 
of Stannous Pyrophosphate: Application to Bleomycin and Red Blood 
Cells. J Nucl Med, 1975. 16(5): p. 435-437. 
277. McRae, J., R.M. Sugar, B. Shipley, and G.R. Hook, Alterations in 
tissue distribution of 99mTc-pertechnetate in rats given stannous tin. 
J Nucl Med, 1974.15(3): p. 151-5. 
278. Chandler, W.M. and L.D. Shuck, Effects of Tin on Pertechnetate 
Distribution. J Nucl Med, 1975. 16(7): p. 690-. 
279. Pavel, D.G., M. Zimmer, and V.N. Patterson, In vivo labeling of red 
blood cells with 99mTc: a new approach to blood pool visualization. 
Journal of Nuclear Medicine, 1977. 18(3): p. 305-8. 
280. Exposures of the Public and Workers from Various Sources of 
Radiation, Effects of Atomic Radiation Report to the General 
Assembly, sources and Effects of Ionizing radiation, 2008, United 
Nations Scientific Committee 
250 
281. Wasserman, H.J., Quantification of gamma camera spatial resolution 
by means of bar phantom images. Nucl Med Commun, 1998.19(11): 
p.1089-97. 
282. Olsen, loP., T. Wilsgaard, and T. Kiserud, Transvaginal three-
dimensional ultrasound: a method of studying anal anatomy and 
function. Ultrasound in Obstetrics & Gynecology, 2011. 37(3): p. 353-
360. 
283. Halligan, S. and G. Buchanan, MR imaging of fistula-in-ano. Eur J 
Radiol, 2003. 47(2): p. 98-107. 
284. Hambye, A.S., R Vandermeiren, A Vervaet, and J. Vandevivere, 
Failure to label red blood cells adequately in daily practice using an in 
vivo method: methodological and clinical considerations.[see 
comment}. European Journal of Nuclear Medicine, 1995.22(1): p. 61-
7. 
285. Srivastava, S.C. and L.R Chervu, Radionuc/ide-Iabeled red blood 
cells: current status and future prospects. Semin Nucl Med, 1984. 
14(2): p. 68-82. 
286. Rao, S.A., J. Knobel, B.D. Collier, and AT. Isitman, Effect of Sn(lI) 
Ion Concentration and Heparin on Technetium-99m Red Blood Cell 
Labeling. J Nucl Med, 1986.27(7): p. 1202-1206. 
287. Hladik, W.B., 3rd, K.K. Nigg, and B.A Rhodes, Drug-induced 
changes in the biologic distribution of radiopharmaceuticals. Semin 
Nucl Med, 1982. 12(2): p. 184-218. 
288. Lee, H.B., J.P. Wexler, S.C. Scharf, and M.D. Blaufox, Pharmacologic 
alterations in Tc-99m binding by red blood cells: concise 
communication. J Nucl Med, 1983.24(5): p. 397-401. 
289. Gorin, AB., W.J. Weidner, RH. Oemling, and N.C. Staub, 
Noninvasive measurement of pulmonary transvascular protein flux in 
sheep. J Appl Physiol, 1978. 45(2): p. 225-33. 
290. Prichard, J.S. and G. de Lee, Proceedings: Non-invasive 
measurement of regional interstitial water spaces, capillary 
permeabiJities and solute fluxes in the lungs, using a radio-isotope 
251 
method. Bull Physiopathol Respir (Nancy), 1975. 11 (2): p. 137P-
141P. 
291. Buonocore, E., G.P. Borkowski, W. Pavlicek, and F. Ngo, NMR 
imaging of the abdomen: technical considerations. AJR Am J 
Roentgenol, 1983.141(6): p. 1171-8. 
292. Hricak, H., C. Alpers, L.E. Crooks, and P.E. Sheldon, Magnetic 
resonance imaging of the female pelvis: initial experience. AJR Am J 
Roentgenol, 1983. 141 (6): p. 1119-28. 
293. Hricak, H., RD. Williams, D.B. Spring, K.L. Moon, Jr., M.W. 
Hedgcock, RA Watson, and L.E. Crooks, Anatomy and pathology of 
the male pelvis by magnetic resonance imaging. AJR Am J 
Roentgenol, 1983.141(6): p.1101-10. 
294. Myhr, G.E., H.E. Myrvold, G. Nilsen, J.E. Thoresen, and P.A Rinck, 
Perianal fistulas: use of MR imaging for diagnosis. Radiology, 1994. 
191(2): p. 545-9. 
295. Hussain, S.M., J. Stoker, W.R Schouten, W.C. Hop, and J.S. 
Lameris, Fistula in ano: endoanal sonography versus endoanal MR 
imaging in classification. Radiology, 1996.200(2): p. 475-81. 
296. Stoker, J., S.M. Hussain, D. van Kempen, AJ. Elevelt, and J.S. 
Lameris, Endoanal coil in MR imaging of anal fistulas. AJR Am J 
Roentgenol, 1996. 166(2): p. 360-2. 
297. Beets-Tan, RG., G.L. Beets, A.G. van der Hoop, AC. Borstlap, H. 
van Boven, M.J. Rongen, C.G. Baeten, and J.M. van Engelshoven, 
High-resolution magnetic resonance imaging of the anorectal region 
without an endocoil. Abdominal Imaging, 1999. 24(6): p. 576-81; 
discussion 582-4. 
298. Beets-Tan, RG., G.L. Morren, G.L. Beets, AG. Kessels, K. el 
Naggar, E. Lemaire, C.G. Baeten, and J.M. van Engelshoven, 
Measurement of anal sphincter muscles: endoanal US, endoanal MR 
imaging, or phased-array MR imaging? A study with healthy 
volunteers. Radiology, 2001. 220(1): p. 81-9. 
299. Schafer, A, P. Enck, G. Furst, T. Kahn, T. Frieling, and H.J. Lubke, 
Anatomy of the anal sphincters. Comparison of anal endosonography 
252 
to magnetic resonance imaging. Dis Colon Rectum, 1994.37(8): p. 
777-81. 
300. Aronson, M.P., RA. Lee, and T.H. Berquist, Anatomy of anal 
sphincters and related structures in continent women studied with 
magnetic resonance imaging. Obstet Gynecol, 1990. 76(5 Pt 1): p. 
846-51. 
301. Fenner, D.E., J.S. Kriegshauser, H.H. Lee, RW. Beart, A. Weaver, 
and J.L. Comella, Anatomic and physiologic measurements of the 
internal and external anal sphincters in normal females. Obstet 
Gynecol, 1998.91(3): p. 369-74. 
302. deSouza, N.M., W.A. Kmiot, R Puni, A.S. Hall, M. Burl, C.1. Bartram, 
and G.M. Bydder, High resolution magnetic resonance imaging of the 
anal sphincter using an internal coil. Gut, 1995. 37(2): p. 284-7. 
303. Hussain, S.M., J. Stoker, A.W. Zwamborn, J.C. Den Hollander, J.W. 
Kuiper, C.A. Entius, and J.S. Lameris, Endoanal MRI of the anal 
sphincter complex: correlation with cross-sectional anatomy and 
histology. J Anat, 1996. 189 ( Pt 3): p. 677-82. 
304. Hussain, S.M., J. Stoker, and J.S. Lameris, Anal sphincter complex: 
endoanal MR imaging of normal anatomy. Radiology, 1995. 197(3): p. 
671-7. 
305. Stoker, J., E. Rociu, A.W. Zwamborn, W.R Schouten, and J.S. 
Lameris, Endoluminal MR Imaging of the Rectum and Anus: 
Technique, Applications, and Pitfalls. Radiographies, 1999. 19'(2): p. 
383-398. 
306. Stoker, J., V.E. Fa, M.J. Eijkemans, W.R Schouten, and J.S. 
Lameris, Endoanal MRI of perianal fistulas: the optimal imaging 
planes. European Radiology, 1998.8(7): p. 1212-6. 
307. de Bazelaire, C.M., G.D. Duhamel, N.M. Rofsky, and D.C. Alsop, MR 
imaging relaxation times of abdominal and pelvic tissues measured in 
vivo at 3.0 T: preliminary results. Radiology, 2004. 230(3): p. 652-9. 
308. Wansapura, J.P., S.K. Holland, RS. Dunn, and W.S. Ball, Jr., NMR 
relaxation times in the human brain at 3.0 tesla. J Magn Reson 
Imaging, 1999.9(4): p. 531-8. 
253 
309. Englund, E., A. Brun, E.M. Larsson, Z. Gyorffy-Wagner, and B. 
Persson, Tumours of the central nervous system. Proton magnetic 
resonance relaxation times T1 and T2 and histopathologic correlates. 
Acta Radiol Diagn (Stockh), 1986.27(6): p. 653-9. 
310. Just, M. and M. Thelen, Tissue characterization with T1, T2, and 
proton density values: results in 160 patients with brain tumors. 
Radiology, 1988. 169(3): p. 779-85. 
311. Kurki, T., N. Lundbom, H. Kalimo, and S. Valtonen, MR classification 
of brain gliomas: value of magnetization transfer and conventional 
imaging. Magn Reson Imaging, 1995.13(4): p. 501-11. 
312. Jain, RK., D.G. Duda, C.G. Willett, D.v. Sahani, A.X. Zhu, J.S. 
Loeffler, T.T. Batchelor, and A.G. Sorensen, Biomarkers of response 
and resistance to antiangiogenic therapy. Nat Rev Clin Oncol, 2009. 
6(6): p. 327-338. 
313. Jackson, A., J.P. O'Connor, G.J. Parker, and G.C. Jayson, Imaging 
tumor vascOlar heterogeneity and angiogenesis using dynamic 
contrast-enhanced magnetic resonance imaging. Clin Cancer Res, 
2007. 13(12): p. 3449-59. 
314. O'Connor, J.P., A. Jackson, G.J. Parker, and G.C. Jayson, DCE-MRI 
biomarkers in the clinical evaluation of antiangiogenic and vascular 
disrupting agents. Br J Cancer, 2007. 96(2): p. 189-95. 
315. Muller-Schimpfle, M., G. Brix, G. Layer, P. Schlag, R Engenhart, S. 
Frohmuller, T. Hess, I. Zuna, W. Semmler, and G. van Kaick, 
Recurrent rectal cancer: diagnosis with dynamic MR imaging. 
Radiology, 1993. 189(3): p. 881-9. 
316. Evelhoch, J.L., Key factors in the acquisition of contrast kinetic data 
for oncology. J Magn Reson Imaging, 1999. 10(3): p. 254-9. 
317. Taylor, J.S., P.S. Tofts, R Port, J.L. Evelhoch, M. Knopp, W.E. 
Reddick, V.M. Runge, and N. Mayr, MR imaging of tumor 
microcirculation: promise for the new millennium. J Magn Reson 
Imaging, 1999. 10(6): p. 903-7. 
318. Tofts, P.S., Modeling tracer kinetics in dynamic Gd-DTPA MR 
imaging. J Magn Reson Imaging, 1997.7(1): p. 91-101. 
254 
319. Torricelli, P., A. Pecchi, G. Luppi, and R Romagnoli, Gadolinium-
enhanced MRI with dynamic evaluation in diagnosing the local 
recurrence of rectal cancer. Abdom Imaging, 2003. 28(1): p. 19-27. 
320. Buadu, L.D., J. Murakami, S. Murayama, N. Hashiguchi, S. Sakai, K. 
Masuda, S. Toyoshima, S. Kuroki, and S. Ohno, Breast lesions: 
correlation of contrast medium enhancement patterns on MR images 
with histopathologic findings and tumor angiogenesis. Radiology, 
1996. 200(3): p. 639-49. 
321. Stoker, J., S. Halligan, and C.1. Bartram, Pelvic floor imaging. 
Radiology, 2001. 218(3): p. 621-41. 
322. Terra, M.P., RG. Beets-Tan, V.P. van der Hulst, M. Deutekom, M.G. 
Dijkgraaf, P.M. Bossuyt, A.C. Dobben, C.G. Baeten, and J. Stoker, 
MRI in evaluating atrophy of the external anal sphincter in patients 
with fecal incontinence. AJR Am J Roentgenol, 2006. 187(4): p. 991-
9. 
323. Terra, M.P., H.G. Beets-Tan, V.P. van Der Hulst, M.G. Dijkgraaf, P.M. 
Bossuyt, A.C. Dobben, C.G. Baeten, and J. Stoker, Anal sphincter 
defects in patients with fecal incontinence: endoanal versus external 
phased-array MR imaging. Radiology, 2005. 236(3): p. 886-95. 
324. Terra, M.P., RG. Beets-Tan, I. Vervoorn, M. Deutekom, M.N. 
Wasser, T.D. Witkamp, A.C. Dobben, C.G. Baeten, P.M. Bossuyt, 
and J. Stoker, Pelvic floor muscle lesions at endoanal MR imaging in 
female patients with faecal incontinence. European Radiology, 2008. 
18(9): p. 1892-901. 
325. Bottomley, P.A., T.H. Foster, RE. Argersinger, and L.M. Pfeifer, A 
review of normal tissue hydrogen NMR relaxation times and 
relaxation mechanisms from 1-100 MHz: dependence on tissue type, 
NMR frequency, temperature, species, excision, and age. Med Phys, 
1984. 11(4): p. 425-48. 
326. Merkle, E.M. and B.M. Dale, Abdominal MRI at 3.0 T: The Basics 
Revisited. American Journal of Roentgenology, 2006. 186(6): p. 
1524-1532. 
255 
327. Markus, J., B. Morrissey, C. deGara, and G. Tarulli, MRI of recurrent 
rectosigmoid carcinoma. Abdominal Imaging, 1997.22(3): p. 338-
342. 
328. Krestin, G.P., Is magnetic resonance imaging the method of choice in 
the diagnosis of recurrent rectal carcinoma? Abdominal Imaging, 
1997.22(3): p. 343-345. 
329. Roberts, C., B. Issa, A. Stone, A. Jackson, J.C. Waterton, and G.J. 
Parker, Comparative study into the robustness of compartmental 
modeling and model-free analysis in DCE-MRI studies. J Magn 
Reson Imaging, 2006. 23(4): p. 554-63. 
330. Biomarkers, d.w.g., Biomarkers and surrogate endpoints: preferred 
defintions and conceptual framework. Clin Pharmacol Ther, 2001. 69: 
p.89-95. 
331. Goligher, J.C., A.G. Leacock, and J.J. Brossy, The surgical anatomy 
of the anal canal. Br J Surg, 1955. 43(177): p. 51-61. 
332. Fitzpatrick R: B.A., Gibbons E, Haywood K, Jenkinson C, Aackintosh 
A, Peters M., A Structured Review of Patient-Reported Measures in 
Relation to Selected Chronic Conditions, Perceptions of Quality of 
Care and Carer Impact., 2006: Oxford: National Centre for Health 
Outcomes Development. 
333. Harris, L.M., J. Robinson, and RG. Menzies, Evidence for fear of 
restriction and fear of suffocation as components of claustrophobia. 
Behav Res Ther, 1999.37(2): p. 155-9. 
334. Mcisaac, H.K., D.S. Thordarson, R Shafran, S. Rachman, and G. 
Poole, Claustrophobia and the magnetic resonance imaging 
procedure. J Behav Med, 1998. 21 (3): p. 255-68. 
335. Jackson, C. and E. Robertson, Etiologic aspects of hemorrhoidal 
disease. Diseases of the Colon & Rectum, 1965.8(3): p. 185-189. 
336. Jacobs, D.M., M.P. Bubrick, G.R Onstad, and C.R Hitchcock, The 
relationship of hemorrhoids to portal hypertension. Dis Colon Rectum, 
1980.23(8): p. 567-9. 
337. Thomson, W.H., The nature and cause of haemorrhoids. Proc R Soc 
Med, 1975.68(9): p. 574-5. 
256 
8 APPENDIX 
B.1 HAEMORRHOID PROM 
Study number 
QUEEN'S MEDICAL CENTRE UNIVERSITY HOSPITAL NHS TRUST 
Today's Date: 
Section I 
Please answer the following questions by ticking the boxes or writing your answers in the 
space provided: 
I. Arc you Male D or .'emale D ? 
2. How old are you? ___ years 
3. How long have you had piles (haemorrhoids),! __ years or months 
or weeks 
4. Are you using any painkillers for your piles ego paracetamol. ibuprofen" 
Yes D 
5. If you answered Yes to Question 4 please write the name and dose of medicine. 
6. Are 'you using any ointment or suppositories for your piles ego Anusol. Anugesic, 
Anacal, Preparation H ? 
Yes D 
7. If you answered Yes to Question 6 please write the name and dose of medicine. 
8. What made you see your GP about your piles? 
Figure 8-1 Section 1 of Haemorrhoid Symptom Index-1 
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This will help us determine if any improvement has occurred after treating your 
piles. 
Please tick the box you feel most appropriate. 
I A) How often do you get pain or discomfort on opening your bowels') 
-I Never 
-1 Less than once a month 
-1 At least once a month, but less than once a week 
-1 At least once a week, but less than once a day 
-1 With each motion 
I B) If you do get pain or discomfort on opening your bowels, how much does this 
affect your life? 
1 Not at all 
Slightly 
l Moderately 
l Quite a bit 
1 A greardeal 
2A) How often do you get bleeding on opening your bowels? 
l Never 
"l Less than once a month 
l At least once a month, but less than once a week 
I At least once a week. but less than once a day 
I With each motion 
2B) If you do get bleeding on opening your bowels, how much does this affect your 
life? 
-l Not at all 
l Slightly 
l Moderately 
l Quite a bit 
l A great deal 
Figure 8-2 Selected page from section 2 of Haemorrhoid Symptom Index-1 
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Queen's Medical Centre Nottingham "'/:b1 
University Hospital NHS Trust 
HAEMORRHOID (PILES) SYMPTOM 
QUESTIONNAIRE 
STUDY NO: 
DATE OF COMPLETION: 
(PLEASE FILL IN ON DATE SPECIFIED, OR IF BLANK THE DAY THAT YOU 
COMPLETED THE QUESTIONNAIRE) 
Please complete all three sections of the questionnaire. 
If you have any difficulty completing the questionnaire, please contact us. 
Dr Caron Parsons 
Department of Surgery 
E Floor West Block 
University Hospital 
Nottingham 
NG72UH 
01158231144 
Email: c ~ r o _ n . p _ a r s o n s @ n Q t t i n g t l ~ m . ~ c . u k k
Mr E F Cantle, Chairman Mr J A MacDonald, Chief Executive 
Queen's Medical Centre, Notlinghem, University Hospital NHS Trust, Notllngham NG7 2UH 
Version 1,6 
19th August 2005 
Figure 8·3 Haemorrhoid PROM Front Cover Page 
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1. Are you? 
2. How old are you? 
I-I 
""':Male c:; Female 
............................ Years 
VERSION 1.6 
19'" AUGUST 2005 
3. What is your current occupation? If you are retired, please state your 
occupation prior to retirement? 
4. How long have you had piles (haemorrhoids)? 
........... Years OR ............ Months 
Section 2: About Your Health 
1. Do you have any serious medical problems, including other bowel 
problems? 
c:; No 
If YES, please give details. 
II 
'-' Yes 
2. Are you currently taking any prescribed medication? 
c:; No elYes 
If YES, please give names of the medicines. 
Figure 8-4 Haemorrhoid PROM section 2 continued 
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3. In the last month, have you used any ointment or suppositories for 
your piles e.g. anusol, anugesic, anacal, preparation H etc? 
" 
-I , 
-No -.-: Yes If YES, how often per week? 
,-, 1--'"1 ,-, 
'I 
- 0 days -1 day - 2 days - 3 days 
" c: 5 days ,--, " -4 days -6 days -7 days 
4. In the last month, have you used any painkillers for your piles e.g. 
paracetamol, ibuprofen? 
" 
-No C;Yes If YES, how. often per week? 
II ,-, CJ 2 days " -0 days -1 day -.-: 3 days 
,-, ,-, ,-, 
" -.-: 4 days 
- 5 days -6 days -7 days 
5. Have you had any previous treatment for your piles before today? 
,-, 
Ii 
Q 
II 
II 
No. 
Yes, rubber bands in clinic. 
Yes, injections in clinic. 
Yes, surgery under an anaesthetic. 
Yes, other 
6. Do you have any relatives with piles? 
C:No QYes 
If YES, how badly were they affected? 
Q Not at all Ii -.-: Slightly Ii 
- Moderately 
Q Quite a bit CJ A great deal 
Figure 8-5 Haemorrhoid PROM sections 1 and 2 
In .............. . 
In .............. . 
In .............. . 
In .............. . 
VERS'ON 1.6 
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VERSION 1.6 
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Section 3: Your Symptoms Now 
• This study is investigating the symptoms of piles. 
• Please answer the following questions about your symptoms OVER THE 
LAST MONTH. 
• Please tick the box that best applies to you. If you are not sure, please make 
a best guess. 
1. Do you get pain or discomfort on opening your bowels? 
~ N o o C'Yes 
If YES, how often in a TYPICAL week? 
II 
- 0 days :=! 1 day ,-, - 2 days " --: 3 days 
CJ4 days II -7 days 
2. Do you get pain or discomfort around the anus without opening your 
bowels? 
C'No 
,-, 
-Yes 
If YES, how often in a TYPICAL week? 
n 
- 0 days II -1 day CJ 2 days 
'-I 
-4 days 
I, 
~ ~ 5 days 
" 
-6 days 
C' 3 days 
CJ 7 days 
3. Do you get bleeding on opening your bowels? 
CJNo DYes 
if YES, how often in a TYPICAL week? 
CJ 0 days I, -' 1 day 
!I 
'-' 4 days II -' 5 days 
n 
--: 2 days 
II 
-6days 
Figure 8-6 Haemorrhoid PROM section 3 
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....., 3 days 
CJ 7 days 
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4, Do you get lumps (piles) around the anus, on straining to open your 
bowels? 
If YES, how often in a TYPICAL week? 
,-, 
- 0 days 
,-, 
~ 2 2 days " -·3 days 
II 
-4 days 1-' - 5 days 
1-' 
- 6 days 
II 
-7 days 
5, Do you experience itch or irritation around the anus? 
It I-I 
-No -Yes 
If YES, how often in a TYPICAL week? 
I-, 
- 0 days 1-' -1 day 
,-, 
- 2 days 
II 
~ 3 3 days 
'I 
-4 days 
I-, 
- 6 days 
6, Do you experi8llce any mucus or slime discharge from the anus? 
~ N o o ~ Y e s s
If YES, how often in a TYPICAL week? 
" - 0 days 
,-, 
~ 2 2 days ~ ~ 3 days 
" -4 days 
,-, 
-5 days CJ 6 days II '-' 7 days 
7. Do you experience soiling of your underclothes? 
c:J No c:J Yes 
If YES, how often in a TYPICAL week? 
00 days c:J 2 days II -1 day ,I -3 days 
CJ4 days 
I) 
- 5 days c:J 6 days II -7 days 
Figure 8·7 Haemorrhoid PROM section 3 continued 
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VERSION 1.6 
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8. Do you experience the feeling of incomplete emptying after opening 
your bowels? 
=i No 
If YES. how often in a TYPICAL week? 
,-, 
- 0 days 
,-, 
-1 day cr 2 days II - 3 days 
I' 
-4 days ::; 5 days 
,-, 
-6 days 
,-, 
-7 days 
9. How much does the pain and discomfort affect the quality of your life? 
Please make a MARK on the line below. 
0= NO AFFECT WHATSOEVER 
10 = COMPETELY DOMINATES YOUR LIFE 
o 10 
10. How much do the other symptoms from your piles affect the quality of 
your life? 
Please make a MARK on the line below. 
0= NO AFFECT WHATSOEVER 
10 = COMPETELY DOMINATES YOUR LIFE 
o 10 
Please check that you have completed all the questions. 
Thank you very much for completing the questionnaire. 
Figure 8·8 Haemorrhoid PROM section 3 continued 
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Occupation Category 
Managers 8.7% 
Professionals 20.0% 
-
Technicians & associate professionals 14.8% 
Clerical support workers 2.6% 
Service & sales workers 11.3% 
Skilled agricultural, forestry & fishery workers 1.7% 
Crafts & related trades workers 9.6% 
Plant & machinery operators & assemblers 7.8% 
Elementary occupations 5.2% 
Retired/ housewife/ single parenU student 18.3% 
- . .. . Table 8-1 Occupation demographiCS of the 115 participants In the 
haemorrhoid PROM. 
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Category Number of patients (%) 
-
1. Infections 0 
2. Neoplasms 2 (1.74) 
3. Blood & blood forming organs 2 (1.74) 
4. Endocrine, nutritional & metabolic 6 (5.22) 
5. Mental & behavioural 5 (4.35) 
6. Nervous system 
.0 
7. Eye 2 (1.74) 
B. Ear 
- 0 
9. Circulatory system 20 (17.40) 
10. Respiratory 3 (2.61) 
11. Digestive 21 (1B.26) 
12. Skin & subcutaneous tissue 0 
13. Musculoskeletal. 
.. 
3 (2.61) 
14. Genitourinary 1 (0.B7) 
.. .. Table 8·2 Summary of medical conditions declared by participants 
completing the haemorrhoid PROM in phase II 
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Figure 8-9 Medication use of patients in phase II. 
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8.2 THREE-DIMENSIONAL UL TRASOUND AND POWER 
DOPPLER 
-VASCULAR INDEX DESCRIPTION 
Vascularisation Index (VI) Colour values 
Total voxels - background values 
Flow Index (FI) 
Vascularisation Flow Index (VFI) 
Weighted colour values 
Colour values 
Weighted colour values 
Total voxels - background values 
Table 8·3 Explanation of calculation of the vascular indices in VOCAL 
g = grey-scale value in ultrasound image normalised to 0 - 100 
Low Intensity = 1, High Intensity = 100 
hg(x) = frequency of grey value x in ultrasound image 
c = colour value in ultrasound image normalised to 0 - 100 
Low Intensity = 1, High Intensity = 100 
hg(c) = frequency of colour value x in ultrasound image 
MG - r1';°1 g.hg(g) 
- 100 
L9=1 hg(g) 
VI = r ~ ~ ~ ~ hc(c) 
r1';°1 hg(g)+ L ~ ~ ~ ~ hc(c) 
FI - r ~ ~ ~ ~ c.hc(c) 
- 100 L C=1 hc(c) 
VFI = r ~ ~ ~ ~ c.hc(c) 
r1';°1 hg(g)+ L ~ ~ ~ ~ hc(c) 
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8.3 MAGNETIC RESONACE IMAGING 
...., The University of Jt Nottingham Sir Peter Mansfield Magnetic Resonance Centre and the Brain&. Body Centre 
Safety Screening Questionnaire 
For ANYONE entering the INNER CONTROLLED AREA marked by red and white tape on the 
doors (Magnetic field safety information is available in the SPMMRC website) 
» Shaded boxes to be filled in by scan volunteers and patients only « 
NAME Date of Visit I Phone Number 
ADDRESS Volunteer Number 
Date of Birth 
Study Ethics Code (or reason for visit) Hospital No (if applicable) 
Weight (Philips scanners only) 
MR scanning uses strong magnetic fields, for your own safety and the safety of others it is very 
important that you do not go into the magnet halls with any metal in or on your body or clothing. 
Please answer the following questions carefully and ask if anything is not clear. 
All information is held in the strictest confidence. 
1. Do you have any implants in your body? e.g. replacement joints, drug pumps 
2. Do you have aneurysm clips (clips put around blood vessels during surgery)? 
YIN 
YIN 
3. Do you have a pacemaker or artificial heart valve? (These stop working near MR Scanners) YIN 
4. Have you ever had any surgery? Please give brief details* YIN 
(*We do not need to know about uncomplicated caesarian delivery, vasectomy or termination of pregnancy) 
5. Do you have any foreign bodies in your body (e.g. shrapnel)? YIN 
6. Have you ever worked in a machine tool shop without eye protection? YIN 
7. Do you wear a hearing aid or cochlear implant? YIN 
8. Could you be pregnant? You must use the pregnancy tests available in the female toilets 
If you are unsure. YIN 
9. Have you ever suffered from tinnitus? YIN 
10. Do you wear dentures, a dental plate or a brace? YIN 
11. Are you susceptible to claustrophobia? YIN 
12. 06 you suffer from blackouts, epilepsy or fits? YIN 
13. Do you have any trans-dermal patches (skin patches)? YIN 
14. Do you have any tattoos? YIN 
15. Will you remove all metal including coins, body-piercing jewellery, false-teeth, hearing aids 
etc before entering the magnet haiL? (lockers available by the changing rooms) YIN 
16. Is there anything else you think we should know? YIN 
I have read, understood, and answered all questions 
Signature: Date: 
Verified by: 
SPMMRC/BBtBC Staff Signature: Date: 
Figure 8-10 Safety screening form completed by all patients and healthy 
volunteers at the Sir Peter Mansfield MagnetiC Resonance Centre. 
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